characterization and application of monoclonal antibody

140
Louisiana State University LSU Digital Commons LSU Historical Dissertations and eses Graduate School 1988 Characterization and Application of Monoclonal Antibody and Bovine Neutrophil Reactivity to Pasteurella Haemolytica Antigens. Frank William Austin Louisiana State University and Agricultural & Mechanical College Follow this and additional works at: hps://digitalcommons.lsu.edu/gradschool_disstheses is Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Historical Dissertations and eses by an authorized administrator of LSU Digital Commons. For more information, please contact [email protected]. Recommended Citation Austin, Frank William, "Characterization and Application of Monoclonal Antibody and Bovine Neutrophil Reactivity to Pasteurella Haemolytica Antigens." (1988). LSU Historical Dissertations and eses. 4556. hps://digitalcommons.lsu.edu/gradschool_disstheses/4556

Upload: others

Post on 20-Jan-2022

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Characterization and Application of Monoclonal Antibody

Louisiana State UniversityLSU Digital Commons

LSU Historical Dissertations and Theses Graduate School

1988

Characterization and Application of MonoclonalAntibody and Bovine Neutrophil Reactivity toPasteurella Haemolytica Antigens.Frank William AustinLouisiana State University and Agricultural & Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion inLSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please [email protected].

Recommended CitationAustin, Frank William, "Characterization and Application of Monoclonal Antibody and Bovine Neutrophil Reactivity to PasteurellaHaemolytica Antigens." (1988). LSU Historical Dissertations and Theses. 4556.https://digitalcommons.lsu.edu/gradschool_disstheses/4556

Page 2: Characterization and Application of Monoclonal Antibody

INFORMATION TO USERS

The most advanced technology has been used to photo­graph and reproduce this manuscript from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer.

The quality of th is reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction.

In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright m aterial had to be removed, a note will indicate the deletion.

Oversize materials (e.g., maps, drawings, charts) are re­produced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book. These are also available as one exposure on a standard 35mm slide or as a 17" x 23" black and w hite photographic p rin t for an additional charge.

Photographs included in the original m anuscript have been reproduced xerographically in this copy. H igher quality 6" x 9" black and white photographic prin ts are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order.

University Microfilms International A Bell & Howell Information Company

300 North Zeeb Road, Ann Arbor, Ml 48106-1346 USA 313/761-4700 800/521-0600

Page 3: Characterization and Application of Monoclonal Antibody
Page 4: Characterization and Application of Monoclonal Antibody

O rder N um ber 8904525

C haracterization and application o f m onoclonal antibody and bovine neutrophil reactiv ity to Pasteurella haemolytica antigens

Austin, Frank William, Ph.D.

The Louisiana State University and Agricultural and Mechanical Col., 1988

U M I300 N. Zeeb Rd.Ann Arbor, MI 48106

Page 5: Characterization and Application of Monoclonal Antibody
Page 6: Characterization and Application of Monoclonal Antibody

CHARACTERIZATION AND APPLICATION OF MONOCLONAL ANTIBODY AND BOVINE NEUTROPHIL REACTIVITY TO

PASTEURELLA HAEMOLYTICA ANTIGENS

A D i s s e r t a t i o n

Submi t t ed t o t h e Gradua te F a c u l t y o f t h e Lo u i s i a n a S t a t e U n i v e r s i t y and

A g r i c u l t u r a l and Mechanical Co l l ege in p a r t i a l f u l f i l l m e n t o f t h e

r e q u i r e m e n t s f o r t h e de g r e e o f Doctor o f Ph i l o s ophy

in t h e

V e t e r i n a r y Mi c r ob i o l ogy and P a r a s i t o l o g y Opt ion o f

The I n t e r d e p a r t m e n t a l Program in

V e t e r i n a r y Medical Sc i e nces

byFrank Wi l l i am A u s t i n

B . S . , Oklahoma S t a t e U n i v e r s i t y , 1979D.V.M. , Oklahoma S t a t e U n i v e r s i t y , 1983

August 1988

Page 7: Characterization and Application of Monoclonal Antibody

ACKNOWLEDGEMENTS

I am s i n c e r e l y g r a t e f u l t o t h e peop l e who have p a r t i c i p a t e d in my

e d u c a t i o n as a v e t e r i n a r y m i c r o b i o l o g i s t a t Lo u i s i an a S t a t e U n i v e r s i t y .

They no t on l y p r ov i d e d t h e o p p o r t u n i t i e s f o r academic g rowt h , b u t a l s o

c o n t r i b u t e d t o my growth as a human b e i ng . Dr. Richard E. C o r s t v e t , my

major p r o f e s s o r , s u p p l i e d s u p p o r t , g u i d a n c e , and f reedom which

s t i m u l a t e d p r o f e s s i o n a l and p e r s o n a l deve l opment . I d e e p l y a p p r e c i a t e

h i s t h o u g h t f u l s u g g e s t i o n s and a c t i o n s . I am a l s o t h a n k f u l t o t h e

f a c u l t y members who have s e r v e d on my g r a d u a t e a d v i s o r y commi t t ee ,

D r . s J . Turk , F. Lozano A . , F.M. E n r i g h t , G.F. Amborski , K.L. S ch no r r ,

M. Newman, and H.U. Cox.

I t hank t h e U n i v e r s i t y , t h e School o f V e t e r i n a r y Med i c i ne ,

Depar tment o f V e t e r i n a r y Mi c r ob i o l ogy and P a r a s i t o l o g y , and Depar tment

o f V e t e r i n a r y P a t ho l ogy f o r t h e p r i v i l e g e o f a l l ow i n g me t o e a r n t h i s

d eg r e e . I wi sh t o thank t h e r e s e a r c h a s s o c i a t e s whose t e c h n i c a l

a s s i s t a n c e and p r a c t i c a l working knowledge he l ped t u r n i d e a s i n t o

r e s u l t s . S pe c i a l t ha nks go t o D. Nobles , A. Smi th , and L. S h a f f e r f o r

t h e i r e n d e v o r s . M. Br ous sa r d and H. Cowgil l d e s e r ve r e c o g n i t i o n f o r

t h e i r e x p e r t i s e i n g r a p h i c a r t and medical pho t og r aphy . I am i n de b t e d

t o S. Whi t l ey f o r t y p i n g t h i s m a n u s c r i p t . Many thanks t o t h e g r a d u a t e

s t u d e n t s who gave s u p p o r t , a d v i c e and f r i e n d s h i p on an u n c o n d i t i o n a l

b a s i s . I hope t o r e f l e c t t h e knowledge, f r i e n d s h i p and love

e n c o u n t e r e d d u r i n g t h i s t r a i n i n g .

Page 8: Characterization and Application of Monoclonal Antibody

TABLE OF CONTENTSPage

TITLE PAGE............................................................................................................................ i

ACKNOWLEDGEMENTS ............................................................................................................. i i

TABLE OF CONTENTS.................................................................................................................. i i i

LIST OF TABLES...................................................................................................................... v

LIST OF FIGURES.................................................................................................................. vi

ABSTRACT..................................................................................................................................... v i i i

CHAPTER I . Development and C h a r a c t e r i z a t i o n o f MonoclonalA n t i b o d i e s A g a i n s t P a s t e u r e l l a ha e mol y t i ca S e r o t ype 1 . . . 1

A. Summary............................................................................................................... 1B. I n t r o d u c t i o n .............. ...................................................................................... 1C. M a t e r i a l s and Methods .............................................................................. 3D. R e s u l t s ............................................................................................................... 8E. D i s c u s s i o n ............................................................................................................15F. B i b l i o g r a p h y .......................................................................................................19

CHAPTER I I . Bovine N e u t r op h i l Response t o P a s t e u r e l l aha e mol y t i ca A n t i g e n s : Measurement o f Cy t o t ox i n A c t i v i t yin a C o l o r i m e t r i c A s s a y .......................................................................................23

A. Summary.....................................................................................................................23B. I n t r o d u c t i o n .......................................................................................................24C. M a t e r i a l s and Methods ................................................................................... 26D. R e s u l t s .....................................................................................................................31E. D i s c u s s i o n ........................................................................................................... 46F. B i b l i o g r a p h y .......................................................................................................50

CHAPTER I I I . C h a r a c t e r i z a t i o n o f a N e u t r a l i z i n g Monoclonal Ant ibody P r e pa r e d A g a i n s t P a s t e u r e l l a h a e mol y t i ca S e r o t y p e 1 C y t o t o x i n .................................................................................................53

A. Summary.....................................................................................................................53B. I n t r o d u c t i o n .......................................................................................................54C. M a t e r i a l s and Methods ...................................................................................56D. R e s u l t s .....................................................................................................................59E. D i s c u s s i o n ........................................................................................................... 65F. B i b l i o g r a p h y ...................................................................................................... 68

CHAPTER IV. S t r u c t u r a l Changes in Bovine N e u t r o p h i l s Exposed t o P a s t e u r e l l a ha e mol y t i ca S e r o t y p e 1 C y t o t o x i n ........................................................................................................................ 70

A. Summary.....................................................................................................................70B. I n t r o d u c t i o n .......................................................................................................70C. M a t e r i a l s and Methods ...................................................................................72

i i i

Page 9: Characterization and Application of Monoclonal Antibody

PAGE

D. R e s u l t s ......................... 74E. D i s c u s s i o n ...................................................................................................... 88F. B i b l i o g r a p h y ................................................................................................. 91

CHAPTER V. P u r i f i c a t i o n o f t h e S e r o t y p e 1 S p e c i f i c Ep i t ope From P a s t e u r e l l a h a e m o l y t i c a u s i n g Monoclonal Ant ibody I mm u n o a f f i n i t y ......................................................................................................... 96

A. Summary............................................................................................................... 96B. I n t r o d u c t i o n ................................................................................................. 97C. M a t e r i a l s and Methods ............................................................................. 99D. R e s u l t s .....................................................................................................................101E. D i s c u s s i o n ........................................................................................................... I l lF. B i b l i o g r a p h y .......................................................................................................116

CHAPTER VI. Conc l us i ons and Fu t u r e P e r s p e c t i v e s ................................... 120

VITAE................................................................................................................................................ 123

iv

Page 10: Characterization and Application of Monoclonal Antibody

L IS T OF TABLES

TABLE PAGE

1.1 D e t e r m i n a t i on o f Monoclonal Ant ibody I s o t y p e .......................... 9

1 . 2 R e a c t i v i t y o f Monoclonal A n t i b o d i e s w i t h£ . Haemolyt i ca Whole Cel l S e r o t y p e s ......................................................10

1 . 3 R e a c t i v i t y o f Monoclonal A n t i b o d i e s w i t hP. mu l t o c i d a Whole Cel l S e r o t y p e s ...........................................................11

1 . 4 R e a c t i v i t y o f Monoclonal A n t i b o d i e s w i t hFormal in o r Pa r a f o r ma l dehyde T r e a t e dP. h a e m o l y t i ca Whole C e l l s o r Ca p s u l a rM a t e r i a l ....................................................................................................................12

1 . 5 C h a r a c t e r i z a t i o n o f Monoclonal A n t i b o d i e sP r e pa r e d A g a i n s t P. h a e mo l y t i ca S e r o t y p e 1 ............................. 14

I I . 1 E v a l u a t i o n o f MTT Formazan S o l v e n t s .............................................32

1 1 . 2 C y t o t o x c i t y o f t h e Cy t o t ox i n P r e p a r a t i o n s ......................................... 38

1 1 . 3 Chemical and Immunologic C h a r a c t e r i z a t i o n o ft h e Cy t o t ox i n P r e p a r a t i o n s ................................................................... 45

I I I . l Ant ibody S o l u t i o n s Capable o f Cy t o t ox i nN e u t r a l i z a t i o n in t h e MTT C o l o r i m e t r i c Assay ........................ 61

V . l R e t e n t i o n o f Ant ibody A c t i v i t y and P r o t e i nC o n c e n t r a t i o n o f P u r i f i e d MonoclonalA n t i b o d y ................................................................................................................. 102

V.2 C h a r a c t e r i z a t i o n o f S a l i n e E x t r a c t a b l e Ca p s u l a rM a t e r i a l from P. h a e m o l y t i ca S e r o t y pe 1 ...................................... 103

V.3 S e l e c t i o n o f an Opt imal E l u a n t f o r I mmunoa f f i n i t yBased on D i s s o c i a t i o n o f B a c t e r i a l A g g l u t i n a t i o n . . . . 104

V.4 Monoclonal Ant ibody Coupl ing E f f i c i e n c y t o CNBrA c t i v a t e d Sepharose 4B ............................................................................ 105

V.5 Chemical D e t e r m i n a t i o n o f I mmunoaf f i n i t yAnt igen S e p a r a t i o n ...................................................................................... 109

V.6 A n a l y s i s o f t h e I mmunoa f f i n i t y Pr oduc t ....................................... 110

v

Page 11: Characterization and Application of Monoclonal Antibody

L IS T OF FIGURES

FIGURE PAGE

1 1 . 1 I n t r a c e l l u l a r a g g r e g a t e s and e x t r a c e l l u l a r c r y s t a l so f MTT formazan produced by bovine n e u t r o p h i l s ..............................33

1 1 . 2 N o n l i n e a r i t y o f abs o r ba nc e v e r s e s n e u t r o p h i l number a t v a r i o u s t ime i n t e r v a l s in t h e MTTc o l o r i m e t r i c a s s a y ................................................................................................ 34

1 1 . 3 L i n e a r r e l a t i o n s h i p between a b s o r ba n c e and MTT i n c u b a t i o n t ime a t d i f f e r e n t n e u t r o p h i l numbersp e r wel 1 ........................................................................................................................35

1 1 . 4 E f f e c t o f methanol f i x e d n e u t r o p h i l s mixed wi t hnormal n e u t r o p h i l s in t h e MTT c o l o r i m e t r i c a s s a y .........................36

1 1 . 5 Dose r e s po n s e o f bov ine n e u t r o p h i l s exposed t o t h ep r e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n in t h e MTT c o l o r i m e t r i c a s s a y ................................................................................................ 37

1 1 . 6 Sigmoidal dose r e s po n s e o f bov ine n e u t r o p h i l s exposed t o t h e 15:1 c o n c e n t r a t e d c y t o t o x i np r e p a r a t i o n in t h e MTT c o l o r i m e t r i c a s s a y .................................. 39

1 1 . 7 Dose r e s po n s e o f bov ine n e u t r o p h i l s t o c y t o t o x i nu l t r a f i l t r a t e in t h e MTT c o l o r i m e t r i c a s s a y ............................. 40

1 1 . 8 Dose r e s po n s e o f n e u t r o p h i l s exposed t o 15:1c o n c e n t r a t e d c y t o t o x i n i n a c t i v a t e d wi t h mi ld h e a t . . . . 42

1 1 . 9 Dose r e s po n s e o f n e u t r o p h i l s t o b o i l e d andc l a r i f i e d 15:1 c o n c e n t r a t e d c y t o t o x i n ........................................... 43

111.1 Cy t o t ox i n a c t i v i t y p r e s e n t in t h e 15:1 c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n u s i n g t heMTT c o l o r i m e t r i c a s s a y .......................................................................................59

1 1 1 . 2 Cy to t o x i n n e u t r a l i z a t i o n by monoclonal a n t i b o d i e sin t h e MTT c o l o r i m e t r i c a s s a y ....................................................................63

1 1 1 . 3 E x t e n t o f c y t o t o x i n n e u t r a l i z a t i o n by t h e nMcAbin a s c i t i c f l u i d compared t o o t h e r n o n - n e u t r a l i z i n g a s c i t i c f l u i d s in t h e MTT c o l o r i m e t r i c a s s a y ....................... . 64

I V . 1 T r an s m i s s i o n e l e c t r o n mi c rograph o f a normal bovinen e u t r o p h i l ................................................................................................................... 76

I V . 2 E l e c t r o n mi c r ogr aph o f a bov ine n e u t r o p h i l exposedt o c y t o t o x i n ( 1 : 8 d i l u t i o n ) f o r 5 m i n u t e s ....................................... 77

vi

Page 12: Characterization and Application of Monoclonal Antibody

FIGURE PAGE

I V . 3 A l t e r a t i o n o f bov ine n e u t r o p h i l g r a n u l e i n t e g r i t yo c c u r i n g a t 5 mi nu t e s c y t o t o x i n ( 1 : 8 d i l u t i o n ) e x p o s u r e ........................................................................................................................78

IV. 4 Bovine n e u t r o p h i l w i t h 2 l a r g e uropods t y p i c a l o fc e l l s f o l l o wi n g a 10 mi nute c y t o t o x i n ( 1 : 8 d i l u t i o n ) e x p o s u r e ................................................................................ 79

I V . 5 T r a n s mi s s i on e l e c t r o n mi c r og r aphs showing g r a n u l e sin n e u t r o p h i l s exposed t o c y t o t o x i n ( 1 : 8 d i l u t i o n ) f o r 10 m i n u t e s ......................................................................................................... 80

IV. 6 Ne u t r o p h i l f o l l o w i n g a 15 mi nute c y t o t o x i n( 1 : 8 d i l u t i o n ) e xpos u r e ............................................................................ 81

I V . 7 C o n c e n t r i c a l l y l a mi n a t ed myel in f i g u r e formed fromt h e l a r g e p e r s i s t e n t g r a n u l e s .............................................................. 82

IV. 8 Ne u t r op h i l a t 20 mi nu t e s p o s t c y t o t o x i n ( 1 : 8 d i l u t i o n )e x p o s u r e ....................... 83

IV . 9 T r a n s mi s s i on e l e c t r o n mi crograph o f a bov inen e u t r o p h i l exposed t o a 1:512 c y t o t o x i n d i l u t i o nf o r 20 m i n u t e s ......................................................................................................... 84

I V . 10 Ne u t r op h i l exposed t o a 1:256 c y t o t o x i n d i l u t i o nf o r 20 m i n u t e s ......................................................................................................... 85

I V . 11 N e u t r op h i l exposed t o a 1:64 c y t o t o x i n d i l u t i o nf o r 20 m i n u t e s ......................................................................................................... 86

I V . 12 N e u t r op h i l exposed t o a 1:32 c y t o t o x i n d i l u t i o nf o r 20 m i n u t e s ..........................................................................................................87

V. l Phase c o n t r a s t mi c rograph o f e n c a p s u l a t e d P. h a e m o l y t i ca s e r o t y p e 1 immobi l i zed onimmunobead s u r f a c e .............................................................................................. 106

V.2 Phase c o n t r a s t mi c rograph o f e n c a p s u l a t e d P.h a e m o l y t i ca s e r o t y p e 2 and immunobeads d e m o n s t r a t i n g s p e c i f i c i t y by a l a ck o fi m m o b i l i z a t i o n ........................................................................................................108

v i i

Page 13: Characterization and Application of Monoclonal Antibody

ABSTRACT

Monoclonal a n t i b o d i e s (McAbs) were p r ep a r e d a g a i n s t P a s t e u r e l l a

ha e mol y t i ca s e r o t y p e 1 (Ph-1) c a p s u l a r m a t e r i a l t o i d e n t i f y , q u a n t i t a t e

and p u r i f y a n t i g e n s . McAbs were s e l e c t e d by ELISA and c h a r a c t e r i z e d

ac c o r d i n g t o t h e i r i s o t y p e , c r o s s - r e a c t i v i t y wi t h P. h a emol y t i ca and P.

mu 1 t o e i d a s e r o t y p e s in ELISA, a n t i g e n f o r ma l i n s e n s i t i v i t y and a b i l i t y

t o cause b a c t e r i a l a g g l u t i n a t i o n . Four groups o f McAbs were

e s t a b l i s h e d each r e c o g n i z i n g a d i f f e r e n t e p i t o p e . Var ious P.

h a emol y t i ca and P. mu 1 t o e i d a s e r o t y p e s were found t o s h a r e s e v e r a l

e p i t o p e s d e m o n s t r a t i n g t h e i r a n t i g e n i c r e l a t e d n e s s .

A c o l o r m e t r i c a s s a y , based on t e t r a z o l i u m dye r e d u c t i o n by bov ine

n e u t r o p h i l s , was adap t ed f o r t h e measurement and c h a r a c t e r i z a t i o n o f

Ph-1 c y t o t o x i n a c t i v i t y . Using d i f f e r e n t c y t o t o x i n p r e p a r a t i o n s which

v a r i e d in c y t o l y t i c a c t i v i t y , c y t o t o x i n a c t i v i t y was i d e n t i f i e d as t h e

i n h i b i t i o n o f dye r e d u c t i o n . S t i m u l a t i o n o f dye r e d u c t i o n by

n e u t r o p h i l s in r e s p o n s e t o t h e c y t o t o x i n p r e p a r a t i o n s was a l s o d e t e c t e d

in t h e a s s a y s u g g e s t i n g n e u t r o p h i l a c t i v a t i o n i n v o l v i n g t h e r e s p i r a t o r y

b u r s t . McAbs and chemica l methods were used t o i d e n t i f y and q u a n t i t a t e

c y t o t o x i n p r e p a r a t i o n a n t i g e n s .

The c o l o r i m e t r i c a s s a y was f u r t h e r a p p l i e d t o s e l e c t and

c h a r a c t e r i z e a c y t o t o x i n - n e u t r a l i z i n g monoclonal a n t i b o d y (nMcAb).

The nMcAb was no t r e a c t i v e i n ELISA, bu t produced s u b s t a n t i a l

n e u t r a l i z a t i o n in t h e c o l o r i m e t r i c a s s a y . The nMcAb was i d e n t i f i e d as

an IgM. McAbs s e l e c t e d ELISA a g a i n s t c a p s u l a r m a t e r i a l d i d no t a f f e c t

n e u t r o p h i l dye r e d u c t i o n in r e s po n s e t o c y t o t o x i n .

Page 14: Characterization and Application of Monoclonal Antibody

U l t r a s t r u c t u r a l changes in bov ine n e u t r o p h i l s exposed t o c y t o t o x i n

were examined o ve r d i f f e r e n t t i me i n t e r v a l s and c o n c e n t r a t i o n s t o

c h a r a c t e r i z e i t s e f f e c t s a t t h e c e l l u l a r l e v e l . I d e n t i c a l t ime and

c o n c e n t r a t i o n dependen t changes i n v o l v i n g c e l l p o l a r i z a t i o n wi t h uropod

f o r m a t i o n , plasma membrane d e f e c t s , and d i f f e r e n t i a l i n t r a c e l l u l a r

d e g r a n u l a t i o n p r o g r e s s i n g t o comple t e l y s i s were o b s e r ve d .

P o l a r i z a t i o n wi t h uropod f o r m a t i on s u gg es t e d t h e p r e s en c e o f a

c h e m o t a c t i c f a c t o r and c o r r e s po n d e d wi t h a c t i v a t i o n obs e rved in t h e

c o l o r i m e t r i c a s s a y .

A McAb was a p p l i e d in i mmu n o a f f i n i t y t o p u r i f y t he Ph-1 s p e c i f i c

e p i t o p e from c a p s u l a r m a t e r i a l . The i mmunoaf f i n i t y p r od u c t c o n t a i n e d

no d e t e c t a b l e p r o t e i n and a t l e a s t one h a l f t h e o r i g i n a l hexosamine

c o n t e n t . McAbs were used in ELISA t o i d e n t i f y and q u a n t i t a t e t h e

p r o d u c t a n t i g e n s . L i p o p o l y s a c c h a r i d e and p a n - p a s t e u r e l l a c a r b o h y d r a t e

were s e l e c t i v e l y r e t a i n e d in a d d i t i o n t o Ph-1 s p e c i f i c c a p s u l a r

p o l y s a c c h a r i d e s u g g e s t i n g e p i t o p e s h a r i n g among p o l y s a c c h a r i d e

a n t i g e n s .

i x

Page 15: Characterization and Application of Monoclonal Antibody

CHAPTER 1

DEVELOPMENT AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES

AGAINST PASTEURELLA HAEMOLYTICA SEROTYPE 1

SUMMARY

P a s t e u r e l l a h a e mo l y t i ca s e r o t y p e 1 (Ph-1) c a p s u l a r m a t e r i a l was

e x t r a c t e d f rom l o g a r i t h m i c growth phase c e l l s and used t o immunize

BALB/c mice f o r monoclonal a n t i b o d y p r o d u c t i o n . Hybridomas p roduc i ng

a n t i b o d y t o Ph-1 c a p s u l a r m a t e r i a l were s e l e c t e d u s i n g an ELISA

p r oc e d u r e and r e p e a t e d l y c l oned by l i m i t i n g d i l u t i o n . Monoclonal

a n t i b o d i e s o b t a i n e d were c h a r a c t e r i z e d and grouped a c c o r d i n g t o t h e i r

i s o t y p e , c r o s s - r e a c t i v i t y w i t h 6 and 24 hour P. h a e m o l y t i c a (Ph) and P.

mu1 t o e i d a (Pm) s e r o t y p e s in ELISA, a n t i g e n f o r m a l i n s e n s i t i v i t y and

a b i l i t y t o cause r a p i d p l a t e a g g l u t i n a t i o n . Four g roups o f a n t i b o d i e s

were e s t a b l i s h e d which were (1) IgM Ph-1 s p e c i f i c a g g l u t i n a t i n g , (2)

IgG^ c r o s s - r e a c t i v e w i t h v a r i o u s Ph s e r o t y p e s , (3) IgM c r o s s - r e a c t i v e

wi t h many Ph and Pm s e r o t y p e s , and (4) IgG^A c r o s s - r e a c t i v e wi t h a l l Ph

and Pm s e r o t y p e s . The Ph-1 s p e c i f i c a n t i g e n and t h e a n t i g e n common t o

a l l Ph and Pm s e r o t y p e s were f o r ma l i n s e n s i t i v e . These s t u d i e s

d e m o n s t r a t e t h e use o f d i f f e r e n t i a l a n t i g e n e x p r e s s i o n by b a c t e r i a l

s e r o t y p e s t o c h a r a c t e r i z e monoclonal a n t i b o d i e s which were produced

a g a i n s t a complex a n t i g e n s o u r ce and i n d i c a t e s t h a t t h e v a r i o u s Ph and

Pm s e r o t y p e s s h a r e s e v e r a l common e p i t o p e s .

INTRODUCTION

P a s t e u r e l l a h a e m o l y t i c a b i o t y p e A, s e r o t y p e 1 (Ph-1) i s t h e

p a t h o g e n i c a g en t most f r e q u e n t l y a s s o c i a t e d wi t h s e v e r e f i b r i n o u s

1

Page 16: Characterization and Application of Monoclonal Antibody

2

1 7pnemonia in pnemonic p a s t e u r e l l o s i s ( s h i p p i n g f e v e r ) o f c a t t l e . *

S u c c e s s f u l d i v i s i o n o f P. h a e m o l y t i ca i n t o d i s c r e t e s e r o t y p e s was

accompl i shed u s i n g s p e c i f i c r a b b i t a n t i s e r a in i n d i r e c t

h e m a g g l u t i n a t i o n and r a p i d p l a t e a g g l u t i n a t i o n r e a c t i o n s . 3 , 4 S o l u b l e

c a p s u l a r p o l y s a c c h a r i d e a n t i g e n s a r e a c c e p t e d t o c o n f e r s e r o t y p e

s p e c i f i c i t y r e c o gn i z e d by a n t i s e r a in t h e s e r e a c t i o n s . 4 , 6 G r e a t e r t ha n

12 s e r o t y p e s have been i d e n t i f i e d which can be d i v i d e d i n t o 2 b i o t y p e s ,

A and T, r e s p e c t i v e o f t h e i r a b i l i t y t o f e r me n t a r a b i n o s e and

7 8t r e h a l o s e . 5 S e r o t y p e s 3 , 4 and 10 be l ong t o b i o t y p e T, w h i l e t h e

rema i n i ng s e r o t y p e s do no t f e r me n t t r e h a l o s e and be l ong t o b i o t y p e A.

S e r o l o g i c a l c r o s s - r e a c t i o n s among t h e v a r i o u s s e r o t y p e s , mo s t l y w i t h i n

b i o t y p e s , have been r e p o r t e d u s i n g s e v e r a l a n a l y t i c a l

3 4 9-12t e c h n i q u e s . * ’ These r e a c t i o n s and c r o s s r e a c t i o n s have d e f i n e d a

complex, y e t d i s t i n g u i s h a b l e a n t i g e n i c p r o f i l e among t h e P a s t e u r e l l a e .

With t h e development o f monoclonal a n t i b o d y t e c h n i q u e s , more t ha n

13a decade ago by Kohler and M i l s t e i n , i t has become p o s s i b l e t o s t u d y

complex a n t i g e n i c sys t ems u s i n g s e r o l o g i c methods . Ce l l s u r f a c e

a n t i g e n s o f l ymphocytes and b a c t e r i a r e p r e s e n t a complex sys t em t o

which monoclonal a n t i b o d i e s have been e x t e n s i v e l y a p p l i e d . Whole c e l l s

o r e x t r a c t s a r e commonly i n j e c t e d i n t o mice and monoclonal a n t i b o d i e s

can be o b t a i n e d which d e f i n e s p e c i f i c s u r f a c e a n t i g e n s in a complex

14-20s u b p o p u l a t i o n o f c e l l s . Because t h e s e r o t y p e s and b i o t y p e s o f

P a s t e u r e l l a h a e m o l y t i ca and o t h e r P a s t e u r e l l a s p e c i e s r e p r e s e n t

a n t i g e n i c a l l y complex s u b p o p u l a t i o n s o f c e l l s , i t s hou l d be p o s s i b l e t o

p roduce monoclonal a n t i b o d i e s which can d i f f e r e n t i a t e s o l u b l e o r

s u r f a c e e x p r e s s e d a n t i g e n s among t h e s e p o p u l a t i o n s . R e a c t i v i t y o f

monoclonal a n t i b o d i e s w i t h c e l l s u r f a c e a n t i g e n s i s commonly measured

Page 17: Characterization and Application of Monoclonal Antibody

3

u s i n g e n zyme- l i nked immunosorbent a s s a y s (ELISA) f o r which many

14-22v a r i a t i o n s e x i s t . U s u a l l y c e l l s a r e a t t a c h e d t o a s o l i d phase (96

wel l p l a t e s ) u s i n g a c r o s s - l i n k i n g a g en t such as g l u t a r a l d e h y d e ,o n p i

p a r a f o r ma l d e h yd e , o r o t h e r f i x a t i v e s . ’ These p ro c e d u r es

o f t e n a l t e r a n t i g e n i c i t y o f c e l l s u r f a c e c o n s t i t u e n t s and t h e r e f o r e t h e

a s s a y r e s u l t s o b t a i n e d . " Ant igen r e a c t i v i t y f o l l o w i n g d i f f e r e n t

t r e a t m e n t s can t h e r e f o r e be used t o d i s t i n g u i s h v a r i o u s a n t i g e n s and

t o d i f f e r e n t i a t e monoclonal a n t i b o d y s p e c i f i c i t i e s . I t i s e a s i l y

e n v i s i o n e d t h a t t h i s cou l d be an i m p o r t a n t phenomena wi t h r e s p e c t t o

t h e immunogenic i ty and e f f i c a c y o f b a c t e r i n s and v a c c i n e s t r e a t e d wi t h

d i f f e r e n t f i x a t i v e a g e n t s .

F u r t h e r a n t i b o d y c h a r a c t e r i z a t i o n s f r e q u e n t l y i n vo l ve

d e t e r m i n a t i o n o f i s o t y p e , s u b i s o t y p e , t h e c a p a c i t y t o n e u t r a l i z e

b i o l o g i c a l a c t i v i t i e s , b a c t e r i o c i d a l o r b a c t e r i o s t a t i c e f f e c t s in t h e

p r e s e n c e o f complement , and i n s o l u b i l i z a t i o n o f a n t i g e n s t h r ough

a g g l u t i n a t i o n o r p r e c i p i t a t i o n . Monoclonal a n t i b o d y t e ch n o l o g y has no t

been e x t e n s i v e l y a p p l i e d t o F\ h a emol y t i ca o r bovine pnemonic

p a s t e u r e l l o s i s . The pu r pos e o f t h i s r e p o r t i s t o d e s c r i b e t he

deve l opment and c h a r a c t e r i z a t i o n o f monoclonal a n t i b o d i e s a g a i n s t F\

h a e mo l y t i ca s e r o t y p e 1 c a p s u l a r m a t e r i a l .

MATERIALS AND METHODS

P. h a e mo l y t i ca a n t i g e n p r e p a r a t i o n :

P a s t e u r e l l a h a e m o l y t i ca b i o t y p e A, s e r o t y p e 1, was m a i n t a i n e d by

l y o p h i l i z a t i o n in skim mi lk and p e r i o d i c animal pas sage as p r e v i o u s l y

Page 18: Characterization and Application of Monoclonal Antibody

31d e s c r i b e d . Agar p l a t e s c o n t a i n i n g 10% ( v / v ) bovine b l ood , 1% ( v / v )

h o r se serum, and 1% ( v / v ) y e a s t h y d r o l y s a t e were used t o p r op a g a t e t h e

b a c t e r i u m in c a n d l e j a r s a t 37C. C a p s u l a r m a t e r i a l was e x t r a c t e d from

326 hour c o n f l u e n t c u l t u r e s a c c o r d i n g t o t h e method o f Gen t ry . The

b a c t e r i a were removed from t h e s o l u b i l i z e d c a p s u l a r m a t e r i a l by

c e n t r i f u g a t i o n a t 12,000 xg f o r 30 min a t 4C. The s u p e r n a t e c o n t a i n i n g

c a p s u l a r a n t i g e n s was f i l t e r s t e r i l i z e d (0.22ym) and d i a l y z e d (8 -10 k

MWC0, F i s h e r S c i . Co. ) e x t e n s i v e l y a g a i n s t d i s t i l l e d w a t e r a t 4C ove r

48 h r s . The d i a l y z e d c a p s u l a r a n t i g e n s were f r o z e n a t -70C and

l y o p h i 1i z ed p r i o r to use .

Mice and immuniza t ions :

The BALB/c mice which were used f o r t h e p r o d u c t i o n o f monoclonal

a n t i b o d i e s were br ed in o u r f a c i l i t i e s . One h a l f mg c a p s u l a r m a t e r i a l

in F r e u n d ' s comple t e a d j u v a n t ( 0 . 5 ml) was used t o immunize 6-8 week

o l d f emale mice by i n t r a p e r i t o n e a l i n j e c t i o n . One month l a t e r , mice

were immunized ag a i n wi t h 0 . 5 mg c a p s u l a r m a t e r i a l in 0 . 5 ml phospha te

b u f f e r e d s a l i n e (PBS, pH 7 . 2 ) by t h e same r o u t e . Blood samples were

wi thdrawn from t h e r e t r o - o r b i t a l p l exus p r i o r t o immunizat ion and 3

days f o l l o w i n g t h e b o o s t e r immuniza t ion f o r measurement o f serum

a n t i b o d y . Su cc e s s f u l immuniza t ion and s e l e c t i o n o f mice f o r monoclonal

a n t i b o d y p r o d u c t i o n was e s t a b l i s h e d u s i n g ELISA ( se e Assay f o r a n t i bo dy

p r o d u c t i o n and hybridoma c l o n i n g ) . Mice havi ng t he h i g h e s t a n t i b o d y

t i t e r t o c a p s u l a r m a t e r i a l were choosen f o r c e l l f u s i o n .

Page 19: Characterization and Application of Monoclonal Antibody

5

Cel l f u s i o n and h y b r id s e l e c t i o n :

Four days f o l l o w i n g t h e b o o s t e r immuni za t i on , s p l e e n c e l l s from

one mouse were f u sed wi t h SP-2 /o mur ine myeloma c e l l s a t a 4 :1 r a t i o in

t h e p r e s e n c e o f 50% ( v / v ) 1450 MW p o l y e t h y l e n e g l y c o l . A f t e r t he

f u s i o n , c e l l s were g e n t l y washed wi t h and d i l u t e d in RPMI-1640

c o n t a i n i n g 15% ( v / v ) f e t a l c a l f serum, O.OlmM h yp ox a n t h i n e , 1 . 6x l0~ mM

t h y m i d i n e , 10 mM sodium b i c a r b o n a t e , 1% ( v / v ) n o n - e s s e n t i a l amino

a c i d s , and lOmM L- g l u t a mi ne (HT-medium) t o a c o n c e n t r a t i o n o f 7 . 5x10^

s p l e n o c y t e s / m l . A l i q u o t s ( 0 . 1ml ) were d e l i v e r e d t o t h e w e l l s o f f o u r

96 we l l p l a t e s which c o n t a i n e d 5x10^ BALB/c t h y mo c y t e s / we l l as f e e d e r

c e l l s . The mixed c e l l p o p u l a t i o n was c u l t u r e d f o r 24 h r a t 37C in t h e

p r e s e n c e o f 5% CO2 . Hybr id c e l l s were s e l e c t e d by t h e d a i l y f e e d i n g of

0 . 1 ml volumes o f HT-medium c o n t a i n i n g 4X10"^ mM a m i n o p t e r i n

(HAT-medium) f o r f o u r c o n s e c u t i v e d a y s . Fo l lowing h y b r id s e l e c t i o n t h e

c e l l s were m a i n t a i n e d and expanded in HT-medium. P l a t e s were v i s u a l l y

a s s e s s e d f o r c l o n a l growth on a d a i l y b a s i s d u r i n g hy b r id c e l l

s e l e c t i o n u s i n g an i n v e r t e d mi c r o s c o p e .

Assay f o r a n t i b o d y p r o d u c t i o n and hybridoma c l o n i n g :

S u pe r n a t e s from hybr idoma c e l l c u l t u r e s o r mouse s e r a were

e v a l u a t e d f o r s p e c i f i c a n t i b o d y c o n t e n t by ELISA u s i n g c a p s u l a r

m a t e r i a l as t h e a n t i g e n . B r i e f l y , 50 pi volumes c o n t a i n i n g 5pg

c a p s u l a r m a t e r i a l i n TEN b u f f e r 0.05M T r i s , 0.001M Na^EDTA, 0.15M NaCl ,

pH 7 . 4 were a i r d r i e d in 96 wel l p o l y s t y r e n e p l a t e s o v e r n i g h t . The

d e s s i c a t e d a n t i g e n was f i x e d wi t h 50 pi pa r a f o r ma l dehyde pe r wel l f o r 5

min and washed 3 t i mes wi t h TEN b u f f e r . Wel ls were b locked wi t h

Page 20: Characterization and Application of Monoclonal Antibody

200 yl a l i q u o t s o f 2% (w/v) BSA in phos pha t e b u f f e r e d s a l i n e (PBS,

0.15M, pH 7 . 2 ) f o r 2 h r and washed. Hybridoma c u l t u r a l s u p e r n a t e s o r

mouse s e r a (50 y l ) were added and a l l owed t o b ind f o r 45 min a t room

t e m p e r a t u r e . The w e l l s were washed 3 t i me s and 50 yl volumes o f g o a t

a n t i - m o us e IgG, IgM h o r s e - r a d i s h p e r o x i d a s e c o n j u g a t e d s e c onda r y

a n t i b o d y (1 : 1500 d i l u t i o n i n TEN b u f f e r ) was added t o t h e w e l l s and

i n c u b a t e d f o r 45 min a t room t e m p e r a t u r e . Unbound c o n j u g a t e d a n t i b o d y

was washed from t h e w e l l s 3 t i mes and hybr idomas s e c r e t i n g a n t i b o d y

s p e c i f i c f o r c a p s u l a r m a t e r i a l were i d e n t i f i e d u s i n g

o r t h op h e n y l e n e d i a mi n e as a s u b s t r a t e . P l a t e s were v i s u a l l y i n s p e c t e d

f o r p o s i t i v e r e a c t i o n s and 10 w e l l s were s e l e c t e d f o r c l o n i n g .

Fo l lowing s e l e c t i o n o f t h o s e hybr idomas s e c r e t i n g a n t i b o d y

s p e c i f i c f o r c a p s u l a r a n t i g e n s , c e l l s were c l oned by l i m i t i n g d i l u t i o n

in 96 wel l p l a t e s . BALB/c thymocytes ( 5x10^ / we l 1) were used as f e e d e r2

c e l l s . Cloned hybr idomas were expanded in 25 cm f l a s k s in HT-medium

and c r y o p r e s e r v e d in t h e same medium c o n t a i n i n g 20% ( v / v ) FCS and 10%

( v / v ) DMS0.

P e r i t o n e a l a s c i t i c f l u i d , f o r each o f t h e c l one d hybr idomas , was

produced in a d u l t BALB/c mice c o n d i t i o n e d one week in advance wi t h 0 . 5

ml p r i s t a n e . P r e c o n d i t i o n e d mice were i n o c u l a t e d w i t h 106 v i a b l e

h yb r i d c e l l s . P e r i t o n e a l a s c i t i c f l u i d was h a r v e s t e d by p e r i o d i c

ab d o mi n o ce n t e s i s b e g i nn i n g 7 days a f t e r i n o c u l a t i o n , c l a r i f i e d by

c e n t r i f u g a t i o n , and s t o r e d a t -70C.

D e t e r m i n a t i o n o f monoclonal a n t i b o d y i s o t y p e :

I s o t y p e s o f t h e 10 s e l e c t e d monoclonal a n t i b o d i e s were d e t e r m i n e d ,

u s i n g hybr idoma c u l t u r a l s u p e r n a t e s , w i t h two d i f f e r e n t co m me r c i a l l y

Page 21: Characterization and Application of Monoclonal Antibody

7

a v a i l a b l e i s o t y p i n g k i t s based on immunodi f fus ion and a n t i b o d y c a p t u r e .

Assay o f monoclonal a n t i b o d y s p e c i f i c i t y :

Monoclonal a n t i b o d i e s , were a s s a y e d f o r t h e i r s p e c i f i c i t y t o o t h e r

P. h a e m o l y t i c a and P. m u l t o c i d a s e r o t y p e s u s i n g t h e ELISA p r oc e d u r e

wi t h s l i g h t m o d i f i c a t i o n s . P. ha e mol y t i ca s e r o t y p e s and b i o t y p e s

4 7 331-12 ' and P. m u l t o c i d a s e r o t y p e s 1-16 were d e f i n e d and p r o p a g a t e d

as d e s c r i b e d f o r Ph-1. Both 6 and 24 h r c u l t u r e s o f t h e b a c t e r i a were

p r e p a r e d and suspended in PBS. B a c t e r i a l s u s p e n s i o n s were a d j u s t e d t o9

1x10 CFU/ml u s i n g a s p e c t r o p h o t o m e t e r and 50 yl a l i q u o t s o f a 1:26

d i l u t i o n , d e t e r mi n e d opt imum by c h ec k e r bo a r d t i t r a t i o n , were used as

a n t i g e n s i n t h e ELISA.

D e t e r m i n a t i o n o f a n t i g e n f o r m a l i n s e n s i t i v i t y :

Ph-1 whole c e l l s o r homologous c a p s u l a r m a t e r i a l were p r e p a r e d as

d e s c r i b e d and d e s s i c a t e d i n t o 96 wel l p l a t e s . The d e s s i c a t e d a n t i g e n

were e i t h e r u n t r e a t e d o r t r e a t e d wi t h 50 yl 10% ( v / v ) b u f f e r e d f o r m a l i n

a n d / o r p a r a f o r ma l d e h y d e f o r 5 min. The w e l l s were washed t h r e e t i mes

and t h e ELISA comple t ed as d e s c r i b e d .

D e t e r m i n a t i o n o f r a p i d s l i d e a g g l u t i n a t i o n o f Ph-1 by a s c i t i c f l u i d s :

P e r i t o n e a l a s c i t i c f l u i d s were c l a r i f i e d by c e n t r i f u g a t i o n a t 2500

xg f o r 5 min, r e s i d u a l p r i s t a n e removed wi t h a p i p e t t e and t h e a s c i t i c

f l u i d pas sed t h r ou g h a 0 . 2 2 urn f i l t e r . F i f t y yl a l i q u o t s o f t h e

c l a r i f i e d a s c i t i c f l u i d s f rom each c l one d hybridoma were mixed wi t h 50g

yl volumes o f 1x10 CFU/ml o f t h e P. h a e m o l y t i c a s e r o t y p e s on a c l e a n e d

Page 22: Characterization and Application of Monoclonal Antibody

8

s l i d e . The s l i d e s were s l o w l y rocked a t room t e m p e r a t u r e and obse r ved

f o r r a p i d a g g l u t i n a t i o n .

RESULTS

Fol lowing h y b r i d c e l l s e l e c t i o n and e xpa ns i on in 96 wel l p l a t e s ,

n e a r l y e v e r y wel l c o n t a i n e d r a p i d l y growing hybr idomas 10 days a f t e r

t h e f u s i o n . S p e c i f i c a n t i b o d y p r o d u c t i o n a g a i n s t P. h a emol y t i ca

s e r o t y p e 1 c a p s u l a r a n t i g e n s was i d e n t i f i e d in 250 c u l t u r e s (74% o f

t o t a l ) . These p o s i t i v e w e l l s were v a r i a b l e in t h e i r de g r e e o f hy b r id

c e l l growth and a n t i b o d y r e a c t i v i t y based on ELISA s u b s t r a t e

a b s o r b a n c e . Ten w e l l s t h a t v a r i e d in a b s o r b a n c e , a l l which c o n t a i n e d

v i g o r o u s l y growing hybr i domas , were chosen f o r c l o n i n g by l i m i t i n g

d i l u t i o n and f u r t h e r s t u d y . These hybr idomas were numbered 1 t h rough

10 and c l oned g r e a t e r t ha n 5 t i mes and s e l e c t e d by ELISA o ve r s e v e r a l

months . Dur ing c l o n i n g 2 hybr idomas proved t o be u n s t a b l e and f a i l e d

t o produce a n t i b o d y as d e t e c t e d by ELISA. A t h i r d hybridoma became

c o n t ami n a t e d and was d i s c a r d e d .

I s o t y p e s o f t h e 10 o r i g i n a l l y s e l e c t e d hybr idomas were de t e r mi n e d

us i n g c u l t u r a l s u p e r n a t e in two d i f f e r e n t methods (Tab l e 1 . 1 ) . The

r e s u l t s o f immunodi f fus ion and a n t i b o d y c a p t u r e were in e x a c t

a gg r ee men t , however , i mmunodi f fus ion was a p p a r e n t l y no t as s e n s i t i v e as

a n t i b o d y c a p t u r e and f a i l e d t o i d e n t i f y many a n t i b o d i e s . A n t i b o d i e s

were i d e n t i f i e d i n e i t h e r t h e IgM o r IgG c l a s s and many hybr idomas were

found t o produce t h e same i s o t y p e and s u b - i s o t y p e o f a n t i b o d y .

Page 23: Characterization and Application of Monoclonal Antibody

9

Table 1.1 - D e t e r m i n a t i o n o f Monoclonal Ant ibody I s o t y p e

Monoclonal I s o t y p e

Ant ibody Immunodi f fus ion Ant ibody Capt ure

1 I gG3 I gG3

2 ND* IgG2A

3 IgM IgM

4 ND IgG2A

5 ND IgG3

6 ND I gG3

7 ND ND

8 IgGl IgGl

9 IgM IgM

10 IgM IgM

* ND = Not de t e rmi ne d

R e a c t i v i t y o f t he seven r ema i n i ng monoclonal a n t i b o d i e s wi th P.

ha e m o l y t i ca s e r o t y p e s ( Tab l e 1 . 2 ) and P. mu l to c i da s e r o t y p e s (Table

1 . 3 ) was d e t e r mi ne d u s i n g whole b a c t e r i a l c e l l s as t h e a n t i g e n s in

ELISA. Monoclonal a n t i b o d i e s were grouped a c c o r d i n g t o t h e i r

r e a c t i v i t y among t h e s e s e r o t y p e s . Four p a t t e r n s o f r e a c t i v i t y were

i d e n t i f i e d : (1) P. ha e mol y t i ca s e r o t y p e 1 s p e c i f i c , (2) c r o s s r e a c t i v e

wi t h P. h a e m o l y t i ca s e r o t y p e s 1, 5 - 8 , and 12 no t c r o s s r e a c t i v e wi th

any P. mu l to c i d a s e r o t y p e s , (3) c r o s s r e a c t i v e wi t h P. haemol y t i ca

s e r o t y p e s 1, 2 , 5 - 8 , and 12 wi t h 6 and 24 h r c u l t u r e v a r i a b i l i t y a l s o

Page 24: Characterization and Application of Monoclonal Antibody

10

c r o s s r e a c t i v e wi t h P. m u l t o c i d a s e r o t y p e s 1 - 7 , 9 , 12, 15, 16, and

(4) c r o s s r e a c t i v e wi t h a l l P. h a e m o l y t i ca and P. m u l t oc i d a s e r o t y p e s .

Monoclonal a n t i b o d i e s grouped on t h e b a s i s o f s e r o t y p e r e a c t i v i t y were

o f t h e same i s o t y p e and s u b - i s o t y p e .

Tab l e 1 .2 - R e a c t i v i t y o f Monoclonal A n t i b o d i e s w i t h P. h a e m o l y t i ca

Whole Cel l S e r o t y p e s

P. h a e mo l y t i ca Monoclonal A n t i b od i e s

s e r o t y p e 3 1 , 5 , 6 9 , 10 2

1 + + + +

2 - - - ( 6 ) + ( 2 4 ) * +

3 - - - +

4 - - - +

5 - + + +

6 - + + +

7 - + + +

8 - + + +

9 - - + ( 6 ) - ( 2 4 ) * +

10 - - - +

11 - - - +

12 - + + +

Denotes d i f f e r e n c e s in r e a c t i v i t y between 6 and 24 h r c u l t u r e s wi t h

b o t h a n t i b o d i e s .

Page 25: Characterization and Application of Monoclonal Antibody

11

Tabl e 1 . 3 - R e a c t i v i t y o f Monoclonal A n t i b o d i e s w i t h P. m u l t o c i d a Whole

Cel l Se r o t y p e s

P. mu l t oc i da Monoclonal A n t i b o d i e s

s e r o t y p e t 3 1 , 5 , 6 9 , 10 2

1 - + +

2 - + +

3 - + +

4 - + +

5 - + +

6 - + +

7 _ + +

8 - - +

9 - + +

12 - + +

14 - - +

15 - + +

16 - ( + . 6 ) * + +

+No d i f f e r e n c e in r e a c t i v i t y between 6 and 24 hr c u l t u r e s .★

Number 6

monoclonal a n t i b o d y p o s i t i v e f o r s e r o t y p e 16 o n l y .

Formal in t r e a t m e n t o f P. ha e mol y t i ca s e r o t y p e 1 whole c e l l s o r

c a p s u l a r m a t e r i a l was found t o c o m p l e t e l y a l t e r t h e a n t i g e n i c i t y ,

r e d u c i n g t h e r e a c t i v i t y o f some monoclonal a n t i b o d i e s in ELISA (Table

1 . 4 ) . The P. h a e m o l y t i ca s e r o t y p e 1 s p e c i f i c a n t i g e n , r e c o g n i z e d by

Page 26: Characterization and Application of Monoclonal Antibody

12

monoclonal a n t i b o d y number 3 , and t h e a n t i g e n common t o a l l P.

ha e mol y t i ca and P. m u l t o c i d a s e r o t y p e s , r ec o g n i ze d by monoclonal

a n t i b o d y number 2 , was a p p a r e n t l y d e s t r o y e d by f o r ma l i n t r e a t m e n t .

Pa ra fo rma l dehyde t r e a t m e n t d i d no t a d v e r s e l y a f f e c t a n t i g e n i c i t y i n

t h i s sys t em. N e i t h e r f o r m a l i n nor pa r a f o r ma l dehyde was n e c e s s a r y f o r

c a p s u l a r m a t e r i a l a n t i g e n i c i t y in ELISA.

Table 1.4 - R e a c t i v i t y o f Monoclonal A n t i b o d i e s wi t h Formal in o r

Pa ra fo rma l dehyde T r e a t e d P. ha e mol y t i ca s e r o t y p e 1 Whole

C e l l s o r Ca p s u l a r M a t e r i a l in ELISA

Ant igenie

Trea tment

3

Monoclonal

1 , 5 , 6

A n t i b od i e s

9 , 10 2

Formal i n / p a r a f o r m a l d e h y d e - + + -

For ma l i n / no p a r a f o r ma l de hyde - + + -

No formal i n / p a r a f o r m a l d e h y d e + + + +

No f o r m a l i n / n o pa r a f o r ma l d e h y d e + + + +

*Whole c e l l s o r c a p s u l a r m a t e r i a l were t r e a t e d f o l l o w i n g a d s o r p t i o n t o

96 wel l p l a t e s .

Rapid s l i d e a g g l u t i n a t i o n o f P. h a e m o l y t i ca s e r o t y p e 1 by

c l a r i f i e d p e r i t o n e a l a s c i t i c f l u i d s was produced on l y by monoclonal

a n t i b o d y number 3. Ot he r monoclonal a n t i b o d i e s were i n c a p a b l e o f

a g g l u t i n a t i n g P. h a e m o l y t i c a s e r o t y p e 1 o r t h e r ema i n i ng s e r o t y p e s .

Page 27: Characterization and Application of Monoclonal Antibody

13

The a b i l i t y o f monoclonal a n t i b o d y number 3 t o a g g l u t i n a t e s e r o t y p e 1

c o r r e s po n d e d w i t h i t s ELISA r e a c t i v i t y (Tab l e s 1.2 and 1 . 3 ) .

A summary c h a r a c t e r i z i n g t h e monoclonal a n t i b o d i e s p r e p a r e d

a g a i n s t F\ h a e m o l y t i c a s e r o t y p e 1 c a p s u l a r m a t e r i a l i s p r e s e n t e d in

Tab l e 1 . 5 . Monoclonal a n t i b o d i e s were p l a c e d in f o u r groups based on

t h e i r c h a r a c t e r i s t i c i s o t y p e s , s e r o t y p e r e a c t i v i t y , a n t i g e n f o r m a l i n

s e n s i t i v i t y , and a g g l u t i n a t i o n . The r e s u l t s o f t h e s e d e t e r m i n a t i o n s

i n d i c a t e d s e v e r a l o f t h e a n t i b o d i e s r e c o g n i z e d t h e same e p i t o p e .

Page 28: Characterization and Application of Monoclonal Antibody

Table 1.5 - C h a r a c t e r i z a t i o n o f Monoclonal A n t i b o d i e s P r epa r ed A g a i n s t

P a s t e u r e l l a haemol y t i ca s e r o t y p e 1

Group

Monoclonal

Ant ibody

Number(s)

I s o t y p e Se r o t ype R e a c t i v i t y

P. haemol y t i ca P. mu l t oc i da

Ant igen

Formal in

S e n s i t i v i t y

A g g l u t i n a t i o n

1 3 IgM 1 None + +

2 1 , 5 , 6 IgG3 1 , 5 - 8 , 1 2*

None - -

3 9 , 10 IgM 1 , 3 , 5 - 8 , 1 2 1 - 7 , 9 , 1 2 , 1 5 , 1 6 - -

4 2 >9G2A a l l a l l + -

Monoclonal a n t i b od y number 6 r e a c t i v e wi t h P. mu l t o c i da s e r o t y p e 16 on l y .

Page 29: Characterization and Application of Monoclonal Antibody

15

DISCUSSION

Monoclonal a n t i b o d i e s were deve l oped a g a i n s t P haemol y t i ca

s e r o t y p e 1 c a p s u l a r m a t e r i a l . The hydr idomas p r oduc ing t h e s e

monoclonal a n t i b o d i e s were s e l e c t e d from a t o t a l o f 250 a n t i bo dy

produc i ng w e l l s g e n e r a t e d by f u s i n g t h e immune s p l e e n c e l l s w i t h SP-2/o

myeloma c e l l s . Ten d i f f e r e n t w e l l s c o n t a i n i n g v i g o r o u s l y growing

hybr idomas were chosen on t h e b a s i s o f a n t i b o d y b i nd i ng wi t h s e r o t y p e 1

c a p s u l a r m a t e r i a l . Monoclonal a n t i b o d y number 3 had t h e h i g h e s t ELISA

r e a c t i v i t y , wh i l e a n t i b o d i e s 1, 5 , 6, and 2 produced modera t e ELISA

a b s o r b a n c e s , and a n t i b o d i e s 9 and 10 d i s p l a y e d low ELISA r e a c t i v i t y

( da t a no t shown). These a n t i b o d i e s were c h a r a c t e r i z e d a c c o r d i n g t o

i s o t y p e , b a c t e r i a l s e r o t y p e s p e c i f i c i t y , a n t i g e n s e n s i t i v i t y t o

f o r ma l i n and a g g l u t i n a t i o n p r o p e r t i e s . The s e r o t y p e d i s t r i b u t i o n of

a n t i g e n s r e c o g n i ze d by t h e monoclonal a n t i b o d i e s were de t e rmi ne d u s i n g

p r i m a r i l y ELISA wi t h d e f i n e d b a c t e r i a l c e l l s . These d e t e r m i n a t i o n s

a l l owed e s t a b l i s h m e n t o f f o u r d i f f e r e n t groups o f a n t i b o d i e s , each

r e c o g n i z i n g an a p p a r e n t l y d i f f e r e n t e p i t o p e . The f i r s t e p i t o p e ,

r e c o g n i ze d by monoclonal a n t i b o d y number 3 , i s P. haemol y t i ca s e r o t y p e

1 s p e c i f i c and i nvo l ved wi t h b a c t e r i a l a g g l u t i n a t i o n . The second

e p i t o p e , d e f i n e d by a n t i b o d i e s 1, 5 , and 6 , i s p r e s e n t on many P.

h a e m o l y t i ca s e r o t y p e s , bu t no t P. mu l to c i d a s e r o t y p e s . The t h i r d

e p i t o p e , bound by a n t i b o d i e s 9 and 10, i s p r e s e n t on many P.

ha e mol y t i ca and P. m u l t oc i d a s e r o t y p e s . F i n a l l y , t h e f o u r t h e p i t o p e ,

p r e s e n t on a l l P. ha e mol y t i ca and P. m u l t oc i d a s e r o t y p e s , i s r e c o g n i ze d

by monoclonal a n t i b o d y number 2. In t h i s s t u d y , on l y P. haemol y t i ca

and P. mu l to c i d a s e r o t y p e s were examined , however , t h i s sys t em may be

ex t ended t o and p o s s i b l y i n c l u d e o t h e r s p e c i e s o f P a s t e u r e l l a , o r o t h e r

Page 30: Characterization and Application of Monoclonal Antibody

16

genera w i t h i n t h e B r u c e l l a c e a e f a m i l y , o r even o t h e r Gram-nega t ive

b a c t e r i a . Thi s sys t em e x e m p l i f i e s t h e use o f a n t i g e n d i s t r i b u t i o n

among b a c t e r i a l s e r o t y p e s t o d i s t i n g u i s h d i f f e r e n t monoclonal

a n t i b o d i e s .

The P. h a emol y t i ca s e r o t y p e 1 s p e c i f i c a n t i g e n i s d e f i n e d

r o u t i n e l y by i n d i r e c t h e m a g g l u t i n a t i o n and r a p i d p l a t e

3 4a g g l u t i n a t i o n . ’ S e r o t y p e s p e c i f i c i t y i s b e l i e v e d t o r e s i d e in

c a p s u l a r p o l y s a c c h a r i d e a n t i g e n s o f P. h a e m o l y t i c a . 4 , 6 S e r o t ype 1

s p e c i f i c a g g l u t i n a t i n g a n t i b o d y has been s u g g e s t e d as n e c e s s a r y f o r

34p r o t e c t i o n from e x p e r i me n t a l d i s e a s e . Immunizat ion o f c a t t l e wi th

c r ude c a p s u l a r e x t r a c t s has a f f o r d e d some de g r e e o f r e s i s t a n c e t oo c oo

e x p e r i me n t a l c h a l l e n g e , ’ however , f o r m a l i n i z e d b a c t e r i n s have been

39 41shown t o have a n e u t r a l o r d e l e t e r i o u s e f f e c t . * The r e s u l t s o f

t h i s s t u d y i n d i c a t e s monoclonal a n t i b o d y number 3 r e c o gn i z e s t he

s e r o t y p e 1 s p e c i f i c c a p s u l a r p o l y s a c c h a r i d e o f P. h a e mol y t i ca and

c a u s e s b a c t e r i a l a g g l u t i n a t i o n . F u r th e r mo r e , i t i s s u gg es t e d t h a t t h e

s e r o t y p e 1 s p e c i f i c a n t i g e n i s f o r ma l i n s e n s i t i v e , which may a c c o u n t ,

a t l e a s t in p a r t , f o r t h e i n e f f e c t i v e n e s s o f f o r m a l i n i z e d b a c t e r i n s t o

i mpa r t d i s e a s e r e s i s t a n c e .

S e r o l o g i c c r o s s - r e a c t i v i t y among t h e e s t a b l i s h e d s e r o t y p e s , w i t h i n

each b i o t y p e , o f P. h a e m o l y t i ca has been d i s c o v e r e d by i n d i r e c t

3 11 4 10h e m a g g l u t i n a t i o n , ’ r a p i d p l a t e a g g l u t i n a t i o n , ELISA, and c r o s s e d

12I m m u n o e l e c t r o p h o r e s i s . Crossed i m mu n o e l ec t r op h o r es i s f u r t h e r

12d em o n s t r a t e d c r o s s - r e a c t i o n s between b i o t y p e s o f P. h a e m o l y t i c a .

However, t h e a n t i g e n s r e s p o n s i b l e f o r t h i s c r o s s - r e a c t i v i t y have

remained u n c h a r a c t e r i z e d . Monoclonal a n t i b o d i e s 1, 5, and 6

c h a r a c t e r i z e d in t h i s s t u d y were c o n s i d e r a b l y c r o s s - r e a c t i v e wi t h many

Page 31: Characterization and Application of Monoclonal Antibody

17

P. h a e m o l y t i ca s e r o t y p e s , bu t n o t between t h e b i o t y p e s . In a n o t h e r

s t u d y , t h e s e monoclonal a n t i b o d i e s were shown t o be s p e c i f i c f o r

l i p o p o l y s a c c h a r i d e s by immunoblo t t i ng and t h e a n t i g e n was l o c a l i z e d

w i t h i n t h e b a c t e r i a l c a p s u l e u s i n g p r o t e i n A-gold l a b e l e d c o n j u g a t e in

42e l e c t r o n mi c r os c o p y . The 1i p o p o l y s a c c h a r i d e e p i t o p e r e c o gn i z e d by

t h e s e a n t i b o d i e s was no t s e n s i t i v e t o f o r m a l i n . These r e s u l t s supp l y

ev i d e n ce t h a t a 1i p o p o l y s a c c h a r i d e e p i t o p e i s common among many

s e r o t y p e s , bu t no t between b i o t y p e s o f P. h a e m o l y t i c a . Thus , some

deg r ee o f c r o s s - r e a c t i v i t y among s e r o t y p e s bu t no t between b i o t y p e s , o f

P. h a e m o l y t i c a ma.y be a t t r i b u t a b l e t o a common 1 i p o p o l y s a c c h a r i d e

e p i t o p e .

The s i m i l a r i t y o f a n t i b o d i e s 1, 5 , and 6 and a n t i b o d i e s 9 and 10

r e a c t i n g w i t h P. h a e m o l y t i ca s e r o t y p e s was f u r t h e r d i s t i n g u i s h e d u s i n g

P. m u l t oc i d a s e r o t y p e s r e c o gn i z e d on l y by t h e l a t t e r g roup . S e r o l o g i c

c r o s s - r e a c t i v i t y among P. h a e m o l y t i ca and P. mu l to c i da s e r o t y p e s has

no t been r e p o r t e d i n t h e l i t e r a t u r e . Monoclonal a n t i b o d i e s 9 and 10

were c r o s s - r e a c t i v e among many s e r o t y p e s o f t h e s e s p e c i e s , bu t not

between b i o t y p e s o f P. h a e m o l y t i c a . Immunoblot a n a l y s i s o f t h e a n t i g e n

r e c o g n i z e d by t h e s e a n t i b o d i e s r e v e a l e d a 29KD p r o t e i n , most l i k e l y o f

o u t e r membrane o r g i n , however , i t s e x a c t l o c a l e c ou l d no t be d e t e r mi ne d

42u s i n g p r o t e i n A-gold p robes due t o t h e a n t i b o d y i s o t y p e .

A n t i g e n i c i t y o f t h e 29KD p r o t e i n was no t a f f e c t e d by f o r ma l i n

t r e a t m e n t . The 29KD p r o t e i n r e p r e s e n t s a p o t e n t i a l sou r ce o f

c r o s s - r e a c t i v i t y among P. h a e m o l y t i ca and P. mu l to c i da s e r o t y p e s .

Common a n t i g e n s o f Gram-nega t i ve b a c t e r i a have been r e p o r t e d in

12 43 45h a e m o l y t i c a and o t h e r b a c t e r i a . ’ Monoclonal a n t i b o d y number 2

Page 32: Characterization and Application of Monoclonal Antibody

18

was c r o s s - r e a c t i v e w i t h a l l P. h a e m o l y t i c a and P. mu l t o c i d a s e r o t y p e s

examined. I t i s unknown wh e t h e r a n t i b o d y number 2 r ec o g n i z e s o t h e r

s p e c i e s o f P a s t e u r e l l a , o r o t h e r members o f t h e f am i ly B r u c e l l a c e a e , o r

o t h e r Gram-nega t i ve b a c t e r i a ; however , t h i s a n t i b o d y d i d no t r e a c t wi t h

E s c h e r i c h i a c o l i , used as b a c t e r i a l a n t i g e n c o n t r o l in t h e ELISA ( d a t a

no t shown) . The a n t i g e n c ou l d no t be d e t e c t e d by i mmunoblo t t i ng and

i t s n a t u r e remains u nd e t e r mi n e d . I t was f o r m a l i n s e n s i t i v e and t h i s

p r o p e r t y may a l s o a c c o u n t , a t l e a s t i n p a r t , f o r t h e f a i l u r e o f

f o r m a l i n i z e d b a c t e r i n s t o i m p a r t p r o t e c t i o n from d i s e a s e .

N e v e r t h e l e s s , t h i s a n t i g e n r e p r e s e n t s a s o u r ce o f c o n s i d e r a b l e

c r o s s - r e a c t i v i t y among P. h a e m o l y t i ca s e r o t y p e s , b i o t y p e s , and P.

m u l t o e i d a .

In summary, deve l opment and c h a r a c t e r i z a t i o n o f t h e r e p o r t e d

monoclonal a n t i b o d i e s has l e a d t o t h e a c q u i s i t i o n o f powerful t o o l s t o

s t u d y t h e a n t i g e n s o f P. h a e m o l y t i c a . Four groups o f a n t i b o d i e s were

e s t a b l i s h e d based on t h e i r c h a r a c t e r i s t i c s each c o r r e s p o n d i n g t o a

d i f f e r e n t a n t i g e n . Th i s s t u d y e x e m p l i f i e d t h e use o f d i f f e r e n t i a l

a n t i g e n e x p r e s s i o n among P a s t e u r e l l a s e r o t y p e s t o d i s t i n g u i s h

monoclonal a n t i b o d i e s p r e p a r e d and s e l e c t e d from a complex a n t i g e n

s o u r c e . F u r t h e r immunologic , b i o c h e m i c a l , and b i o l o g i c a l e x pe r i me n t s

a r e needed t o more f u l l y c h a r a c t e r i z e t h e a n t i b o d y g r ou ps , t h e s p e c i f i c

a n t i g e n s r e c o g n i z e d , and t h e i r r e l a t i o n s h i p t o d i s e a s e .

Page 33: Characterization and Application of Monoclonal Antibody

BIBLIOGRAPHY

1. J e n s en R, P i e r s o n RE, Braddy PM, e t a l . Sh i pp i ng f e v e r pneumonia i n y e a r l i n g f e e d l o t c a t t l e . J Am Vet Med Assoc 1976; 169:500-506.

2. Rehmutul l a AJ, Thompson RG. A r ev i e w o f t h e l e s i o n s in s h i p p i n g f e v e r o f c a t t l e . Can Vet J 1981; 2 2 : 1 - 8 .

3. B i b e r s t e i n EL, G i l l s M, Knight H. S e r o l o g i c a l t y p e s of P a s t e u r e l l a h a e m o l y t i c a . Corne l l Vet 1960; 50 :283-300 .

4. Frank GH, Wessman GE. Rapid p l a t e a g g l u t i n a t i o n p r oc e d u r e f o r s e r o t y p i n q P a s t e u r e l l a h a e m o l y t i c a . J C l i n Mi c rob i o l 1978; 7 : 141 - 145 .

5. Knight ND, B i b e r s t e i n , EL, A l l i s o n M. The r o l e o f c a p s u l a r and somat i c a n t i g e n s in immuniza t ion o f mice a g a i n s t P a s t e u r e l l a h a e m o l y t i ca i n f e c t i o n . Cor ne l l Vet 1969; 5 9 : 55 - 64 .

6. Adlam CJM, Knigh t s A, Mugridge JC, e t a l . P u r i f i c a t i o n , c h a r a c t e r i z a t i o n , and immunological p r o p e r t i e s o f s e r o t y p e - s p e c i f i c c a p s u l a r p o l y s a c c h a r i d e o f P a s t e u r e l l a ha e m o l y t i ca ( s e r o t y p e A - l ) o r q a n i s ms . J Gen Mi c rob i o l 1984; 130:2415-2426.

7. Smith GR. The c h a r a c t e r i s t i c s o f two t y p e s o f P a s t e u r e l l a h a e m o l y t i ca a s s o c i a t e d wi t h d i f f e r e n t p a t h o l o g i c a l c o n d i t i o n s . J Pa tho l B a c t e r i o l 1961; 81 : 431 - 440 .

8. F r a s e r J , L a i r d S, Gi lmour NJL. A new s e r o t y p e ( b i o t y p e T) o fP a s t e u r e l l a h a e m o l y t i c a . Res Vet Sci 1982; 32 :127 - 128 .

10. B u r r e l l s C, Evens HB, Dawson AM. A n t i g e n i c r e l a t i o n s h i p s between t h e s e r o v a r s o f P a s t e u r e l l a h a e m o l y t i c a d em o n s t r a b l e by en zyme- l i nked immunosorbent a s s a y (ELISA). Vet Mi c rob i o l 1983; 8 : 18 7 - 19 8 .

11. B i b e r s t e i n EL. C r o s s - r e a c t i o n s between t y p e s o f P a s t e u r e l l a h a e m o l y t i c a . Co r ne l l Vet 1965; 55 : 495- 499 .

12. Tsai L-H, C o l l i n s MT, Hoiby N. A n t i g e n i c a n a l y s i s o f P a s t e u r e l l a h ae m o l y t i c a s e r o v a r s 1 t h r ough 15 by c r o s s e d i m m u n o e l e c t r o p h o r e s i s . Am J Vet Res 1988; 49 : 213 - 222 .

13. Kohler G, M i l s t e i n C. Cont inuous c u l t u r e s o f f used c e l l ss e c r e t i n g a n t i b o d y o f p r e d e f i n e d s p e c i f i c i t y . Na tur e 1975;256 : 495-497 .

14. A p i c e l l a MA, B e n n e t t KM, Hermerath CA, Rober t s DE. Monoclonal a n t i b o d y a n a l y s i s o f 1 i p o p o l y s a c c h a r i d e from N e i s s e r i a qon o r r h o e a e and N e i s s e r i a m e n i n g i t i d i s . I n f e c t Immun 1981; 34 :751 - 756 .

19

Page 34: Characterization and Application of Monoclonal Antibody

20

15. G i l 7i s TP, Buchanan TM. P r od uc t i o n and p a r t i a l c h a r a c t e r i z a t i o n o f monoclonal a n t i b o d i e s t o Mycobacter ium l e p r a e . I n f e c t Immun 1982; 37 : 1 7 2 - 17 8 .

16. Hancock REW, Wieczorek AA, Mutha r i a LM, Pool K. Monoclonal a n t i b o d i e s a g a i n s t Pseudomonas a e r u g i n o s a o u t e r membrane a n t i g e n s : I s o l a t i o n and c h a r a c t e r i z a t i o n . I n f e c t Immmun 1982;37 : 166 - 171 .

17. Rober t son SM, Kettman JR, M i l l e r JN, Norgard MV. Murine monoclonal a n t i b o d i e s s p e c i f i c f o r v i r u l e n t Treponema p a l l i d um ( N i c h o l s ) . I n f e c t Immun 1982; 36:1076-1085.

18. Ro b e r t s o n , SM, F r i s c h CF, Gul ig PA, e t . a l . Monoclonal a n t i b o d i e s d i r e c t e d a g a i n s t a c e l l s u r f a c e exposed o u t e r membrace p r o t e i n o f Haemophi lus i n f l u e n z a e t y p e b . I n f e c t Immun 1982; 36 : 8 0 - 88 .

19. Mackie EB, Longenecker M, Robin HR, e t a l . Immune r e s po ns e o f t h e mouse t o Gr am- nega t i ve b a c t e r i a l o u t e r membrane e x t r a c t s as a s s e s s e d wi t h monoclonal a n t i b o d i e s . J Immunol 1982;1 2 9 ( 2 ) : 829-832 .

20. Newman MJ, Beegle KH, Antczak DF. Xenogenic monoclonal a n t i b o d i e s t o c e l l s u r f a c e a n t i g e n s o f e qu i ne lymphocytes . Am J Vet Res 1984; 4 5 ( 4 ) : 6 2 6 - 6 3 2 .

21. S u t e r L, Bruggen J , Sorg C. Use o f an enzyme- l i nked immunosorbent a s s a y (ELISA) f o r s c r e e n i n g o f hydridoma a n t i b o d i e s a g a i n s t c e l l s u r f a c e a n t i g e n s . J Immunol Meth 1980;39 : 407-411 .

22. Brennand DM, Danson MJ, Hough DW. A compar i son o f ELISA s c r e e n i n g methods f o r t he p r o d u c t i o n o f monoclonal a n t i b o d i e s a g a i n s t s o l u b l e p r o t e i n a n t i g e n s . J Immunol Meth 1986; 9 3 : 9 - 1 4 .

23. Levy R, D i l l e y J . The in v i t r o a n t i b o d y r e s p o n s e t o c e l l s u r f a c e a n t i g e n s . I I . Monoclonal a n t i b o d i e s t o human leukemia c e l l s . J Immunol 1977; 119 :394-400 .

24. Nimmo GR, Lew AM, S t a n l e y CM, Steward MW. I n f l u e n c e o f a n t i b o d y a f f i n i t y on t h e pe r fo rmance o f d i f f e r e n t a n t i b o d y a s s a y s . J Immunol Meth 1984; 72 : 177 - 187 .

25. Rotmans J P , Scheven BAA. The e f f e c t o f a n t i g e n c r o s s - l i n k i n g on t h e s e n s i t i v i t y o f t h e e n zyme- l i nked immunosorbent a s s a y . J Immunol Meth 1984; 7 4 : 5 3 -6 4 .

26. Smi th AD, Wi lson JE. A m o d i f i e d ELISA t h a t s e l e c t i v e l y d e t e c t s monoclonal a n t i b o d i e s r e c o g n i z i n g n a t i v e a n t i g e n . J Immunol Meth. 1986; 94 : 3 1 - 3 5 .

27. Hancock WW, Becker GJ , A t k i ns RC. A compar i son o f f i x a t i v e s and immunohis tochemicaI t e c h n i q u e s f o r use wi t h monoclonal a n t i b o d i e s t o c e l l s u r f a c e a n t i g e n s . Am J Cl i n Pa t h . 78 :825-831 .

Page 35: Characterization and Application of Monoclonal Antibody

21

28. Dunn SD, Tozer RG, Ant c z a k , DF, Heppel LA. Monoclonal a n t i b o d i e s t o E s c h e r i c h i a c o l i Fj -ATPase. J Biol Chem 1985; 260:10418-10425.

29. Vaidya HC, D i e t z l e r DN, Ladenson JH. Inadequacy o f t r a d i t i o n a lELISA f o r s c r e e n i n g hypridoma s u p e r n a t e s f o r mur ine monoclonal a n t i b o d i e s . Hybridoma 1985; 4 : 27 1 - 17 6 .

30. F r i g u e t B, Dj avad i - Oha n i ance L, Goldberg ME. Some monoclonal a n t i b o d i e s r a i s e d w i t h a n a t i v e p r o t e i n b ind p r e f e r e n t i a l l y t o t h e d e n a t u r e d a n t i g e n . Mol Immunol 1984; 21 :673-677 .

31. Newman PR, C o r s t v e t RE, P a n c i e r a RJ. D i s t r i b u t i o n o f P a s t e u r e l l aha e m o l y t i ca and P a s t e u r e l l a mu l to c i da in t h e bovine lung f o l l o w i n g v a c c i n a t i o n and c h a l l e n g e as an i n d i c a t o r o f lung r e s i s t a n c e . Am J Vet Res 1982; 43 : 471-422 .

32. Gent ry MJ, C o r s t v e t RE, P a n c i e r a RJ. E x t r a c t i o n o f c a p s u l a rm a t e r i a l f rom P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1982; 43 :2070-2073 .

33. Hedd les ton KL, G a l l a g h e r JE, Rebers PA. Gel d i f f u s i o n p r e c i p i t i n t e s t f o r s e r o t y p i n q P a s t e u r e l l a mu l to c i d a from a v i a n s p e c i e s . Avian Dis 1972; 16 :925-936 .

34. Shewen PE, Wi l k i e BN. V a c c i n a t i on o f c a l v e s wi t h l e u k o t o x i c c u l t u r e s u p e r n a t e from P a s t e u r e l l a h a e m o l y t i ca . Can J Vet Res 1988; 5 2 : 30 - 36 .

35. Confer AW, L e s s l e y , BA, P a n c i e r a RJ, Fu l t on RW, Kreps JA. Serum a n t i b o d i e s t o a n t i g e n s d e r i v e d from a s a l i n e e x t r a c t o f P a s t e u r e l l a h a e m o l y t i c a : c o r r e l a t i o n wi t h r e s i s t a n c e t o e x p e r i me n t a l bov ine pneumonic p a s t e u r e l l o s i s . Vet Immunol Immunopathol 1985; 10 :265-278 .

36. L e s s l e y BA, Confer AW, Mosier DA, Gent ry MJ, Durham JA Rummage JA. S a l i n e - e x t r a c t e d a n t i g e n s o f P a s t e u r e l l a h a e m o l y t i c a : s e p a r a t i o n by c h r o ma t o f o c u s i n g , p r e l i m i n a r y c h a r a c t e r i z a t i o n , and e v a l u a t i o n o f immunogeni c i t y . Vet Immunol Immunopathol 1985; 10 :279-296 .

37. Matsumota M, Schmi tz JA, Syuto B, Watrons BJ, Mat t son DE. Immunogenici ty o f a s o l u b l e a n t i g e n a g a i n s t P a s t e u r e l l a h a e m o l y t i c a - a s s o c i a t e d pneumonia in c a l v e s . Vet Res Commun 1984; 8 : 117 - 130 .

38. Yates WDG, S t o c k d a l e PHG, Babiuk LA, Smith RJ. P r e v en t i on o f e x pe r i me n t a l bov ine pneumonic p a s t e u r e l l o s i s wi t h an e x t r a c t o f P a s t e u r e l l a h a e m o l y t i c a . Can J Comp Med 1983; 47 :250-256 .

39. F r i end SCE, Wi lk i e BN, Thomson RG, Barnuum DA. Bovine pneumonic p a s t e u r e l l o s i s : e x p e r i me n t a l i n d u c t i o n in v a c c i n a t e d and n o n v ac c i n a t e d c a l v e s . Can J Comp Med 1977; 4 1 : 7 7 - 83 .

Page 36: Characterization and Application of Monoclonal Antibody

22

40. Mar t i n SW, Meek AH, Davis DG, Johnson JA, C u r t i s RA. F ac t o r s a s s o c i a t e d wi t h m o r b i d i t y and m o r t a l i t y in f e e d l o t c a l v e s : t h e Bruce County b e e f p r o j e c t , y e a r two. Can J Comp Med 1981; 45 : 103 - 112 .

41. Confer AW, P a n c i e r a RJ, Fu l t on RW, e t a l . E f f e c t o f v a c c i n a t i o n w i t h l i v e o r k i l l e d P a s t e u r e l l a h a e m o l y t i ca on r e s i s t a n c e t o e x pe r i me n t a l bov ine pneumonic p a s t e u r e l l o s i s . Am J Vet Res 1985; 4 6 : 342 - 347 .

42. Schno r r KL, Todd WJ, C o r s t v e t , RE, A u s t i n FW, Nobles D. I d e n t i f i c a t i o n and l o c a l i z a t i o n o f P a s t e u r e l l a ha e mol y t i ca a n t i g e n s by monoclonal a n t i b o d i e s . The F i r s t I n t e r n a t i o n a l V e t e r i n a r y Immunology Symposium, pg 133.

43. P e t e r s H, J u r s M, J ann B e t a l . Monoclonal a n t i b o d i e s t o e n t e r o b a c t e r i a l common a n t i g e n and t o E s c h e r i c h i a c o l i1i p o p o l y s a c c h a r i d e o u t e r c o r e : Demons t r a t i on o f an a n t i g e n i c d e t e r m i n a n t s h a r e d by e n t e r o b a c t e r i a l common a n t i g e n and E. c o l i K5 c a p s u l a r p o l y s a c c h a r i d e . I n f e c t Immun 1985; 50 :459-466 .

44. Makela PH, Mayer H. E n t e r o b a c t e r i a l common a n t i g e n . B a c t e r i o l Rev 1976; 40 : 591 - 632 .

45. Mayer H, Schmidt G. Chemis t ry and b i o l o g y o f t h e e n t e r o b a c t e r i a l common a n t i g e n (ECA). Cur r Top Mi c rob i o l Immunol 1979; 8 5 : 99 - 153 .

46. Lugowski C, Romanowska E, Keene L, Li ndberg B. I d e n t i f i c a t i o n o f a t r i s a c c h a r i d e r e p e a t i n g u n i t in t h e e n t e r o b a c t e r i a l common a n t i g e n . C a r bohydr a t e Res 1983; 118:173-181 .

Page 37: Characterization and Application of Monoclonal Antibody

CHAPTER 2

BOVINE NEUTROPHIL RESPONSE TO PASTEURELLA HAEMOLYTICA ANTIGENS:

MEASUREMENT OF CYTOTOXIN ACTIVITY IN A COLORIMETRIC ASSAY

SUMMARY

A c o l o r i m e t r i c a s s a y , based on m i t o c h o n d r i a l r e d u c t i o n o f a

t e t r a z o l i u m dye ( 3 - ( 4 , 5 - d i m e t h y l t h i a z o l - 2 - y l ) - 2 , 5 - d i p h e n y l t e t r a z o l i u m

bromide) (MTT) was a d ap t e d f o r t h e measurement o f P a s t e u r e l l a

h ae m o l y t i c a s e r o t y p e 1 c y t o t o x i n u s i n g bovine n e u t r o p h i l s . Cy t o t ox i n

was produced in a d e f i n e d medium and c o n c e n t r a t e d by u l t r a f i l t r a t i o n .

Five c y t o t o x i n p r e p a r a t i o n s , a p r e c o n c e n t r a t e , a 15:1 c o n c e n t r a t e , an

u l t r a f i I t r a t e and 15:1 c o n c e n t r a t e s i n a c t i v a t e d a t e i t h e r 56C o r by

b o i l i n g f o r 1 h r f o l l owe d by c l a r i f i c a t i o n , were used t o measure

c y t o t o x i n a c t i v i t y in t h e a s s a y . Chemical and immunologic methods

were used t o i d e n t i f y and q u a n t i t a t e a n t i g e n s in t h e c y t o t o x i n

p r e p a r a t i o n s . N e u t r o p h i l c y t o t o x i c i t y was i d e n t i f i e d as i n h i b i t i o n o f

t e t r a z o l i u m dye r e d u c t i o n which i n d i c a t e d t h a t n e u t r o p h i l s were

k i l l e d . At d i f f e r e n t c o n c e n t r a t i o n s each o f t h e c y t o t o x i n

p r e p a r a t i o n s , e x c e p t t h e u l t r a f i l t r a t e , caused n e u t r o p h i l s t i m u l a t i o n

o f t e t r a z o l i u m dye r e d u c t i o n r e l a t i v e t o unexposed c e l l s whe t he r

c y t o t o x i c i t y was p r e s e n t o r n o t . R e s u l t s o f t h i s s t u d y i n d i c a t e t h e

MTT c o l o r i m e t r i c a s s a y can measure bov ine n e u t r o p h i l c y t o t o x i c i t y o r

s t i m u l a t i o n . N e u t r op h i l s t i m u l a t i o n o f t e t r a z o l i u m dye r e d u c t i o n may

r e f l e c t a c t i v a t i o n v i a t h e r e s p i r a t o r y b u r s t in r e s po n s e t o c y t o t o x i n

p r e p a r a t i o n a n t i g e n s .

23

Page 38: Characterization and Application of Monoclonal Antibody

24

INTRODUCTION

The p a t h o g e n e s i s o f bov ine pneumonic p a s t e u r e l l o s i s ( s h i p p i n g

f e v e r ) i s c u r r e n t l y r ec o g n i z e d t o i n v o l v e t h e i n t e r a c t i o n o f many

1 2h o s t , pa t hogen and env i ro n me n t a l f a c t o r s . 5 The s e v e r e f i b r i n o u s

pneumonia c h a r a c t e r i z i n g t h i s d i s e a s e i s most commonly a s s o c i a t e d wi t h

lower r e s p i r a t o r y t r a c t i n f e c t i o n by P a s t e u r e l l a h a e m o l y t i ca s e r o t y p e

1-31. In t h e a c u t e s t a g e s o f pneumonic p a s t e u r e l l o s i s , a s i g n i f i c a n t

s t e p in t h e p a t h o g e n e s i s i s t h e r a p i d acc u mu l a t i o n o f p r i m a r i l y

4-7n e u t r o p h i l s in a l v e o l a r s p a c e s .

During l o g a r i t h m i c - p h a s e g rowt h , P. ha e mol y t i ca has been shown t o

l i b e r a t e a s o l u b l e c y t o t o x i n ( l e u k o t o x i n ) which i s s p e c i f i c a l l y

c y t o l y t i c f o r rumi nan t pulmonary macrophages , p e r i p h e r a l blood

8-12mononuclear c e l l s , and n e u t r o p h i l s . ~ Cy t o t ox i n i s b e l i e v e d t o

c o n t r i b u t e t o t h e p a t h o g e n e s i s o f t h e pulmonary l e s i o n by d i r e c t l y

i mp a i r i n g phagocy t e f u n c t i o n and hence b a c t e r i a l c l e a r a n c e from t he

l ung . Cy t o t ox i n may f u r t h e r c o n t r i b u t e t o t h e p a t h o g e n e s i s by c a u s in g

t h e r e l e a s e a n d / o r g e n e r a t i o n o f i n f l ammat ory m e d i a t o r s from

n e u t r o p h i l s . P. h a e m o l y t i c a c y t o t o x i n has been c h a r a c t e r i z e d as a

h e a t l a b i l e , t r y p s i n s e n s i t i v e p r o t e i n wi t h an a p p r ox i ma t e m o l e c u l a r

we i gh t o f 105 ,000. The c y t o l y t i c a c t i v i t y can be n e u t r a l i z e d by1 1 fi

a n t i b o d y from a v a r i e t y o f s o u r c e s . " R e s i s t a n c e t o e x p e r i m e n t a l l y

induced and n a t u r a l l y o c c u r i n g pneumonic p a s t e u r e l l o s i s has been

c o r r e l a t e d wi t h h igh t i t e r s o f c y t o t o x i n n e u t r a l i z i n g serum

17-19a n t i b o d i e s . However, c y t o t o x i n p r e p a r a t i o n s c o n t a i n s e v e r a l

s o l u b l e a n t i g e n s o f P. h a e m o l y t i c a i n c l u d i n g c a p s u l a r p o l y s a c c h a r i d e s ,

20-221i p o p o l y s a c c h a r i d e s and p o s s i b l y o t h e r u n i d e n t i f i e d components .

The d i v e r s i t y o f serum a n t i b o d i e s and t h e i m p u r i t i e s o f c y t o t o x i n

Page 39: Characterization and Application of Monoclonal Antibody

25

p r e p a r a t i o n s a n t i g e n s have hampered i d e n t i f i c a t i o n o f many, p o s s i b l y

i m p o r t a n t i n t e r a c t i o n s between n e u t r o p h i l s and t h e s e components .

Most a s s a y s d e s i gne d t o q u a n t i t a t e c y t o t o x i n have r e l i e d on

plasma membrane damage as an i n d i c a t o r o f a c t i v i t y . These a s s a y s

8 9 11 12 14i n c l u d e measurement o f t r y p a n b l u e dye e x c l u s i o n , *

^ c h r o mi u m r e l e a s e , 8 > 1 0 , 1 1 , 1 4 , 1 6 mi c r o t j - t e r n e u t r a l r ed

19 23 24d y e - e l u t i o n , ’ and monol ayer i n t e g r i t y . A d d i t i o n a l l y , a luminol

depende n t ch e mi l u mi n e s c e n t ( LDCL) - i nhb i t i on a s s a y has been d e s c r i b e d ,or n c

u s i n g bovine n e u t r o p h i l s , f o r d e t e c t i n g c y t o t o x i n a c t i v i t y . *

These a s s a y s have a l s o been used t o measure c y t o t o x i n n e u t r a l i z a t i o n

by a n t i b o d y in serum and n a s a l o r b r o n c h o a l v e o l a r wa s h i ngs . The

LDCL- inhbi t i on a s s a y was found t o be t h e most s e n s i t i v e in d e t e c t i n g

c y t o t o x i n a c t i v i t y when compared t o a s s a y s depende n t on c e l l l y s i s and

25membrane i n t e g r i t y as i n d i c a t o r s o f c y t o t o x i c i t y . I t was

h y p o t h e s i z e d t h a t t h e LDCL - i n h b i t i o n a s s a y was more s e n s i t i v e

beca use i t measured m e t a b o l i c impai rment o f t h e n e u t r o p h i l .

Most r e c e n t l y a m i c r o t i t e r c o l o r i m e t r i c a s s a y based on MTT

( 3 - ( 4 , 5 - d i m e t h y l t h i a z o l - 2 - y l ) - 2 , 5 - d i p h e n y l t e t r a z o l i u m bromide) dye

r e d u c t i o n by bov ine n e u t r o p h i l s was r e p o r t e d t o q u a n t i t a t e c y t o t o x i n

27and i t s n e u t r a l i z a t i o n . The MTT c o l o r m e t r i c a s s a y was a da p t ed from

28t h e methods o r i g i n a l l y d e s c r i b e d by Mossmann f o r t h e q u a n t i t a t i o n o f

c e l l u l a r p r o l i f e r a t i o n and c y t o t o x i c i t y . The MTT c o l o r i m e t r i c a s s a y

has s i n c e been r e p o r t e d to measure c e l l u l a r a c t i v a t i o n i nde pe nde n t o f

29p r o l i f e r a t i o n . The p r i n c i p l e o f t h i s a s s a y i s t h e r e d u c t i o n o f

y e l l o w MTT dye t o a da rk b l u e i n s o l u b l e formazan by m e t a b o l i c a l l y

a c t i v e m i t o c h o n d r i a and i t s s ub se q u e n t p h o t o m e t r i c q u a n t i t a t i o n .

MTT c o l o r i m e t r i c a s s a y s o f f e r a un i que means o f measu r i ng n e u t r o p h i l

Page 40: Characterization and Application of Monoclonal Antibody

26

r e s po n s e t o t o x i n s and a n t i g e n s because n e u t r o p h i l s undergo a

3 0 -3 2r e s p i r a t o r y b u r s t i n v o l v i n g i n c r e a s e d m i t o c h o n d r i a l a c t i v i t y .

Assays o f n e u t r o p h i l me tabo l i sm i n r e s p o n s e t o P. ha e mol y t i ca

a n t i g e n s i n c y t o t o x i n p r e p a r a t i o n s a r e needed t o ga i n a b e t t e r

u n d e r s t a n d i n g o f t h e p a t h o g e n e s i s in pneumonic p a s t e u r e l l o s i s . The

p u r pos e s o f t h i s s t u d y were t o a d a p t , o p t i m i z e , and v a l i d a t e t h e MTT

c o l o r i m e t r i c a s s a y u s i n g bovine n e u t r o p h i l s f o r t h e measurement o f

c y t o t o x i n a c t i v i t y and t o i d e n t i f y component a n t i g e n s in c y t o t o x i n

p r e p a r a t i o n s u s i n g monoclonal a n t i b o d i e s and chemica l methods . The

MTT c o l o r i m e t r i c a s s a y was a l s o adap t ed f o r t h e s e l e c t i o n and

a s s e s s m e n t o f a c y t o t o x i n n e u t r a l i z i n g monoclonal a n t i b o d y and t o

d e t e r m i n e t h e e f f e c t s o f o t h e r monoclonal a n t i b o d i e s a g a i n s t a n t i g e n s

in c y t o t o x i n p r e p a r a t i o n s on n e u t r o p h i l r e s p o n s e s .

MATERIALS AND METHODS

B a c t e r i a l c u l t u r e s and c y t o t o x i n p r o d u c t i o n :

P a s t e u r e l l a h a e m o l y t i ca b i o t y p e A, s e r o t y p e 1, o r i g i n a l l y

i s o l a t e d from t h e t r a c h e a o f a f e e d l o t c a l f , was m a i n t a i n e d by

l y o p h i l i z a t i o n in skim mi lk and p e r i o d i c animal pas s age as p r e v i o u s l y

33d e s c r i b e d . L y o p h i l i z e d c u l t u r e s were r e c o n s t i t u t e d and s t r e a k e d f o r

i s o l a t i o n on a g a r p l a t e s c o n t a i n i n g 10% ( v / v ) c i t r a t e d bov ine b l ood ,

1% ( v / v ) h o r s e serum, and 1% ( v / v ) y e a s t h y d r o l y s a t e . I s o l a t e d

c o l o n i e s were s e l e c t e d and suspended in D u l b e c c o ' s phospha t e b u f f e r e d

s a l i n e (PBS, pH7.4) f o r c o n f l u e n t i n c o l u a t i o n o f f r e s h media . Agar

p l a t e s were i n c u b a t e d in c a n d l e j a r s a t 37C f o r 18 t o 24 h r .

Co n f l u e n t c u l t u r e s were h a r v e s t e d , suspended in D u l b e c c o ' s PBS, and

a d j u s t e d t o an o p t i c a l d e n s i t y o f 0 . 25 a t 650 nm u s i n g a 1:10

Page 41: Characterization and Application of Monoclonal Antibody

27

gd i l u t i o n . Thi s s u s p e n s i o n c o n t a i n e d 1X10 CFU/ml as d e t e r mi ne d by

p l a t e c o u n t .

P. h a emol y t i ca c y t o t o x i n was produced in a d e f i n e d medium u s i n g

m o d i f i c a t i o n s o f p r e v i o u s l y d e s c r i b e d m e t h o d s . ^ A 10 .0 ml sample o f

t h e b a c t e r i a l s u s p e n s i o n was used t o i n o c l u l a t e 500 ml RPMI-1640,

c o n t a i n i n g lOmM L- g l u t a mi ne and 10 mM sodium b i c a r b o n a t e , g i v i n g a

f i n a l i n o c u l a t i o n d e n s i t y o f 2X10^ CFU/ml. Fo l lowing i n c u b a t i o n f o r

5 . 5 h r a t 37C in t h e p r e s e n c e o f 5% CO2 , t h e b a c t e r i a were p e l l e t e d by

c e n t r i f u g a t i o n a t 12 ,000 xg f o r 30 min a t 4C. The s u p e r n a t e was

c o l l e c t e d , pa s sed t h r ough a 0 . 22 um f i l t e r , and c o n c e n t r a t e d 15:1

u s i n g a PM-30 membrane f i t t e d in an u l t r a f i l t r a t i o n c e l l a t 4C.

Samples o f p r e c o n c e n t r a t e d c y t o t o x i n and c y t o t o x i n u l t r a f i l t r a t e were

r e t a i n e d f o r s u b se q u e n t a n a l y s i s . A l i q u o t s o f c o n c e n t r a t e d c y t o t o x i n

were h e a t i n a c t i v a t e d a t e i t h e r 56C f o r 1 hr o r by b o i l i n g f o r 1 hr

f o l l owe d by a h igh speed c e n t r i f u g a t i o n s t e p and 0 . 22 urn f i l t r a t i o n .

The b a c t e r i a l p e l l e t s and c y t o t o x i n p r e p a r a t i o n s were c u l t u r e d on t h e

a p p r o p r i a t e media t o e n s u r e p u r i t y and s t e r i l i t y r e s p e c t i v e l y .

Cy t o t o x in p r e p a r a t i o n s were s t o r e d a t -70C.

A n a l y s i s o f t h e c y t o t o x i n p r e p a r a t i o n s :

P r o t e i n c o n c e n t r a t i o n s o f t h e c y t o t o x i n p r e p a r a t i o n s were

34d e t e r mi n e d u s i n g t h e method o f B r ad f o r d . Q u a n t i t a t i o n o f

35hexosamines was per fo rmed a c c o r d i n g t o p r e v i o u s l y p u b l i s h e d methods .

An t i ge ns p r e s e n t in t h e c y t o t o x i n p r e p a r a t i o n s were q u a n t i t a t e d in

ELISA u s i n g p r e v i o u s l y d e f i n e d monoclonal a n t i b o d i e s ( Chap t e r 1) .

F i f t y pi d i l u t i o n s o f t h e c y t o t o x i n p r e p a r a t i o n s i n D u l b e c c o ' s PBS

were d e s s i c a t e d in t h e w e l l s o f 96 wel l p l a t e s o v e r n i g h t . The

Page 42: Characterization and Application of Monoclonal Antibody

ads o r bed a n t i g e n s were n o t t r e a t e d wi t h a f i x a t i v e and monoclonal

a n t i b o d i e s i n a s c i t i c f l u i d ( 1 : 2 0 d i l u t i o n ) were used t o q u a n t i t a t e

t h e a n t i g e n s . The r ema i n i ng ELISA s t e p s were comple ted as d e s c r i b e d

( Ch a p t e r 1) . The a n t i g e n t i t e r was e x p re s s e d as t h e i n v e r s e o f t h e

h i g h e s t d i l u t i o n p r oduc i ng an abs o r ba nc e va l ue 1.5 t i mes g r e a t e r t ha n

normal mouse serum used as a c o n t r o l . C y t o t ox i c a c t i v i t y p r e s e n t in

t h e 5 c y t o t o x i n p r e p a r a t i o n s was de t e r mi ne d u s i n g bovine n e u t r o p h i l s

8 9 11and t r y p a n b l u e dye e x c l u s i o n . ’ * E q u i v a l e n t p r o p o r t i o n s o f

n e u t r o p h i l s and c y t o t o x i n p r e p a r a t i o n s were used i n t h e t r y p a n b lu e

dye e x c l u s i o n and MTT c o l o r i m e t r i c a s s a y s f o r c y t o t o x i n a c t i v i t y .

P r e p a r a t i o n o f bov ine n e u t r o p h i l s :

Bovine n e u t r o p h i l s were p r e p a r e d u s i n g m o d i f i c a t i o n s o f t h e

36method d e s c r i b e d by Boyum. B r i e f l y , h e p a r i n i z e d b lood (10 U/ml) was

c e n t r i f u g e d a t 500xg f o r 30 min a t 22C and t h e b u f f y c o a t s and upper

t h i r d o f t h e packed c e l l volume were c o l l e c t e d . The c o n t a mi n a t i n g

e r y t h r o c y t e s were l y s ed w i t h an equal volume o f i c e co l d 0.87% NH^Cl

(pH 7 . 2 ) f o r 15 min. The r e s u l t i n g l e u k o cy t e s were p e l l e t e d a t 200 xg

f o r 5 min and washed t w i c e in cal c ium-magnes ium f r e e Hank' s b a l an c e d

s a l t s o l u t i o n ( pH7 . 4 ) . The l e u k o c y t e s u s p e n s i o n was c a r e f u l l y l a y e r e d

on d i s c o n t i n u o u s d e n s i t y g r a d i e n t s c o n t a i n i n g F i c o l 1 - sod i um

d i a t r i z o a t e 1 .077 g/ml on t o p o f 1 .119 g / m l . N e u t r o p h i l s were

i s o l a t e d a t t h e 1 . 0 7 7 / 1 . 1 1 9 g/ml i n t e r p h a s e by c e n t r i f u g a t i o n a t 400xg

f o r 15 min a t 22C. The mononuc lea r c e l l l a y e r a t t h e upper g r a d i e n t

i n t e r p h a s e was d i s c a r d e d . N e u t r o p h i l s were washed t h r e e t i me s p r i o r

t o s u s p e n s i o n in D u l b e c c o ' s PBS f o r enumera t i on and u s e . Thi s

p r o ce d u r e r o u t i n e l y produced c e l l s u s p e n s i o n s c o n s i s t i n g o f a t l e a s t

Page 43: Characterization and Application of Monoclonal Antibody

29

90% n e u t r o p h i l s w i t h an o v e r a l l v i a b i l i t y o f g r e a t e r t ha n 95% when

e v a l u a t e d by d i f f e r e n t i a l s t a i n s and t r y pa n b l ue dye e x c l u s i o n . The

n e u t r o p h i l s u sp e n s i o n was a d j u s t e d t o a f i n a l working c o n c e n t r a t i o n o f

5 X 106 c e l l s / m l .

E v a l u a t i o n o f MTT formazan s o l v e n t s :

One hundred ul a l i q u o t s o f t h e n e u t r o p h i l s u s p e n s i o n (5 X 10^

c e l l s / m l ) were d e l i v e r e d t o t h e w e l l s o f a 96 wel l f l a t bot tom t i s s u e

c u l t u r e p l a t e u s i n g a m u l t i c h a n n e l p i p e t t o r . The p l a t e was

c e n t r i f u g e d f o r 5 min a t 500xg t o f a c i l i t a t e n e u t r o p h i l a d h e r en c e .

A l i q u o t s (25 u l ) o f MTT dye a t 5 mg/ml Du l b e c c o ' s PBS were added t o

t h e w e l l s and t h e n e u t r o p h i l s were a l l owed t o r educe t h e dye f o r 4

h r a t 37C. D i f f e r e n t o r g a n i c s o l v e n t s , d e t e r g e n t s , and combi na t i ons

( lOOp1) were added t o t h e w e l l s and t h e p l a t e was a g i t a t e d on a

micro-ELISA s h a k e r . S o l v e n t s were v i s u a l l y e v a l u a t e d f o r t h e i r

a b i l i t y t o r a p i d l y and c o m p l e t e l y s o l u b i l i z e MTT formazan formed by

n e u t r o p h i l monol aye r s in 96 wel l p l a t e s .

V a l i d a t i o n and o p t i m i z a t i o n o f t h e MTT c o l o r i m e t r i c a s s a y :

Two f o l d t e s t t u b e d i l u t i o n s o f t h e n e u t r o p h i l s u s p e n s i o n were6 4

per formed between 5X10 c e l l s / m l and 7.81X10 c e l l s / m l in D u l b e c c o ' s

PBS. A l i q u o t s (100 u l ) o f t h e s e s u sp e n s i o n s were d i s p e n s e d in

r e p l i c a t e s o f 5 i n t o 96 we l l p l a t e s which were t hen c e n t r i f u g e d t o

encour a ge c e l l a d he r e n c e . Twenty f i v e pi a l i q u o t s o f MTT dye (5

mg/ml) were added t o each w e l l . P l a t e s were i n c u b a t e d a t 1 hour

i n t e r v a l s between 1 . 5 and 4 . 5 h r a t 37C. Fol lowing MTT i n c u b a t i o n

wi t h n e u t r o p h i l s , MTT formazan was s o l u b i l i z e d wi t h hexamethyl

Page 44: Characterization and Application of Monoclonal Antibody

30

p h os ph o r i c t r i a m i d e (HMPT) (100 u l ) by v o r t e x i n g f o r 7 min.

S o l u b i l i z e d formazan was q u a n t i t a t e d s p e c t r o p h o t o m e t r i c a l l y w i t h an

ELISA p l a t e r e a d e r s e t a t a t e s t wave l e ng t h o f 570 nm, a r e f e r e n c e

wave l e ng t h o f 630 nm, and a c a l i b r a t i o n s e t t i n g o f 1 . 00 . Cont ro l

b l a n k s , c o n s i s t i n g o f r e p l i c a t e w e l l s i n which MTT was added t o t h e

maximum c e l l # /we l l i mmed i a t e l y p r i o r t o s o l u b i l i z a t i o n , were

s u b t r a c t e d from a b s o r ba n c e v a l u e s and t h e n e t d e t e r m i n e d . The mean

and s t a n d a r d d e v i a t i o n o f t h e r e p l i c a t e t e s t s were de t e r mi n e d and

p l o t t e d .

In a s e p a r a t e s i m i l a r e x p e r i m e n t , methanol o r f o r m a l i n f i x e d and

washed n e u t r o p h i l s were mixed wi t h v i a b l e n e u t r o p h i l s a t v a r i o u s

p r o p o r t i o n s w h i l e keep i ng t h e t o t a l number c o n s t a n t a t e i t h e r 5X 10^

c e l l s / m l o r 2 . 5 X 10^ c e l l s / m l . Absorbance was measured a t 1 hour

i n t e r v a l s between 2 . 5 and 4 . 5 h r a t 37C. The mean and s t a n d a r d

d e v i a t i o n o f 4 r e p l i c a t e w e l l s was d e t e r mi n e d and p l o t t e d .

MTT c o l o r i m e t r i c a s s a y f o r d e t e r m i n a t i o n o f c y t o t o x i n a c t i v i t y :

S e r i a l two f o l d (50 y l ) d i l u t i o n s o f t h e c y t o t o x i n p r e p a r a t i o n s

i n D u l b e c c o ' s PBS were pe r fo rmed i n s e p e r a t e 96 wel l p l a t e s . F i f t y yl

SP-2 /o mur ine myeloma c e l l c o n d i t i o n e d medium (RPMI-1640 wi t h 15%

( v / v ) FCS, 0 . 01 mM h y p o x a n t h i n e , 0 . 0 1 mM t h y m i d i n e , 10 mM sodium

b i c a r b o n a t e , 1% ( v / v ) n o n - e s s e n t i a l amino a c i d s and L - g l u t a m i n e ) was

added t o each w e l l . A l i q u o t s (100 u l ) o f t h e n e u t r o p h i l s u s p e n s i o n (5

X 10^ c e l l s / m l ) were added t o t h e w e l l s and t h e p l a t e s were i n c u b a t e d

f o r 20 min a t 37C. Fo l lowing i n c u b a t i o n , t h e p l a t e s were c e n t r i f u g e d

and g e n t l y washed wi t h t h r e e 150 yl volumes o f D u l b e c c o ' s PBS and

a s p i r a t e d t o remove i n t r a c e l l u l a r p r o d u c t s r e l e a s e d from t h e

Page 45: Characterization and Application of Monoclonal Antibody

31

n e u t r o p h i l s . N e u t r op h i l c y t o l y s i s was a l s o examined in w e l l s u s i n g an

i n v e r t e d l i g h t m i c r os co p e . T w e n t y - f i ve ul a l i q u o t s o f MTT s o l u t i o n

were added t o t h e w e l l s and t h e n e u t r o p h i l s were a l l owed t o r educe t h e

dye f o r 4 h r a t 37C. The r e s u l t i n g formazan was s o l u b i l i z e d and

q u a n t i t a t e d as d e s c r i b e d . C o n t r o l s c o n s i s t e d o f r e p l i c a t e w e l l s

t r e a t e d i d e n t i c a l l y bu t u s i n g D u l b e c c o ' s PBS in p l a c e o f t h e c y t o t o x i n

p r e p a r a t i o n s and w e l l s in which MTT was added i mmedi a t e l y p r i o r t o

t h e s o l u b i l i z a t i o n s t e p . The mean and s t a n d a r d d e v i a t i o n o f g r o s s

d a t a from 4 r e p l i c a t e s f o r each c y t o t o x i n p r e p a r a t i o n d i l u t i o n was

d e t e r mi n e d and p l o t t e d .

RESULTS

I n i t i a l e x p e r i m e n t s d em o n s t r a t e d t h a t bov ine n e u t r o p h i l s r educed

MTT t o a deep b l u e i n s o l u b l e formazan as has been p u b l i s h e d f o r

l ymphocytes ( F i g u r e I I . 1 ) . However, a c i d i s o p r op a n o l o n l y p a r t i a l l y

d i s s o l v e d MTT formazan u s i n g t h e d e s c r i b e d e x pe r i m e n t a l c o n d i t i o n s .

D i f f e r e n t o r g a n i c s o l v e n t s and d e t e r g e n t s were t h e r e f o r e e v a l u a t e d f o r

t h e i r a b i l i t y t o d i s s o l v e MTT formazan produced by a d h e r e n t

n e u t r o p h i l s . Rapid and compl e t e s o l u b i l i z a t i o n o f MTT formazan was

a c h i e v e d u s i n g HMPT (50% f i n a l c o n c e n t r a t i o n ) and s ha k i ng f o r 7 min.

However, p r o lo n g e d i n c u b a t i o n (>1 hour ) o f HMPT wi t h MTT s o l u t i o n

r e s u l t e d i n s po n t a n e o u s r e d u c t i o n ( da t a no t shown) . O t he r s o l v e n t s

were found t o be u n s a t i s f a c t o r y f o r a v a r i e t y o f r ea s o n s (Tab l e I I . 1 ) .

Page 46: Characterization and Application of Monoclonal Antibody

32

Tabl e I I . 1 - E v a l u a t i o n o f MTT Formazan S o l v e n t s .

★S o l v e n t S o l u b i l i z a t i o n

methanol none

e t h a n o l none

propanol incompl e t e

i s o pr op a n o l (100%,70%,50%) incompl e t e

0 . 0 4 N HC1 i n i s o p r op a n o l incompl e t e

i s o pr op a n o l w i t h 1 t o 10% Tr i t onX-100 i nc ompl e t e

i s o p r op a n o l w i t h 1 t o 10% SDS+ g e l a t i o n o f w e l l s

i s o p r op a n o l i n DMSO ( 7 5 : 2 5 , 50 :50) i nc ompl e t e

DMSO incompl e t e

DMF none

Acetone none

P y r i d i n e o f p l a t e

HMPT r a p i d and comple t e

*used a t 100% u n l e s s i n d i c a t e d

A b b r e v i a t i o n s : SDS = sodium dodecyl s u l f a t e ; DMSO = d imethyl

s u l f o x i d e ; DMF = d imethy l formamide; HMPT = hexamethyl p h os pho r i c

t r i a m i d e .

Page 47: Characterization and Application of Monoclonal Antibody

33

#

#

Fi g u r e I I . 1 - I n t r a c e l l u l a r a g g r e g a t e s and e x t r a c e l l u l a r c r y s t a l s o f

MTT formazan produced by bov i ne n e u t r o p h i l s ; l i g h t mi c r os c o p y , X

1, 000.

Page 48: Characterization and Application of Monoclonal Antibody

570n

m

34

A p l o t o f n e u t r o p h i l number p e r wel l a g a i n s t a b s o r ba nc e a t 570 nm

r e v e a l e d a n o n - l i n e a r r e l a t i o n s h i p a t each c o n c e n t r a t i o n o ve r t ime

( F i g u r e I I . 2 ) .

0 .2 7 0 4 .5 hours

3 .5 hours

0.2022 .5 hours

1.5 hours0 .1 3 5

0 .0 6 7

0 .0 0 00 .0 7 8 0 .1 5 6 0 .3 1 2 0 .6 2 5 1.25 2 .5 0 5 .0 0

Neutrophil Numbers (X 106 )/well

F i g u r e I I . 2: N o n l i n e a r i t y o f a bs o r ba nc e v e r s e s n e u t r o p h i l number a t

v a r i o u s t i me i n t e r v a l s in t h e MTT c o l o r i m e t r i c a s s a y .

Page 49: Characterization and Application of Monoclonal Antibody

uiuozs

Rear rangement o f t h i s d a t a showed t h e r e was a l i n e a r r e l a t i o n s h i p

between abs o r ba nc e and t i me a t a c o n s t a n t n e u t r o p h i l number ( F i g u r e

I I . 3 ) .

0 .2 7 0 5.0X1 OVwell

0 .2 0 2

0 .1 3 52.5X1 OVwell

0 .0 6 7■fl.25 X 1 0 /well* 6 .2 5 X 1 o V w e l l * 3 .1 2 X 1 0 /well0 .0 0 0

1.5 2 .5 3 .5 4.5Incubation Time - Hours

F i g u r e I I . 3 - L i n e a r r e l a t i o n s h i p between abs o r ba nc e and MTT

i n c u b a t i o n t i me a t d i f f e r e n t n e u t r o p h i l numbers p e r w e l l .

Page 50: Characterization and Application of Monoclonal Antibody

“ - - - ~ - -s sys t em absorbance resu ltc

a d v e r s e l y a f f e c t e d ( F i g u r e I , . 4 ) . " 0 t

0 .2 2 5

0 .1 6 8

c n v l 0 5/w e l l live

g 0.112ID

<

0 .0 5 6

0 . 0 0 02.5

3 .7 5 X 1 0 s/well live 1.25X lo V w e l l fixed 1

2 .5 X 1 0 s/w e l l live: 2 .5 X 1 0 s/w e i l f ix e d ,2 .5 X1 OVwell live- 1 .8 7 X 1 0 s/well l i v e .

6 .25X 10V w el l fixed1 .25 X 1 0s/well live

l".25X10*/well fixed

3.5Incubation Time - Hours 4.5

neutropfiiis ^

produced iden t ica i r e su i ts (not sdoun). " " ^ neUtr°phils

The optimum conditions for the MTT •

* 5 X 10* neutrophils per weH w i t h a m i 7 ^ ^ ^ *

u s i n g HMPT as a formazan s o l v e n t . ^ a t l ° " ^ ° f 4 ^ ^

Page 51: Characterization and Application of Monoclonal Antibody

37

D i f f e r e n t dose r e s p o n s e cu r ves were produced u s i n g each o f t h e 5

c y t o t o x i n p r e p a r a t i o n s . P r e c o n c e n t r a t e d c y t o t o x i n r e s u l t e d in an

immediate l i n e a r c o n c e n t r a t i o n dependent i n c r e a s e in abso r bance

f o l l owe d by i n c r e a s e d dye r e d u c t i o n r e l a t i v e t o unexposed n e u t r o p h i l s

( F i g u r e I I . 5 ) .

0 . 1 6 0

0 .1 4 0

0 .1 2 0

EeoN

< 0.100 PreconcentratedCytotoxin

0 . 0 8 0

0 . 0 6 0 ■

0 1 2 3 4 5 6 7 8 9 10 11Log2 -Cytotoxin Dilution

F i g u r e 1 1 . 5. Dose r e s p o n s e o f bov ine n e u t r o p h i l s exposed t o t h e

p r e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n in t h e MTT c o l o r i m e t r i c a s s a y ,

♦ i n d i c a t e s a b s o r b a n c e t e s t va l ue o b t a i n e d u s i n g unexposed n e u t r o p h i l s .

Page 52: Characterization and Application of Monoclonal Antibody

38

N e u t r o p h i l s r esponded w i t h more v a r i a n c e t o t h e h i g h e r d i l u t i o n s o f

p r e c o n c e n t r a t e d c y t o t o x i n . Ce l l l y s i s was no t e v i d e n t in p l a t e w e l l s

u s i n g an i n v e r t e d m i c r o s c o p e , even a t low d i l u t i o n s o f p r e c o n c e n t r a t e d

c y t o t o x i n . Trypan b l u e dye e x c l u s i o n a s s a y s r e v e a l e d minimal

c y t o t o x i c i t y and mor pho l og i c a l change upon exposu r e t o t he

p r e c o n c e n t r a t e d p r e p a r a t i o n (Tab l e I I . 2 ) .

Tab l e 1 1 . 2. C y t o t o x i c i t y o f t h e Cy t o t ox i n P r e p a r a t i o n s Determined

Using Trypan Blue Dye Ex c l u s io n .

Cy t o t ox i n P r e p a r a t i o n *•k

% C y t o t o x i c i t y

P r e c o n c e n t r a t e 20

15x C o n c e n t r a t e 90-95

U l t r a f i l t r a t e 5

56C/ l ho u r - 15x C o n c e n t r a t e 10

B o i l e d / l h o u r - 15x C o n c e n t r a t e 5

*Trypan b l u e dye e x c l u s i o n a s s a y per fo rmed u s i n g same p r o p o r t i o n o f

n e u t r o p h i l s and c y t o t o x i n p r e p a r a t i o n s as in c o l o r i m e t r i c a s s a y .

tUsed a t 100%, no d i l u t i o n .

A s igmoi da l r e l a t i o n s h i p between a b s o r ba n c e and c o n c e n t r a t e d

c y t o t o x i n d i l u t i o n was e s t a b l i s h e d u s i n g t h e MTT c o l o r i m e t r i c a s s a y .

I n c r e a s i n g t h e c y t o t o x i n c o n c e n t r a t i o n lowered t h e i n i t i a l s t a r t i n g

a b s o r ba n c e o f t h e p r e c o n c e n t r a t e d p r e p a r a t i o n and deve l oped a b a s e l i n e

up t o a 1 :8 d i l u t i o n ( F i g u r e I I . 6 ) .

Page 53: Characterization and Application of Monoclonal Antibody

39

0 .1 4 515x Concentrated

Cytotoxin

0 .1 2 5

0 .1 0 5

Eeor*

< 0 .0 8 5

0 .0 6 5

0 .0 4 5

0 1 2 3 4 5 6 7 8 9 10 11Log2 -Cytotoxin Dilution

Fi g u r e I I . 6 - Sigmoidal dose r e s p o n s e o f bovine n e u t r o p h i l s exposed t o

t h e 15:1 c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n in t h e MTT c o l o r i m e t r i c

a s s a y . * i n d i c a t e s a b s o r ba n c e produced by normal n e u t r o p h i l s .

Thi s b a s e l i n e was f o l l owe d by a l i n e a r c o n c e n t r a t i o n dependen t

i n c r e a s e in ab s o r ba n c e wi t h i n c r e a s i n g c y t o t o x i n d i l u t i o n s i m i l a r t o

t h e p r e c o n c e n t r a t e d p r e p a r a t i o n . The c o n c e n t r a t e d c y t o t o x i n

p r e p a r a t i o n a l s o caused enhanced dye r e d u c t i o n a t h igh d i l u t i o n s

r e l a t i v e t o unexposed c e l l s . The b a s e l i n e o f t h i s cu r ve c o n s i s t e d o f

Page 54: Characterization and Application of Monoclonal Antibody

40

t o t a l l y l y s ed c e l l s and MTT r e d u c t i o n t o formazan was no t e v i d e n t when

viewed wi t h an i n v e r t e d m i c r o s c o pe . The c o n c e n t r a t e d c y t o t o x i n

p r e p a r a t i o n produced 90-95% c y t o t o x i c i t y as a s s e s s e d by t r y p a n b l ue

dye e x c l u s i o n (Tab l e I I . 2 ) .

The u l t r a f i l t r a t e f rom c y t o t o x i n c o n c e n t r a t i o n , c o n t a i n i n g

a n t i g e n s l e s s t ha n 30 KD, produced a l i n e a r , c o n c e n t r a t i o n i nde penden t

r e l a t i o n s h i p when ab s o r ba n c e was p l o t t e d a g a i n s t d i l u t i o n ( F i g u r e

I I . 7 ) .

0 . 1 5 0Cytotoxin

Ultrafiltrate

0 .1 4 0

0 . 1 3 0

0 . 1 2 0

0.110

0.100

0 . 0 9 0 0 1 2 3 4 5 6 7 8 9 10 11Log2 -Cytotoxin Dilution

F i g u r e I I . 7. Dose r e s p o ns e o f bovine n e u t r o p h i l s t o c y t o t o x i n

u l t r a f i l t r a t e in t h e MTT c o l o r i m e t r i c a s s a y . *abso r bance v a l ue o f

n e u t r o p h i l s no t exposed t o c y t o t o x i n .

Page 55: Characterization and Application of Monoclonal Antibody

41

Dye r e d u c t i o n by n e u t r o p h i l s appe a r e d t o be i nd e pe n d e n t o f

u l t r a f i l t r a t e d i l u t i o n and ex t r eme v a r i a t i o n was o b t a i n e d a t each

a s s a y p o i n t . No d i f f e r e n c e in n e u t r o p h i l morphology was obs e r ve d

among t h e w e l l s u s i n g an i n v e r t e d mi c r os c o p e . N e u t r o p h i l s exposed t o

c y t o t o x i n u l t r a f i l t r a t e were no t undergo i ng c y t o l y s i s as e v i de n c e d by

t r y p a n b l u e dye e x c l u s i o n ( Tab l e I I . 2 ) .

I n a c t i v a t i o n o f t h e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n , by

h e a t i n g a t 56C f o r 1 h r produced a b e l l shaped cu r ve in t he

c o l o r i m e t r i c a s s a y ( F i g u r e I I . 8 ) .

Page 56: Characterization and Application of Monoclonal Antibody

42

0 . 1 5 5

0 . 1 4 5

0 . 1 3 5EcoNU»

< 0 . 1 2 5

0 . 1 1 5 15x Concentrated Cytotoxin

56°C 1 hour0 .1 0 5

0 1 2 3 4 5 6 7 8 9 10 11Log2 -Cytotoxin Dilution

Fi g u r e I I . 8. Dose r e s p o n s e o f bov i ne n e u t r o p h i l s exposed t o 15:1

c o n c e n t r a t e d c y t o t o x i n which had been i n a c t i v a t e d wi t h mi l d h e a t (56°C

f o r 1 h r ) . *de no t e s a b s o r b a n c e v a l u e produced by unexposed c e l l s .

The b a s e l i n e and lowered i n i t i a l s t a r t i n g a b s o r ba n c e o f t h e f u l l y

a c t i v e c o n c e n t r a t e d p r e p a r a t i o n was a b s e n t . However, MTT r e d u c t i o n by

n e u t r o p h i l s i n c r e a s e d w i t h r e s p e c t t o d i l u t i o n , t he n d e c r e a s e d t o an

ab s o r ba n c e v a l u e c h a r a c t e r i s t i c o f unexposed c e l l s . Ne u t r op h i l l y s i s

was n o t a p p a r e n t i n t h e p l a t e w e l l s and c y t o t o x i c i t y was no t e v i d e n t

v i s u a l l y u s i n g t r y p a n b l u e dye .

Page 57: Characterization and Application of Monoclonal Antibody

43

B o i l i n g t h e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n f o r 1 h r , f o l l owed

by c l a r i f i c a t i o n , r e s u l t e d i n a d i f f e r e n t dose r e s po ns e by t h e

n e u t r o p h i l s ( F i g u r e I I . 9 ) .

0 .1 5 5

0 .1 4 5

0 .1 3 5

EeON10

< 0 .1 2 5

15x Concentrated Cytotoxin

Boiled 1 hour * = 0 . 0 9 5 +/-0.007

0 .10 5

Log 2 "Cytotoxin Dilution

Fi g u re I I . 9. Dose r e s p o n s e o f n e u t r o p h i l s t o b o i l e d and c l a r i f i e d

c o n c e n t r a t e d ( 1 5 : 1 ) c y t o t o x i n . * i n d i c a t e s normal n e u t r o p h i l s .

MTT r e d u c t i o n was g r e a t e s t when t h e b o i l e d p r e p a r a t i o n was used a t t h e

h i g h e s t t e s t c o n c e n t r a t i o n and t he n d e c r e a s e d w i t h d i l u t i o n o f t h e

c y t o t o x i n p r e p a r a t i o n . The c y t o t o x i n u l t r a f i l t r a t e and h e a t

i n a c t i v a t e d p r e p a r a t i o n s caused n e u t r o p h i l s t o r es pond w i t h more

v a r i a n c e as i n d i c a t e d by t h e l a r g e s t a n d a r d d e v i a t i o n s c h a r a c t e r i z i n g

Page 58: Characterization and Application of Monoclonal Antibody

44

each d i l u t i o n . Cel l l y s i s was no t e v i d e n t in p l a t e w e l l s and

c y t o t o x i c i t y was n o t e v i d e n t u s i n g t r y p a n b l ue dye wi t h t h e s e

p r e p a r a t i o n s .

Chemical and immunologic a n a l y s i s o f t h e c y t o t o x i n p r e p a r a t i o n s

d e m o n s t r a t e d d i f f e r e n c e s i n t h e p r o t e i n and a n t i g e n c o n t e n t wh i l e

hexosamine c o n c e n t r a t i o n remained r e l a t i v e l y c o n s t a n t (Table I I . 3 ) .

The u l t r a f i l t r a t e , f rom c y t o t o x i n c o n c e n t r a t i o n , c o n t a i n e d a n e a r l y

e q u i v a l e n t hexosamine c o n c e n t r a t i o n r e l a t i v e t o t h e c o n c e n t r a t e d

p r e p a r a t i o n s , bu t o n l y t h e p a n - p a s t e u r e l l a c a r b o h y d r a t e a n t i g e n was

d e t e c t e d a t s i g n i f i c a n t l e v e l s as d e t e c t e d by monoclonal a n t i b o d i e s in

ELISA. Hea t i ng t h e c o n c e n t r a t e d p r e p a r a t i o n a t 56C f o r 1 h r d id not

a l t e r t h e ELISA r e a c t i v i t y o f t h e a n t i g e n s . B o i l i n g t h e c o n c e n t r a t e d

p r e p a r a t i o n , f o l l owe d by c l a r i f i c a t i o n , s i g n i f i c a n t l y reduced t h e

amount o f 29 k i l o d a l t o n p r o t e i n and i t was u n d e t e c t a b l e u s i n g ELISA.

The r ema i n i ng a n t i g e n s were no t a f f e c t e d by b o i l i n g .

Page 59: Characterization and Application of Monoclonal Antibody

45

Table I I . 3 - Chemical and Immunologic C h a r a c t e r i z a t i o n o f t h e

Cy t o t ox i n P r e p a r a t i o n s .

Assay

C y t o t ox i n P r e p a r a t i o n s

Pre-Con­

c e n t r a t e

15:1 Con­

c e n t r a t e

U l t r a ­

f i l t r a t e 5 6 C / l h r

Bo i l ed

/ I h r

P r o t e i n (ug/ml ) <5. 0 70 . 0 0 . 0 6 6 . 0 <10.0

Hexosamine (yM/ml) 0 . 038 0 . 050 0 . 045 0 . 050 0 . 050

McAb ELISA:*

L i p o p o l y s a c c h a r i d e 64 >256 0 >256 >256

P a n - p a s t e u r e l l a CH^O >256 >256 256 >256 >256

Ser o t ype 1 s p e c i f i c Ag 32 >256 0 >256 >256

29KD p r o t e i n 64 >256 4 >256 0

★Monocolonal a n t i b o d i e s were used a t c o n s t a n t c o n c e n t r a t i o n s (1 : 20

a s c i t i c f l u i d d i l u t i o n ) in ELISA. Ant i ge n t i t e r was e x p r e s s e d as t he

i n v e r s e o f t h e h i g h e s t d i l u t i o n p r o d u c i n g an a ds o r ba nc e va l ue 1.5 t imes

g r e a t e r t han t h e a bs o r ba nc e o b t a i n e d wi t h normal mouse serum.

Page 60: Characterization and Application of Monoclonal Antibody

46

DISCUSSION

In t h e p r e s e n t s t u d y , bov ine n e u t r o p h i l s were obs e r ved t o reduce

MTT dye t o a deep b l u e formazan under d e f i n e d c o n d i t i o n s in D u l b e c c o ' s

PBS. The MTT formazan o c c u r r e d as i n t r a c e l l u l a r a g g r e g a t e s and

e x t r a c e l l u l a r c r y s t a l s . E x t r a c e l l u l a r c r y s t a l f o rm a t i on i n d i c a t e d

p a r t i a l s o l u b i l i t y o f MTT formazan in D u l b e c c o ' s PBS. T h e r e f o r e , a

s o l v e n t was sough t t o d i s s o l v e MTT formazan w i t h o u t removing t h e wel l

c o n t e n t s t o e n s u r e measurement o f a l l r educed MTT. Acid i s o p r o p a n o l ,

28 29used s u c c e s s f u l l y by o t h e r i n v e s t i g a t o r s , 5 was no t e f f e c t i v e under

our e x p e r i me n t a l c o n d i t i o n s because i t would not c o mp l e t e l y s o l u b i l i z e

MTT formazan when d i l u t e d by t he wel l c o n t e n t s . HMPT was found t o be a

r a p i d and comple t e formazan s o l v e n t t h a t was e f f e c t i v e in t h e p r e s en c e

o f t h e wel l c o n t e n t s . HMPT d i d not i n t e r f e r e wi t h a b s o r ba n c e a t a t e s t

wave l eng t h o f 570 nm and a r e f e r e n c e wave leng th o f 630 nm and

e f f e c t i v e l y s o l u b i l i z e d n e u t r o p h i l s and t h e formazan t h e y p roduced .

A n o n - l i n e a r r e l a t i o n s h i p between a b s o r ba n c e and n e u t r o p h i l number

p e r wel l was e s t a b l i s h e d u s i n g t h e d e s c r i b e d p r o c e d u r e s . Thi s i s in

d i r e c t c o n t r a d i c t i o n t o o t h e r r e p o r t s which d e s c r i b e a l i n e a r

28 29r e l a t i o n s h i p between t h e s e p a r a m e t e r s . ’ Al though many c o n d i t i o n s

i n t h i s s t u d y were v a r i e d from t h o s e o r i g i n a l l y d e s c r i b e d , t h e r ea s on

f o r t h i s n o n - l i n e a r i t y remains l a r g e l y un d e t e r mi n e d . However, a

c o o p e r a t i v e e f f e c t by t h e n e u t r o p h i l s i n MTT r e d u c t i o n i s a p l a u s a b l e

e x p l a n a t i o n . Our a s s a y p r oc e d u r e p roduces a l i n e a r r e l a t i o n s h i p

between abs o r ba nc e and MTT i n c u b a t i o n t ime a t c o n s t a n t c e l l numbers .

The s l o p e o f t h e s e l i n e a r r e l a t i o n s h i p s a t d i f f e r e n t c e l l numbers

i n c r e a s e d wi t h r e s p e c t t o i n c r e a s i n g c e l l c o n c e n t r a t i o n which s u p p o r t s

a c o o p e r a t i v e e f f e c t o f t h e n e u t r o p h i l s in dye r e d u c t i o n . When

Page 61: Characterization and Application of Monoclonal Antibody

47

ab s o r ba n c e was p l o t t e d a g a i n s t MTT i n c u b a t i o n t i me by o t h e r

28 29i n v e s t i g a t o r s , n o n - l i n e a r r e l a t i o n s h i p s wre o b t a i n e d . ’ I t was

h y p o t h e s i z e d t h a t p r o g r e s s i v e c e l l de a t h d u r i n g MTT i n c u b a t i o n was

r e s p o n s i b l e f o r t h e n o n - l i n e a r i t y . L a t e r t h i s was proven and c o r r e c t e d

29v a l u e s r e v e a l e d a l i n e a r r e l a t i o n s h i p ove r t i me . The l i n e a r

r e l a t i o n s h i p between a d s o r ba n c e and t ime in t h i s s t u d y i n d i c a t e d a

c o n s t a n t r a t e o f MTT r e d u c t i o n . The r a t e o f MTT r e d u c t i o n was no t

a f f e c t e d by mixing e i t h e r methanol o r f o r ma l i n f i x e d and washed

n e u t r o p h i l s w i t h normal c e l l s in t h e a s s a y .

O p t i m i z a t i o n and v a l i d a t i o n s t u d i e s o f t h e MTT c o l o r i m e t r i c a s s a y

u s i n g bovine n e u t r o p h i l s r e s u l t e d in t h e d e c i s i o n t o use HMPT as a MTT5

formazan s o l v e n t , 5X10 n e u t r o p h i l s p e r w e l l , and a MTT i n c u b a t i o n t ime

o f 4 h r f o r t h e measurement o f c y t o t o x i n a c t i v i t y . The l a t t e r two

p a r am e t e r s were chosen because t h e y produced a n e a t l y c o n f l u e n t

monolayer and me a s u re a b le a b s o r ba n c e v a l u e s r e s p e c t i v e l y .

C y t o t ox i n a c t i v i t y i n t h e MTT c o l o r i m e t r i c a s s a y was measured

u s i n g d i f f e r e n t c y t o t o x i n p r e p a r a t i o n s which v a r i e d in t h e i r a b i l i t y t o

cause c y t o t o x i c i t y as a s s e s s e d by t r y p a n b l u e dye e x c l u s i o n a s s a y s .

The p r e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n i n h i b i t e d MTT r e d u c t i o n a t

low d i l u t i o n s r e l a t i v e t o unexposed n e u t r o p h i l s . I n c r e a s i n g t h e

c y t o t o x i n c o n c e n t r a t i o n caused f u r t h e r i n h i b i t i o n o f MTT r e d u c t i o n and

t o t a l l y l y s ed c e l l s . I n a c t i v a t e d c y t o t o x i n p r e p a r a t i o n s d i d n o t cause

i n h i b i t i o n o f MTT r e d u c t i o n . The i n h i b i t i o n o f MTT r e d u c t i o n was

i n t e r p r e t e d as c y t o t o x i n a c t i v i t y i n t h e MTT c o l o r i m e t r i c a s s a y .

Enhanced MTT r e d u c t i o n by t h e n e u t r o p h i l s o cc u r r e d in r e s po n s e t o

a l l c y t o t o x i n p r e p a r a t i o n s e x c e p t t h e u l t r a f i l t r a t e . N e u t r o p h i l s were

s t i m u l a t e d t o r educe more MTT a t d i f f e r e n t c o n c e n t r a t i o n s among t h e

Page 62: Characterization and Application of Monoclonal Antibody

48

c y t o t o x i n p r e p a r a t i o n s . A p p a r e n t l y enhanced m i t o c h o n d r i a l a c t i v i t y

o c c u r r e d a t d i f f e r e n t c o n c e n t r a t i o n s o f t h e p r e p a r a t i o n s whe t he r

c y t o t o x i c a c t i v i t y was p r e s e n t o r n o t . These f i n d i n g s i n d i c a t e t h e MTT

c o l o r i m e t r i c a s s a y i s c a p a b l e o f measu r i ng more t han n e u t r o p h i l

c y t o l y s i s . Enhanced MTT dye r e d u c t i o n most l i k e l y r e f l e c t s n e u t r o p h i l

a c t i v a t i o n v i a t h e r e s p i r a t o r y b u r s t . Ne u t r op h i l a c t i v a t i o n

may a c c o u n t f o r t h e i r r a p i d and i n t e n s e i n f l u x i n t o pulmonary t i s s u e

4-7f o l l o w i n g e x p e r i m e n t a l c h a l l e n g e .

From t h e r e s u l t s o b t a i n e d , i t i s u n c l e a r whe t he r c y t o t o x i n a t low

c o n c e n t r a t i o n s , i n a c t i v a t e d c y t o t o x i n , o t h e r component a n t i g e n s , o r

comb i n a t i on s o f them a r e r e s p o n s i b l e f o r n e u t r o p h i l s t i m u l a t i o n o f MTT

r e d u c t i o n . S i nce most p r o t e i n was removed from t h e b o i l e d p r e p a r a t i o n ,

which caused n e u t r o p h i l s t i m u l a t i o n o f MTT r e d u c t i o n , i t i s u n l i k e l y

t h a t p r o t e i n in i t s e l f was r e s p o n s i b l e f o r n e u t r o p h i l a c t i v a t i o n .

S i m i l a r l y , beca use t he o n l y d e t e c t a b l e a n t i g e n in t h e u l t r a f i l t r a t e was

p a n - p a s t e u r e l l a c a r b o h y d r a t e , which d i d no t cause n e u t r o p h i l

a c t i v a t i o n , i t i s u n l i k e l y t h i s a n t i g e n was s o l e l y r e s p o n s i b l e f o r

enhanced MTT r e d u c t i o n . L i p o p o l y s a c c h a r i d e and c a p s u l a r p o l y s a c c h a r i d e

were t h e on l y two a n t i g e n s , d e t e c t a b l e u s i n g t h e d e s c r i b e d methods ,

which were common t o a l l p r e p a r a t i o n s r e s u l t i n g in n e u t r o p h i l

s t i m u l a t i o n . C l e a r l y , more e x t e n s i v e f r a c t i o n a t i o n o r p u r i f i c a t i o n o f

a n t i g e n s in t h e c y t o t o x i n p r e p a r a t i o n s a r e needed t o i d e n t i f y

components r e s p o n s i b l e f o r n e u t r o p h i l a c t i v a t i o n .

Because c y t o t o x i n a c t i v i t y was c h a r a c t e r i z e d in t h e p r e s en ce o f

SP-2 / o mur ine myeloma c e l l c o n d i t i o n e d medium, t h e MTT c o l o r i m e t r i c

a s s a y shou l d be r e a d i l y a d a p t a b l e f o r t h e s e l e c t i o n o f a c y t o t o x i n

n e u t r a l i z i n g monoclonal a n t i b o d y . Measurement o f c y t o t o x i n a c t i v i t y in

Page 63: Characterization and Application of Monoclonal Antibody

49

t h e p r e s e n c e o f o t h e r body f l u i d s , such as immune and non-immune

s e rums , na s a l o r b r o n c h o a l v e o l a r wa s h i n g s , may e x t e n d t h e use o f t h i s

a s s a y f o r s t u d y i n g o t h e r i n t e r a c t i o n s . F u r th e r mo r e , t h e i n c o r p o r a t i o n

o f monoclonal a n t i b o d i e s t o component a n t i g e n s o f c y t o t o x i n

p r e p a r a t i o n s may a i d i d e n t i f i c a t i o n o f n e u t r o p h i l m e t a b o l i c r e s p o n s e s

t o p a r t i c u l a r a n t i g e n s o r t h e i r immune complexes . The MTT c o l o r i m e t r i c

a s s a y has p o t e n t i a l a p p l i c a t i o n f o r i n v e s t i g a t i n g t h e m e t a b o l i c

r e s po ns e o f n e u t r o p h i l s f rom o t h e r s p e c i e s t o a wide v a r i e t y o f

a n t i g e n s , t o x i n s and a n t i b o d i e s .

Page 64: Characterization and Application of Monoclonal Antibody

BIBLIOGRAPHY

1. Thompson RG, Chander S, Savan M, Fox ML. I n v e s t i g a t i o n o f f a c t o r s o f p r o b a b l e s i g n i f i c a n c e in t h e p a t h o g en e s i s o f pneumonic p a s t e u r e l l o s i s i n c a t t l e . Can J Comp Med 1975;39 : 194-207 .

2. L i l l i e LE. The bovine r e s p i r a t o r y d i s e a s e complex. Can Vet J 1974;15 : 233-242 .

3. J e ns e n R, P i e r s o n RE, Braddy PM, e t a l . Sh ipp ing f e v e r pneumonia i n y e a r l i n g f e e d l o t c a t t l e . J Am Vet Med Assoc 1976;169: 500-506.

4. B r e i d e r MA, Walker RD, Hopkins FM, e t a l . Plumonary l e s i o n s i nduced by P a s t e u r e l l a ha e mol y t i ca in n e u t r o p h i l s u f f i c i e n t and n e u t r o p h i l d e f i c i e n t c a l v e s . Can J Vet Res 1988;52:205-209.

5. Slocombe RF, Mahark J , I n g e r s o l l R, e t a l . Impor t ance o f n e u t r o p h i l s in t h e p a t h o g e n e s i s o f a c u t e pneumonia p a s t e u r e l l o s i s in c a l v e s . Am J Vet Res 1985; 46: 2253-2258.

6. Walker RD, Hopkins FM, S hu l t z TW, e t a l . Changes in l e u k o c y t e p o p u l a t i o n i n pulmonary l a vage f l u i d s o f c a l v e s a f t e r i n h a l a t i o n o f P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1985;46:2429-2433.

7. Slocombe RF, Derksen FJ , Robinson NE, e t a l . I n t e r a c t i o n o f c o l ds t r e s s and P a s t e u r e l l a h a e mol y t i ca in t h e p a t h o g e n e s i s o f pneumonic p a s t e u r e l l o s i s in c a l v e s : Method o f i n d u c t i o n andhema t o l og i c and p a t h o l o g i c changes . Am J Vet Res 1984;45 : 1757-1763 .

8. Berggren KA, Ba l uyu t CS, Simonson RR e t a l . C y t o t ox i c e f f e c t s o f P a s t e u r e l l a h a e m o l y t i ca on bovine n e u t r o p h i l s . Am J Vet Res 1981;42 : 1383-1388 .

9. Himmel ME, Yates MD, Lauerman LH, S q u i r e PG. P u r i f i c a t i o n and p a r t i a l c h a r a c t e r i z a t i o n o f a macrophage c y t o t o x i n from P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1982;43 : 764-767 .

10. Shewen PE, Wi l k i e BN. Evidence f o r t h e P a s t e u r e l l a haemol y t i ca c y t o t o x i n as a p r o d u c t o f a c t i v e l y growing b a c t e r i a . Am J Vet Res 1985; 46 : 1212 - 1214 .

11. Shewen PE, Wi lk i e BN. Cy t o t ox i n o f P a s t e u r e l l a haemol y t i ca a c t i n g on bovine l e u k o c y t e s . I n f e c t Immun 1982; 35 : 91-94 .

12. Kaeh le r KL, Markham RJF, Muscopla t CC, Johnson DW. Evidence o f t h e s p e c i e s s p e c i f i c i t y in t h e c y t o c i d a l e f f e c t s o f P a s t e u r e l l a h a e m o l y t i c a . I n f ec Immun 1980 ; 30 : 615-616 .

13. Chang Y-F, Renshaw, H.W., Ri c ha r ds AB. P a s t e u r e l l a ha e mol y t i cal e u k o t o x i n : Phys i ochemi ca l c h a r a c t e r i s t i c s and s u s c e p t i b i l i t y o fl e u k o t o x i n t o e n zyma t i c t r e a t m e n t . Am J Vet Res 1986 ; 47 : 716-723 .

50

Page 65: Characterization and Application of Monoclonal Antibody

51

14. Ba l uyu t CS, Simonson RR, Bewrick WJ, Maheswaran SK. I n t e r a c t i o n o f P a s t e u r e l l a ha e mol y t i ca w i t h bov ine n e u t r o p h i l s :I d e n t i f i c a t i o n and p a r t i a l c h a r a c t e r i z a t i o n o f a c y t o t o x i n . Am Vet Res 1981;42 : 1920-1926 .

15. Chang Y-F, Young RY, Pos t D, S t r uc k DK. I d e n t i f i c a t i o n and c h a r a c t e r i z a t i o n o f t h e P a s t e u r e l l a h a e mo l y t i ca l e u k o t o x i n .I n f e c t Immun. 1987 ; 55 : 2348-2354 .

16. Cho HJ, Bohac JG, Yates WDG, Ohmann HB. A n t i c y t o t o x i n a c t i v i t y o f bov ine s e r a and body f l u i d s a g a i n s t P a s t e u r e l l a h a emol y t i ca Al c y t o t o x i n . Can J Comp Med 1984;48 : 151-155 .

17. Shewen PE, Wi l k i e BN. P a s t e u r e l l a ha e mol y t i ca c y t o t o x i n n e u t r a l i z i n g a c t i v i t y in s e r a from O n t a r i o b e e f c a t t l e . Can J Comp Med 1983;47 : 497-498 .

18. Gent ry MJ, Confer AW, P a n c i e r a RJ. Serum n e u t r a l i z a t i o n of c y t o t o x i n from P a s t e u r e l l a ha e mol y t i ca s e r o t y p e 1 and r e s i s t a n c e t o e x pe r i me n t a l bov ine pneumonic p a s t e u r e l l o s i s . Vet Immunol. Immunopathol 1985; 9 :239 - 250 .

19. Moore RN, Walker RD, Shaw GA, Hopkins FM, Shul l BS.A n t i l e u k o t o x i n a n t i b o d y produced in t h e bovine lung a f t e r a e r o s o l e xpos u r e t o v i a b l e P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1985;46 : 1949-1952 .

20. Shewen PE, Wi l k i e BN. V a c c i n a t i o n o f c a l v e s wi t h l e u k o t o x i c c u l t u r e s u p e r n a t a n t f rom P a s t e u r e l l a h a e m o l y t i c a . Can J Vet Res 1988 ; 52 : 30 - 36 .

21. Otulakowski GL. Shewen PE, Udoh AE, Me l l o r s A, Wi lk i e BN. P r o t e o l y s i s o f s i a l o g y c o p r o t e i n s by P a s t e u r e l l a haemol y t i ca c y t o t o x i c c u l t u r e s u p e r n a t a n t . I n f e c t Immun 1983 ; 42 : 64- 70 .

22. Mosier DA, Less l e y BA, Confer AW, Antone SM, Gent ry MJ. Chromatographic s e p a r a t i o n and c h a r a c t e r i z a t i o n o f P a s t e u r e l l a ha e mol y t i ca c y t o t o x i n . Am J Vet Res 1986;47 : 2233-2241 .

23. Gr ee r CN, Shewen PE. Automated c o l o r i m e t r i c a s s a y f o r t h e d e t e c t i o n o f P a s t e u r e l l a h a e m o l y t i ca l e u k o t o x i n . Vet Mic rob i o l 1986; 12 :33-42 .

24. Gent ry MJ, Confer AW, Kreps JA. Simple v i s u a l a s s a y f o r d e t e r m i n a t i o n o f P a s t e u r e l l a h a e m o l y t i ca c y t o t o x i n n e u t r a l i z i n g a n t i b o d y t i t e r s in c a t t l e s e r a . J . C l i n Mi c rob i o l 1985; 22 : 968-972 .

25. Chang Y-F, Renshaw HW, Marens RJ, L i v i n g s t o n CW. P a s t e u r e l l a h a e m o l y t i ca l e u k o t o x i n : Chemi luminescent r e s po n s es o f p e r i p h e r a l b lood l e u k o t y t e s f rom s e v e r a l d i f f e r e n t mammalian s p e c i e s t o l e u k o t o x i n - and o p s o n i n - t r e a t e d l i v i n g and k i l l e d P a s t e u r e l l a ha e mol y t i ca and S t a p h y l oc o c c u s a u r e u s . Am J Vet Res 1986 ; 47 : 67 - 74 .

Page 66: Characterization and Application of Monoclonal Antibody

52

26. Chang Y-F, Rensbaw HW. P a s t e u r e l l a h a e mol y t i ca l e u k o t o x i n : Compar ison o f chromium r e l e a s e , t r y p a n b l u e dye e x c l u s i o n , and luminol depende n t c h e m i l u m i n e s c e n c e - i n h i b i t i o n a s s a y s f o r s e n s i t i v i t y in d e t e c t i n g l e u k o t o x i n a c t i v i t y . Am J Vet Res 1986 ;47 : 134 - 138 .

27. Vega MV, Maheswaran SK, L e i n i n g e r JR, Ames TR. A d a p t a t i on o f a c o l o r i m e t r i c m i c r o t i t r a t i o n a s s a y f o r q u a n t i f y i n g P a s t e u r e l l a h a e m o l y t i ca Al l e u k o t o x i n and a n t i l e u k o t o x i n . Am J Vet Res. 1987 ;48 : 1559-1564 .

28. Mossmann T. Rapid c o l o r i m e t r i c a s s a y f o r c e l l u l a r growth and s u r v i v a l : A p p l i c a t i o n t o p r o l i f e r a t i o n and c y t o t o x i c i t y a s s a y s .J Immunol Meth 198 3 ; 6 5 : 55 - 63 .

29. G e r l i e r D, Thomasset N. Use o f t h e MTT c o l o r i m e t r i c a s s a y t o measure c e l l a c t i v a t i o n . J Immunol Meth 1986 ; 94 : 57 - 63 .

30. El sbach P, Weiss J . Oxygen-dependent and o x yge n - i nde pe nde n t mechanisms o f m i c r o b i c i d a l a c t i v i t y o f n e u t r o p h i l s . Immunol L e t t e r s 1985; 11 : 159-163 .

31. Bo r r e g a a r d N. The r e s p i r a t o r y b u r s t o f p h a g o c y t o s i s :B i oc he mi s t r y and s u b c e l l u l a r l o c a l i z a t i o n . Immunol L e t t e r s 1985 ;11 : 165 - 171 .

32. S p i t z n a g e l JK. Mi c r ob i o l i n t e r a c t i o n s wi t h n e u t r o p h i l s . Rev I n f e c t Dis 1983; 5 ( suppl 4) S806-S822.

33. Newman PR, C o r s t v e t RE, P a n c i e r a RJ. D i s t r i b u t i o n o f P a s t e u r e l l a h a e mo l y t i ca and P a s t e u r e l l a m u l t o c i d a in t h e bov ine lung f o l l o w i n g v a c c i n a t i o n and c h a l l e n g e e xpos u r e as an i n d i c a t o r o f lung r e s i s t a n c e . Am J Vet Res 1982; 43 : 417-422 .

34. B r a d f o r d MM. A r a p i d and s e n s i t i v e method f o r t h e q u a n t i t a t i o n o f microgram q u a n t i t i e s o f p r o t e i n u t i l i z i n g t h e p r i n c i p l e o f p r o t e i n - d y e b i n d i n g . Anal Biochem 1976; 72 :248-254 .

35. Smith RL, G i l k e r s o n E. Q u a n t i t a t i o n o f g l ycosami nog l ycan hexosamine u s i n g 3 - m e t h y l - 2 - b e n z o t h i a z o l o n e hydrazone h y d r o c h l o r i d e . Anal Biochem 1979; 98 : 478- 480 .

36. Boyum A. S e p a r a t i o n o f l e u k o c y t e s f rom b lood and bone marrow. Scand J Cl i n Lab I n v e s t 1968; 21( supp l 9 7 ) : 7 7 - 8 9 .

Page 67: Characterization and Application of Monoclonal Antibody

CHAPTER 3

CHARACTERIZATION OF A NEUTRALIZING MONOCLONAL ANTIBODY PREPARED

AGAINST PASTEURELLA HAEMOLYTICA SEROTYPE 1 CYTOTOXIN

SUMMARY

P a s t e u r e l l a h a e m o l y t i c a s e r o t y p e 1 (Ph-1) c y t o t o x i n was produced

in a d e f i n e d medium, c o n c e n t r a t e d by u l t r a f i l t r a t i o n and used t o

immunize BALB/c mice f o r monoclonal a n t i b o d y p r o d u c t i o n . A hybridoma

produc i ng a n t i b o d y c a p a b l e o f c y t o t o x i n n e u t r a l i z a t i o n was s e l e c t e d

u s i n g a t e t r a z o l i u m dye (MTT) c o l o r i m e t r i c a s s a y wi t h i s o l a t e d bov ine

p e r i p h e r a l b lood n e u t r o p h i l s as t a r g e t c e l l s . Ne u t r o ph i l r e s po n s e t o

o t h e r d e f i n e d monoclonal a n t i b o d i e s , s e l e c t e d by ELISA, a g a i n s t

component a n t i g e n s in t h e c y t o t o x i n p r e p a r a t i o n was a l s o e v a l u a t e d i n

t h e MTT c o l o r i m e t r i c a s s a y . R e a c t i v i t y o f t h e c y t o t o x i n n e u t r a l i z i n g

a n t i b o d y t o 6 and 24 h r c u l t u r e s o f known P. h a e m o l y t i ca (Ph)

s e r o t y p e s as wel l as Ph-1 whole c e l l s , c a p s u l a r m a t e r i a l , and

c y t o t o x i n p r e p a r a t i o n s t r e a t e d in v a r i o u s ways was d e t e r mi n e d u s i n g an

ELISA p r o c e d u r e . A s c i t i c f l u i d c o n t a i n i n g t h e n e u t r a l i z i n g a n t i b o d y

was e v a l u a t e d f o r t h e e x t e n t o f c y t o t o x i n n e u t r a l i z a t i o n u s i n g t h e MTT

c o l o r i m e t r i c a s s a y . Using s t a n d a r d s e r o l o g i c methods t h e i s o t y p e o f

t h e n e u t r a l i z i n g a n t i b o d y was i d e n t i f i e d as IgM. The n e u t r a l i z i n g

a n t i b o d y was no t r e a c t i v e in ELISA wi t h Ph whole c e l l s , c a p s u l a r

m a t e r i a l , o r c y t o t o x i n p r e p a r a t i o n s r e g a r d l e s s o f s e r o t y p e , c u l t u r e

a g e , o r t r e a t m e n t . N e u t r a l i z i n g a c t i v i t y was d e t e c t a b l e a t a

1 :200 , 000 d i l u t i o n o f a s c i t i c f l u i d i n t h e MTT c o l o r i m e t r i c a s s a y .

Monoclonal a n t i b o d i e s s e l e c t e d by ELISA d id no t a f f e c t n e u t r o p h i l

r e s po ns e t o t h e c y t o t o x i n p r e p a r a t i o n in t h e MTT c o l o r i m e t r i c a s s a y .

53

Page 68: Characterization and Application of Monoclonal Antibody

54

INTRODUCTION

Bovine pneumonic p a s t e u r e l l o s i s , commonly known as s h i p p i n g f e v e r ,

i s a s e v e r e f i b r i n o u s bronchopneumonia c a u s i n g ma jo r economic l o s s e s t o

1 2t h e Nor th American f e e d l o t c a t t l e i n d u s t r y . P a s t e u r e l l a h a e m o l y t i c a

s e r o t y p e 1 (Ph-1) i s t h e p a t h o g e n i c a g e n t most f r e q u e n t l y i s o l a t e d in

1-3a s s o c i a t i o n wi t h t h i s d i s e a s e . P. ha e mol y t i ca has been shown t o

s e c r e t e , i n t o c u l t u r a l s u p e r n a t e , a h e a t l a b i l e , immunogenic p r o t e i n

c y t o t o x i n ( l e u k o t o x i n ) which i s s p e c i f i c a l l y c y t o l y t i c f o r r umi nan t

a l v e o l a r macrophages and p e r i p h e r a l b lood l e u k o c y t e s . ^ " ® Cy to t o x i n i s

c u r r e n t l y viewed as a p o t e n t i a l v i r u l e n c e f a c t o r o f P. h a e m o l y t i c a ,

b e l i e v e d t o c o n t r i b u t e t o t h e p a t h o g e n e s i s o f pneumonic p a s t e u r e l l o s i s

t h r ough i t ' s l y t i c e f f e c t on pulmonary d e f e n s e c e l l s . The i n t e r a c t i o n

o f c y t o t o x i n w i t h n e u t r o p h i l s i s t h o u g h t t o be i m p o r t a n t beca use o f t h e

n e u t r o p h i l ' s e a r l y and p r edomi nan t i n f l u x i n t o lung t i s s u e f o l l o w i n g

7 8e x p e r i m e n t a l c h a l l e n g e , 5 a b i l i t y t o c l e a r b a c t e r i a t h r ough

9 10p h a g o c y t o s i s , and p o t e n t i a l t o c a us e t i s s u e damage. * The

a s s o c i a t i o n o f h igh c y t o t o x i n n e u t r a l i z i n g serum a n t i b o d y t i t e r s w i t h

d i s e a s e r e s i s t a n c e may i n d i c a t e t h e i mpor t ance o f c y t o t o x i n in t he

11-13p a t h o g e n e s i s o f pneumonic p a s t e u r e l l o s i s . L i k e wi s e , t h e l ack of

p a t h o p h y s i o l o g i c changes in n e u t r o p e n i c c a t t l e e x p e r i m e n t a l l y

c h a l l e n g e d wi t h P. h a e m o l y t i c a a r e t h o ug h t t o r e f l e c t t h e impor t anceg

o f n e u t r o p h i l s i n t h e d i s e a s e .

However, Ph-1 l i b e r a t e s s e v e r a l s o l u b l e a n t i g e n s i n t o c u l t u r a l

s u p e r n a t e in a d d i t i o n t o c y t o t o x i n which a r e known t o a f f e c t t h e

n e u t r o p h i l . O t he r component a n t i g e n s o f c y t o t o x i n p r e p a r a t i o n s

i n c l u d e 1i p o p o l y s a c c h a r i d e s , c a p s u l a r p o l y s a c c h a r i d e s , o t h e r

c a r b o h y d r a t e s and p r o t e i n s ( Ch a p t e r 2 ) . At t empt s t o p u r i f y c y t o t o x i n

Page 69: Characterization and Application of Monoclonal Antibody

55

from o t h e r s o l u b l e a n t i g e n s o f P. ha e mol y t i ca have r e s u l t e d i n a

14 15s u b s t a n t i a l l o s s o f c y t o t o x i c a c t i v i t y . * Co n s e q u e n t l y , d i r e c t

a s s a y s f o r c y t o t o x i n , i n d e p e n d e n t o f i t s c e l l u l a r e f f e c t s , have no t

been d ev e l op e d .

Because c y t o t o x i n i s immunogenic and i t s e f f e c t s a r e n e u t r a l i z a b l e

by a n t i b o d y we d ec i de d t o use t h e s e p r o p e r t i e s t o deve l op a monoclonal

a n t i b o d y a g a i n s t c y t o t o x i n . S p e c i f i c monoclonal a n t i b o d y a g a i n s t

c y t o t o x i n c ou l d a i d i n i t s i d e n t i f i c a t i o n , q u a n t i t a t i o n , and l a r g e

s c a l e p u r i f i c a t i o n u s i n g con t empor a r y immunologic t e c h n i q u e s .

Fu r th e r m o r e , s p e c i f i c n e u t r a l i z a t i o n o f c y t o t o x i n may a l l ow

i d e n t i f i c a t i o n o f novel i n t e r a c t i o n s o f n e u t r o p h i l s wi t h o t h e r

component a n t i g e n s in c y t o t o x i n p r e p a r a t i o n s . A d d i t i o n a l l y , t h e e f f e c t

o f s p e c i f i c a n t i b o d i e s a g a i n s t component a n t i g e n s o f c y t o t o x i n

p r e p a r a t i o n s i s unknown and c ou l d a l s o i d e n t i f y more s u b t l e

i n t e r a c t i o n s wi t h n e u t r o p h i l s . Assays and r e a g e n t s c o n c e r n i n g t he

i n t e r a c t i o n o f s p e c i f i c a n t i b o d i e s and a n t i g e n s w i t h n e u t r o p h i l s a r e

needed t o ga i n a b e t t e r u n d e r s t a n d i n g o f t h e p a t h o g e n e s i s in pneumonic

p a s t e u r e l l o s i s .

The r e s p o n s e o f n e u t r o p h i l s t o a c t i v e and h e a t i n a c t i v a t e d

c y t o t o x i n p r e p a r a t i o n s in t h e MTT c o l o r i m e t r i c a s s a y has been

c h a r a c t e r i z e d ( Ch a p t e r 2 ) . At d i f f e r e n t c o n c e n t r a t i o n s , both a c t i v e

and i n a c t i v e p r e p a r a t i o n s were found t o s t i m u l a t e n e u t r o p h i l r e d u c t i o n

o f t e t r a z o l i u m dye. Thi s a s s a y was c a r r i e d ou t in t h e p r e s en c e o f

SP-2 /o mur ine myeloma c e l l c o n d i t i o n e d medium f o r e q u i v a l e n c e wi th

n e u t r a l i z a t i o n by monoclonal a n t i b o d y . The p r imary purpose o f t h i s

s t u d y was t o s e l e c t and c h a r a c t e r i z e a n e u t r a l i z i n g monoclonal

a n t i b o d y a g a i n s t Ph-1 c y t o t o x i n u s i n g t h e MTT c o l o r i m e t r i c a s s a y .

Page 70: Characterization and Application of Monoclonal Antibody

56

A d d i t i o n a l o b j e c t i v e s o f t h i s i n v e s t i g a t i o n were t o d e t e r mi n e t h e

e f f e c t o f o t h e r component a n t i g e n s in c y t o t o x i n p r e p a r a t i o n s (Ch a p t e r

2) on bov ine n e u t r o p h i l r e s p o n se s u s i n g d e f i n e d monoclonal a n t i b o d i e s

i n t h e MTT c o l o r i m e t r i c a s s a y .

MATERIALS AND METHODS

P. h a e mo l y t i ca s e r o t y p e 1 c y t o t o x i n :

Ph-1 c y t o t o x i n was produced in RPMI-1640 c o n t a i n i n g lOmM sodium

b i c a r b o n a t e and lOmM L - g l u t a m i n e , c o n c e n t r a t e d 15:1 by

u l t r a f i l t r a t i o n , and s t o r e d a t -70C as p r e v i o u s l y d e s c r i b e d (Chap t e r

2 ).

MTT c o l o r i m e t r i c a s s a y o f c y t o t o x i n a c t i v i t y :

C y t o t o x i c a c t i v i t y in t h e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n was

measured and s t a n d a r d i z e d u s i n g t h e MTT c o l o r i m e t r i c a s s a y d e s c r i b e d in

Ch ap t e r 2. The a s s a y was per formed in t h e p r e s en c e o f SP-2/o mur ine

myeloma c e l l c o n d i t i o n e d medium f o r e q u i v a l e n c e wi t h c y t o t o x i n

n e u t r a l i z a t i o n a s s a y s .

MMT c o l o r i m e t r i c a s s a y f o r c y t o t o x i n n e u t r a l i z a t i o n :

A 1 :8 d i l u t i o n o f t h e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n was used

in t h e MTT c o l o r i m e t r i c a s s a y f o r c y t o t o x i n n e u t r a l i z a t i o n . C y t o t ox i n

n e u t r a l i z a t i o n was de t e r mi n e d by t h e i n t r o d u c t i o n and compar i son o f

e i t h e r n e u t r a l i z i n g o r n o n - n e u t r a l i z i n g se rums , hybridoma c u l t u r a l

s u p e r n a t e s , o r p e r i t o n a l a s c i t i c f l u i d s (50^1) i n p l a c e o f t h e SP-2 / o

mur ine myeloma c e l l c o n d i t i o n e d medium in t h e a s s a y o f c y t o t o x i n

Page 71: Characterization and Application of Monoclonal Antibody

57

a c t i v i t y . N e u t r a l i z a t i o n was a l l owed t o o c c u r f o r 15 min p r i o r t o

a dd i ng t h e n e u t r o p h i l s .

The e x t e n t o f c y t o t o x i n n e u t r a l i z a t i o n :

N e u t r a l i z a t i o n by p e r i t o n e a l a s c i t i c f l u i d s was d e t e r mi n e d u s i n g a

10 f o l d d i l u t i o n s e r i e s i n t h e c o l o r i m e t r i c a s s a y . Def ined monoclonal

a n t i b o d i e s g e n e r a t e d a g a i n s t Ph-1 c a p s u l a r m a t e r i a l (Ch a p t e r 1) were

a l s o e v a l u a t e d in t h e a s s a y . Checkerboard combi na t i ons o f t h e s e

a n t i b o d i e s , in equal p r o p o r t i o n s o f hybridoma c u l t u r a l s u p e r n a t e , were

f u r t h e r examined f o r c y t o t o x i n n e u t r a l i z a t i o n . Wel ls i n which

n e u t r o p h i l s were exposed t o RPMI-1640 in p l a c e o f c y t o t o x i n were used

as p o s i t i v e n e u t r a l i z a t i o n c o n t r o l s t o r e p r e s e n t l i v e c e l l s . Nega t i ve

c o n t r o l s c o n s i s t e d o f n e u t r o p h i l s exposed t o a 1 :8 d i l u t i o n o f

c o n c e n t r a t e d c y t o t o x i n . R e s u l t s were e x p r e s s e d as t h e mean o f

q u a d r u p l i c a t e s p l u s o r minus one s t a n d a r d d e v i a t i o n .

P ro d u c t i o n o f monoclonal a n t i b o d y :

Six t o e i g h t week o l d f ema le BALB/c mice were immunized by

i n t r a p e r i t o n e a l i n j e c t i o n w i t h 0 . 5 ml c o n c e n t r a t e d c y t o t o x i n . Four

weeks l a t e r , mice were immunized a s econd t i me u s i n g t h e same r o u t e

and inoculum. Two weeks f o l l o w i n g t h e second i mmuni z a t i on , mice were

immunized a g a i n by i n t r a v e n o u s i n o c u l a t i o n wi t h 0 . 1 ml c o n c e n t r a t e d

c y t o t o x i n . Three days a f t e r t h e l a s t i mmuni za t i on , s e r a was c o l l e c t e d

f rom t h e r e t r o - o r i b i t a l p l e x u s and e v a l u t e d f o r c y t o t o x i n

n e u t r a l i z a t i o n in t h e MTT c o l o r i m e t r i c a s s a y . A s i n g l e mouse,

p r od u c i n g t h e h i g h e s t a b s o r ba n c e v a l u e in t h e c o l o r i m e t r i c a s s a y f o r

c y t o t o x i n n e u t r a l i z a t i o n , was s e l e c t e d f o r hybridoma p r o d u c t i o n .

Page 72: Characterization and Application of Monoclonal Antibody

58

S p l e n o c y t e s , from t h e mouse n e u t r a l i z i n g t h e most c y t o t o x i n , were

fu s e d wi t h SP-2/o mur ine myeloma c e l l s on t h e f o u r t h day f o l l o wi n g t h e

l a s t immuniza t ion and hybr idomas were s e l e c t e d wi t h HAT medium as

p r e v i o u s l y d e s c r i b e d ( C h a p t e r 1 ) . Hybridoma c u l t u r e s u p e r n a t e s were

e v a l u a t e d f o r c y t o t o x i n n e u t r a l i z a t i o n u s i n g t h e MTT c o l o r i m e t r i c

a s s a y . Hybridomas s e c r e t i n g a n t i b o d y c a p a b l e o f c y t o t o x i n

n e u t r a l i z a t i o n were c l oned by l i m i t i n g d i l u t i o n . A s c i t i c f l u i d s were

produced by i n j e c t i n g c l on e d hybr idomas i n t o t h e p e r i t o n e a l c a v i t y o f

BALB/c mice p r e c o n d i t i o n e d one week in advance wi t h 0 . 5 ml p r i s t a n e .

ELISA r e a c t i v i t y o f t h e c y t o t o x i n n e u t r a l i z i n g monoclonal a n t i b o d y :

R e a c t i v i t y o f t h e c y t o t o x i n n e u t r a l i z i n g monoclonal a n t i b od y wi th

Ph-1 whole c e l l s , c a p s u l a r m a t e r i a l , and c o n c e n t r a t e d c y t o t o x i n

p r e p a r a t i o n s which had been e i t h e r u n t r e a t e d , f i x e d wi t h f o r m a l i n ,

p a r a f o r ma l d e h yd e , o r both were de t e r mi n e d in an ELISA p rocedure

( Chap t e r s 1 and 2 ) . In a s e p a r a t e ELISA e x p e r i me n t , P. haemol y t i ca

s e r o t y p e s 1 t h r ough 12 whole c e l l s from 6 and 24 h r c u l t u r e s were used

as a n t i g e n s . Monoclonal a n t i b o d i e s deve l oped a g a i n s t s e r o t y p e 1

c a p s u l a r m a t e r i a l were used as p o s i t i v e c o n t r o l s . R e a c t i v i t y in ELISA

was de t e r mi n e d u s i n g hybridoma c u l t u r a l s u p e r n a t e s as t h e pr imary

a n t i b o d y s o l u t i o n .

I s o t y p e d e t e r m i n a t i o n :

The i s o t y p e o f t h e c y t o t o x i n n e u t r a l i z i n g monoclonal a n t i b o d y was

d e t e r mi n e d u s i n g c o m m e r i c i a l l y a v a i l a b l e k i t s based on a n t i b o d y c a p t u r e

ELISA and immunod i f fus i on . Hybridoma c u l t u r a l s u p e r n a t e was used in

i s o t y p e d e t e r m i n a t i o n s .

Page 73: Characterization and Application of Monoclonal Antibody

RESULTS

F i g u r e I I I . l i l l u s t r a t e s t h e MTT c o l o r i m e t r i c a s s a y r e s u l t s o f

c y t o t o x i c a c t i v i t y p r e s e n t i n t h e 15:1 c o n c e n t r a t e d c y t o t o x i n

p r e p a r a t i o n .

0 .1 4 515x Concentrated

Cytotoxin

0 .1 2 5

0 .1 0 5

0 .0 8 5

0 .0 6 5

0 .0 4 5

2 3 4 5 6 7 8 9 10 110 1Log2 -Cytotoxin Dilution

F ig u r e I I I . l - Cy t o t o x i c a c t i v i t y p r e s e n t in t h e 15:1 c o n c e n t r a t e d

c y t o t o x i n p r e p a r a t i o n u s i n g t h e MTT c o l o r i m e t r i c a s s a y . A 1:8

d i l u t i o n o f t h e c o n c e n t r a t e d c y t o t o x i n p r e p a r a t i o n was used in t h e

a s s a y f o r c y t o t o x i n n e u t r a l i z a t i o n , i n d i c a t e s a bs o r ba nc e v a l ue

p roduced by normal n e u t r o p h i l s .

Page 74: Characterization and Application of Monoclonal Antibody

60

C y t o t o x i c a c t i v i t y was i n e x c e s s o f n e u t r o p h i l number up t o a 1:8

c y t o t o x i n d i l u t i o n , p r o d u c i n g a b a s e l i n e o f t o t a l l y l y s e d c e l l s . At a

1 : 8 and h i g h e r c y t o t o x i n d i l u t i o n s , ab s o r ba nc e i n c r e a s e d wi t h r e s p e c t

t o d i l u t i o n . T h e r e f o r e , a 1 :8 d i l u t i o n o f t h e c o n c e n t r a t e d c y t o t o x i n

p r e p a r a t i o n was used in t h e MTT c o l o r i m e t r i c a s s a y f o r c y t o t o x i n

n e u t r a l i z a t i o n .

Normal mouse s e r a was i n c a p a b l e o f c y t o t o x i n n e u t r a l i z a t i o n in t h e

MTT c o l o r i m e t r i c a s s a y ( Tab l e I I I . l ) .

Page 75: Characterization and Application of Monoclonal Antibody

61

Tab l e I I I . l - Ant ibody S o l u t i o n s Capable o f Cy t o t ox i n N e u t r a l i z a t i o n

in t h e MTT C o l o r i m e t r i c Assay.

An t ibody S o l u t i o n Cy t o t ox i n N e u t r a l i z a t i o n

Normal mouse serum -

C a p s u l a r m a t e r i a l immune

mouse serum

+

Cy t o t ox i n immune mouse

serum

C a p s u l a r m a t e r i a l monoclonal

a n t i b o d i e s : a n t i - * +

+

1i p o p o l y s a c c h a r i d e -

p a n - p a s t e u r e l l a c a r b o h y d r a t e -

s e r o t y p e 1 c a p s u l a r p o l y s a c c h a r i d e -

29 KD p r o t e i n -

♦Monoclonal a n t i b o d i e s p r e s e n t in e i t h e r hybridoma c u l t u r a l s u p e r n a t e

o r p e r i t o n e a l a s c i t i c f l u i d .

t Ch e cke r boa r d c o m b i n a t i on s o f monoclonal a n t i b o d i e s a g a i n s t c a p s u l a r

m a t e r i a l a n t i g e n s a l s o e v a l u a t e d .

Page 76: Characterization and Application of Monoclonal Antibody

62

Sera from mice immunized w i t h e i t h e r c a p s u l a r m a t e r i a l (Ch a p t e r 1) or

c o n c e n t r a t e d c y t o t o x i n e f f e c t i v e l y n e u t r a l i z e d c y t o t o x i n a c t i v i t y .

T h e r e f o r e , d e f i n e d monoclonal a n t i b o d i e s g e n e r a t e d a g a i n s t P.

h a e m o l y t i c a s e r o t y p e 1 c a p s u l a r m a t e r i a l a n t i g e n s (Chap t e r 1) were

e v a l u a t e d f o r c y t o t o x i n n e u t r a l i z a t i o n . These a n t i b o d i e s d i d not

n e u t r a l i z e c y t o t o x i c a c t i v i t y . Checkerboard c ombi na t i ons o f t h e s e

a n t i b o d i e s were a l s o e v a l u a t e d f o r n e u t r a l i z a t i o n w i t h o u t s uc c e s s

( da t a not shown).

Fo l lowing t h e f u s i o n o f s p l e n o c y t e s , from c y t o t o x i n immune mice ,

wi t h SP-2 /o mur ine myeloma c e l l s , s e l e c t i o n o f a p p r o x i m a t e l y 1000

h y b r i d c e l l s was a cc ompl i she d u s i ng HAT medium. One l i n e from t h e s e

h y b r i d s , t ermed n e u t r a l i z i n g monoclonal a n t i b o d y (nMcAb), was s e l e c t e d

u s i n g c u l t u r e s u p e r n a t e s in t h e MTT c o l o r i m e t r i c a s s a y f o r c y t o t o x i n

n e u t r a l i z a t i o n ( F i g u r e I I I . 2 ) . The hybridoma p roduc i ng t h e nMcAb was

c l oned by l i m i t i n g d i l u t i o n and s e l e c t e d u s i n g t h e MTT c o l o r i m e t r i c

a s s a y f o r c y t o t o x i n n e u t r a l i z a t i o n .

Page 77: Characterization and Application of Monoclonal Antibody

63

0 .295-

0 . 2 2 1 -

£ 0.147- <

0.073- T

0 . 0 0 0 1 i '— — — i— — — i— — — i— i inMcAb *1 * 2 * 3 # 1 0 control 1 control2

Hybridoma Cultural Supernates

Fi g u r e I I I . 2 - Cy t o t ox i n n e u t r a l i z a t i o n by monoclonal a n t i b o d i e s in

t h e MTT c o l o r i m e t r i c a s s a y . nMcAb = n e u t r a l i z i n g monoclonal a n t i b o d y ;

#1 = a n t i - 1 i p o p o l y s a c c h o r i d e ; #2 = a n t i - p a n - p a s t e u r e l l a c a r b o h y d r a t e ;

#3 a n t i - s e r o t y p e 1 c a p s u l a r p o l y s a c c h a r i d e ; #10 = a n t i - 2 9 KD p r o t e i n .

Hybridoma c u l t u r a l s u p e r n a t e s were no t d i l u t e d . Cont ro l A r e p r e s e n t s

l i v e c e l l s no t exposed t o c y t o t o x i n . Cont ro l B r e p r e s e n t s dead c e l l s

exposed t o a 1:8 d i l u t i o n o f c o n c e n t r a t e d c y t o t o x i n .

The e x t e n t o f c y t o t o x i n n e u t r a l i z a t i o n by t h e nMcAb in p e r i t o n e a l

a s c i t i c f l u i d i s d i s p l a y e d in F i g u r e I I I . 3.

Colorimetric Assay for Cytotoxin NeutralizationNeutrophils 5x10s/well Cytotoxin dilution 1:8

_L

Page 78: Characterization and Application of Monoclonal Antibody

64

Colorimetric Assay for Cytotoxin Neutralization0.2951

Neutrophils 5x10a/weli Cytotoxin Dilution 1:8

0 . 2 2 1 -

Eeo 0.147-

0.073 ■

0 .0 0 01:200 1:2000 1:20000 1 :2 00000

Ascitic Fluid Dilution1:201:2

Fi g u r e I I I . 3 - E x t e n t o f c y t o t o x i n n e u t r a l i z a t i o n by t h e nMcAb (--------- )

in a s c i t i c f l u i d compared t o o t h e r n o n - n e u t r a l i z i n g a s c i t i c f l u i d s

( -------) in t h e MTT c o l o r i m e t r i c a s s a y .

Cy t o t ox i n n e u t r a l i z a t i o n was no t d e t e c t a b l e u s i n g a s c i t i c f l u i d s

c o n t a i n i n g monoclonal a n t i b o d i e s a g a i n s t s e r o t y p e 1 c a p s u l a r m a t e r i a l

a n t i g e n s ( Ch a p t e r 1 ) . The n o n - n e u t r a l i z i n g a s c i t i c f l u i d s , c o n t a i n i n g

a n t i b o d i e s a g a i n s t e i t h e r 1i p o p o l y s a c c h a r i d e , p a n - p a s t e u r e l l a

c a r b o h y d r a t e , s e r o t y p e I c a p s u l a r p o l y s a c c h a r i d e o r t h e 29KD p r o t e i n o f

P. h a e m o l y t i c a , produced i d e n t i c a l r e s u l t s in t h e MTT c o l o r i m e t r i c

a s s a y f o r n e u t r a l i z a t i o n . C y t o t ox i n n e u t r a l i z a t i o n by t h e nMcAb was

d e t e c t a b l e o u t t o a 1 : 2 0 0 , 00 0 a s c i t i c f l u i d d i l u t i o n where one

s t a n d a r d d e v i a t i o n o f t h e n e u t r a l i z i n g and n o n - n e u t r a l i z i n g a s c i t i c

f l u i d s conve r ge d .

Page 79: Characterization and Application of Monoclonal Antibody

65

When t h e nMcAb in hybr idoma c u l t u r a l s u p e r n a t e was e v a l u a t e d f o r

r e a c t i v i t y w i t h P. h a e m o l y t i ca a n t i g e n s i n ELISA c o n s i s t a n t l y n e g a t i v e

r e s u l t s were o b t a i n e d . The nMcAb was no t r e a c t i v e wi t h P. ha e mol y t i ca

s e r o t y p e 1 whole c e l l s , c a p s u l a r m a t e r i a l , o r c o n c e n t r a t e d c y t o t o x i n

p r e p a r a t i o n s . The nMcAb was no t r e a c t i v e wi t h P. h a e m o l y t i ca s e r o t y p e s

1 t h r ough 12 whole c e l l s . N e i t h e r a n t i g e n f o r m a l i z a t i o n nor f i x a t i o n

w i t h p a r a f o r ma l de hyde i mpa r t e d ELISA r e a c t i v i t y . Monoclonal a n t i b o d i e s

g e n e r a t e d a g a i n s t Ph-1 c a p s u l a r m a t e r i a l (Ch a p t e r 1) were used as

p o s i t i v e c o n t r o l s , s u b s t a n t i a t i n g t h e n e g a t i v e ELISA r e a c t i v i t y o f t h e

nMcAb.

Both a n t i b o d y c a p t u r e ELISA and immunodi f fus ion conf i rmed t h e

p r e s en ce o f mur ine a n t i b o d y in hybridoma c u l t u r a l s u p e r n a t e s w i t h

n e u t r a l i z i n g a c t i v i t y and i d e n t i f i e d t h e i s o t y p e as an IgM.

DISCUSSION

The e x pe r i me n t a l r e s u l t s d e m o n s t r a t e d t h a t P. h a emol y t i ca

c y t o t o x i n a c t i v i t y can be n e u t r a l i z e d by monoclonal a n t i b o d y .

Cy t o t ox i n n e u t r a l i z i n g a c t i v i t y was p r e s e n t in c u l t u r a l s u p e r n a t e and

p e r i t o n e a l a s c i t i c f l u i d d e r i v e d o n l y f rom t h e hybr idoma s e l e c t e d u s i ng

t h e MTT c o l o r i m e t r i c a s s a y . The a n t i b o d y n a t u r e o f c y t o t o x i n

n e u t r a l i z i n g a c t i v i t y i s s u p p o r t e d by t h e p r e s e n c e o f mur ine IgM in

hybridoma c u l t u r a l s u p e r n a t e which n e u t r a l i z e d c y t o t o x i c a c t i v i t y w h i l e

o t h e r monoclonal a n t i b o d i e s and SP-2 /o mur ine myeloma c e l l c o n d i t i o n e d

medium cou l d n o t . High c y t o t o x i n n e u t r a l i z i n g t i t e r s were o b t a i n e d

w i t h p e r i t o n e a l a s c i t i c f l u i d from hybr idomas p r o d u c i n g t h e nMcAb

compared t o o t h e r n o n - n e u t r a l i z i n g monoclonal a n t i b o d i e s u s i n g t h e MTT

c o l o r i m e t r i c a s s a y .

Page 80: Characterization and Application of Monoclonal Antibody

66

Although nMcAb b i n d i n g t o P. h a e m o l y t i c a s e r o t y p e 1 a n t i g e n

p r e p a r a t i o n s in ELISA c ou l d n o t be d e m o n s t r a t e d , r e g a r d l e s s o f t h e

c o n d i t i o n s e v a l u a t e d , a c o o p e r a t i v e r e s e a r c h team has shown nMcAb

b i n d i n g t o a 105 k i l o d a l t o n p r o t e i n s e p a r a t e d by e l e c t r o p h o r e s i s and

b l o t t e d t o n i t r o c e l l u l o s e . 9 Th i s 105 k i l o d a l t o n p r o t e i n has r e c e n t l y

been shown t o c o n s t i t u t e a ma j o r component o f c y t o t o x i n . ^ I t i s

unknown why nMcAb b i n d i n g c ou l d no t be d e m o ns t r a t e d in ELISA, y e t

d e t e c t a b l e u s i n g immunob l o t t i ng t e c h n i q u e s . P o l y c l o n a l r a b b i t

a n t i b o d i e s p r e p a r e d a g a i n s t t h e 105 KD p r o t e i n , which have

n e u t r a l i z i n g a c t i v i t y , have been shown t o b ind t o l o g a r i t h m i c growth1 fs

phase P. h a e m o l y t i ca c e l l s u s i n g i n d i r e c t immunof l uores cence . These

a n t i b o d i e s a l s o bound t o a 95 KD p r ima r y p r o t e o l y t i c breakdown p r od u c t

i d e n t i f i e d by i mmunob l o t t i ng and i t was u n c l e a r which o f t h e s e

p r o t e i n s was l a b e l e d in i mmunof l uor e sce nce . Othe r lower m o l e c u l a r

14 15we i g h t forms have a l s o been d e t e c t e d . s P r o t e o l y t i c d e g r a d a t i o n o r

d e n a t u r a t i o n o f t h e c y t o t o x i n e p i t o p e r e s p o n s i b l e f o r n e u t r a l i z a t i o n

c ou l d be r e s p o n s i b l e f o r t h e l a ck o f nMcAb r e a c t i v i t y in ELISA.

Cy t o t ox i n a c t i v i t y was a l s o n e u t r a l i z e d by s e r a f rom mice

immunized wi t h e i t h e r P. h a e m o l y t i ca s e r o t y p e 1 c a p s u l a r m a t e r i a l o r

c y t o t o x i n (Tab l e 1 ) . T h e r e f o r e , monoclonal a n t i b o d i e s deve l oped

a g a i n s t c a p s u l a r m a t e r i a l , s p e c i f i c f o r 1i p o p o l y s a c c h a r i d e ,

p a n - p a s t e u r e l l a c a r b o h y d r a t e , c a p s u l a r p o l y s a c c h a r i d e , and a 29 KD

p r o t e i n ( Ch a p t e r 1) were e v a l u a t e d in t h e MTT c o l o r i m e t r i c a s s a y .

a Maheswaran SK, U n i v e r s i t y o f Mi n ne s o t a , S t . Pau l : Pe r s ona l

communica t ion 1987.

Page 81: Characterization and Application of Monoclonal Antibody

67

These a n t i b o d i e s were i n c a p a b l e o f c y t o t o x i n n e u t r a l i z a t i o n and d i d not

a f f e c t n e u t r o p h i l r e d u c t i o n o f MTT dye in r e s po n s e t o a n t i g e n s in t h e

c y t o t o x i n p r e p a r a t i o n ( F i g u r e 2 ) . A p p a r e n t l y , t h e component a n t i g e n s

i d e n t i f i e d o r t h e i r a n t i g e n - a n t i b o d y complexes have l i t t l e e f f e c t on

t h e r e s p o n s e o f n e u t r o p h i l s in t h e a s s a y .

The main a d v a n t a g e s o f t h e MTT c o l o r i m e t r i c a s s a y were speed and

s e n s i t i v i t y , a l l o w i n g a l a r g e number o f samples t o be e v a l u a t e d f o r

c y t o t o x i n n e u t r a l i z a t i o n . These f e a t u r e s a l l owed e f f i c i e n t s c r e e n i n g

of hybridoma c u l t u r e d s u p e r n a t e s n e c e s s a r y t o d e t e c t monoclonal

a n t i b o d y c a p a b l e o f n e u t r a l i z i n g P. ha e mol y t i ca c y t o t o x i n . The use o f

t h e a s s a y was f u r t h e r ex t ende d t o d e t e r mi n e t h e e x t e n t o f c y t o t o x i n

n e u t r a l i z a t i o n by p e r i t o n e a l a s c i t i c f l u i d s and t h e e f f e c t o f d i f f e r e n t

a n t i b o d i e s and combi na t i ons on n e u t r o p h i l r e s p o n s e . The r e s u l t s o f t he

a s s ay were m i c r o s c o p i c a l l y and g r o s s l y a p p a r e n t , a i d i n g in r a p i d

q u a l i t a t i v e a s s e s s m e n t . The MTT c o l o r i m e t r i c a s s a y i s a r a p i d ,

s e n s i t i v e , and v e r s i t i l e means o f s t u d y i n g bovine n e u t r o p h i l

i n t e r a c t i o n w i t h b a c t e r i a l t o x i n s , a n t i g e n s , and s p e c i f i c a n t i b o d i e s .

Page 82: Characterization and Application of Monoclonal Antibody

BIBLIOGRAPHY

1. J ensen R, P i e r s o n RE, Braddy PM, e t a l . Sh ipp ing f e v e r pneumonia i n y e a r l i n g f e e d l o t c a t t l e . J Am Vet Med Assoc 1976;169: 500-506 .

2. Rehmutul l a AJ, Thompson RG. A revi ew o f t h e l e s i o n s in s h i p p i n g f e v e r o f c a t t l e . Can Vet J 1981; 2 2 : 1 - 8 .

3. C o l l i e r JR. S i g n i f i c a n c e o f b a c t e r i a in bov ine r e s p i r a t o r yd i s e a s e . J Am Vet Med Assoc 1968;153:1645-1651.

4. Benson ML, Thomson RG, V a l l i VEO. The bovine a l v e o l a r macrophageI I . In v i t r o s t u d i e s w i t h P a s t e u r e l l a h a e m o l y t i ca . Can J Comp Med 1978;42 : 368-369 .

5. Ba l uyn t CS, Simonson RR, Bemrick WJ, Maheswaran SK. I n t e r a c t i o n o f P a s t e u r e l l a h a e m o l y t i c a w i t h bov ine n e u t r o p h i l s :I d e n t i f i c a t i o n and p a r t i a l c h a r a c t e r i z a t i o n o f a c y t o t o x i n . Am J Vet Res 1981;42 : 1920-1926 .

6. Kaeh le r KL, Markham RJF, Muscopla t CC, Johnson DW. Evidence f o r t h e s p e c i e s s p e c i f i c i t y in t h e c y t o c i d a l e f f e c t s o f P a s t e u r e l l a h a e m o l y t i c a . I n f e c t Immun 1980 ;30 : 615-616 .

7. Slocombe RF, Derksen FJ , Robinson NE, e t a l . I n t e r a c t i o n o f co l ds t r e s s and P a s t e u r e l l a ha e mol y t i ca in t h e p a t h o g e n e s i s o f pneumonic p a s t e u r e l l o s i s in c a l v e s : Method o f i n d u c t i o n andhema t o l og i c and p a t h o l o g i c c hange s . Am J Vet Res 1984;45 : 1757-1763 .

8. Walker RD, Hopkins FM, S h u l t z TW, e t a l . Changes in l e u k o c y t e p o p u l a t i o n s in pulmonary l a vage f l u i d s o f c a l v e s a f t e r i n h a l a t i o n o f P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1985;46:2429-2433.

9. Slocombe RF, Malark J , I n g e r s o l R, Derkson FJ , e t a l . Impor t ance o f n e u t r o p h i l s i n t h e p a t h o g e n e s i s o f a c u t e pneumonic p a s t e u r e l l o s i s in c a l v e s . Am J Vet Res 1985; 46: 2253-2257.

10. B r i e d e r MA, Walker RD, Hopkins FM, e t a l . Pulmonary l e s i o n sinduced by P a s t e u r e l l a h a e m o l y t i ca in n e u t r o p h i l s u f f i c i e n t andn e u t r o p h i l d e f i c i e n t c a l v e s . Can J Vet Res 1988 ;52 : 205-209 .

11. Cho HJ, Bohae JG, Yates WDG, Ohmann HB. A n t i c y t o t o x i n a c t i v i t y o f bovine s e r a and body f l u i d s a g a i n s t P a s t e u r e l l a haemol y t i ca A- l c y t o t o x i n . Can J comp Med 1984;48 : 151-155 .

12. Gent ry MJ, Confer AW, P a n c i e r a RJ. Serum n e u t r a l i z a t i o n o f c y t o t o x i n from P a s t e u r e l l a h a e m o l y t i c a , s e r o t y p e 1 and r e s i s t a n c e t o e x p e r i m e n t a l bov i ne pneumonic p a s t e u r e l l o s i s . Vet Immunol Immunopathol 1985 ; 9 : 239 - 250 .

13. Shewen PE, Wi l k i e BN. P a s t e u r e l l a haemol y t i ca c y t o t o x i nn e u t r a l i z i n g a c t i v i t y in s e r a from O n t a r i o b e e f c a t t l e . Can JComp Med 1983 ;47 : 497 - 498 .

68

Page 83: Characterization and Application of Monoclonal Antibody

69

14. Himmel ME, Yates MD, Lauerman LH, S q u i r e PG. P u r i f i c a t i o n and p a r t i a l c h a r a c t e r i z a t i o n o f a macrophage c y t o t o x i n from P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1982 ; 43 : 764-767 .

15. Mosier DA, L e s s l e y BA, Confer AW, e t a l . Chromatographic s e p a r a t i o n and c h a r a c t e r i z a t i o n o f P a s t e u r e l l a ha e mol y t i ca c y t o t o x i n . Am J Vet Res 1986;47 : 2233-2241 .

16. Chang YF, Young R, Pos t D, S t r uc k DK. I d e n t i f i c a t i o n and c h a r a c t e r i z a t i o n o f t h e P a s t e u r e l l a h a e m o l y t i ca l e u k o t o x i n . I n f e c t Immun 1987;55 : 2348-2354 .

Page 84: Characterization and Application of Monoclonal Antibody

CHAPTER 4

STRUCTURAL CHANGES IN BOVINE NEUTROPHILS EXPOSED TO

PASTEURELLA HAEMOLYTICA SEROTYPE 1 CYTOTOXIN

SUMMARY

P a s t e u r e l l a h a e m o l y t i c a s e r o t y p e 1 (Ph-1) c y t o t o x i n was produced

in a d e f i n e d medium, c o n c e n t r a t e d by u l t r a f i l t r a t i o n and used t o

c h a r a c t e r i z e s t r u c t u r a l changes in i s o l a t e d bovine p e r i p h e r a l blood

n e u t r o p h i l s . N e u t r o p h i l s were exposed t o Ph-1 c y t o t o x i n o ve r v a r i o u s

t ime i n t e r v a l s and c o n c e n t r a t i o n s f o r exa mi na t i on u s i n g l i g h t and

t r a n s m i s s i o n e l e c t r o n mi c r os copy . Ne u t r oph i l c y t o t o x i c i t y was

obs e r ved t o i n v o l v e c e l l p o l a r i z a t i o n wi t h uropod f o r m a t i o n , plasma

membrane d e f e c t s , and d i f f e r e n t i a l i n t r a c e l l u l a r d e g r a n u l a t i o n

p r o g r e s s i n g t o compl e t e d e g e n e r a t i o n and l y s i s w i t h i n 20 min.

I d e n t i c a l c y t o t o x i c changes were noted t h r o u g ho u t bo th p a r am e t e r s

s u g g e s t i n g c y t o t o x i c i t y i s both t ime and c o n c e n t r a t i o n depende n t .

INTRODUCTION

Bovine pneumonic p a s t e u r e l l o s i s o r s h i p p i n g f e v e r i s a s e v e r e

f i b r i n o u s pneumonia c a u s i n g ma jor economic l o s s t o t h e f e e d l o t c a t t l e

1 2i n d u s t r y . ’ Al though numerous p r e d i s p o s i n g f a c t o r s a r e t h o ug h t t o

i n f l u e n c e t h e p a t h o g e n e s i s o f t h i s d i s e a s e , i n f e c t i o n o f t h e lower

r e s p i r a t o r y t r a c t w i t h P a s t e u r e l l a h a emol y t i ca s e r o t y p e 1 (Ph-1) i s

t h e ma jo r caus e o f pneumonia and de a t h a s s o c i a t e d wi t h bov ine

1-4r e s p i r a t o r y d i s e a s e . P. h a emol y t i ca has been shown t o produce a

p r o t e i n c y t o t o x i n ( l e u k o t o x i n ) which i s t o x i c f o r bov ine a l v e o l a r

5-7ma crophages , p e r i p h e r a l b lood mononuc lear c e l l s , and n e u t r o p h i l s .

70

Page 85: Characterization and Application of Monoclonal Antibody

71

Thi s c y t o t o x i n may c o n t r i b u t e t o t h e p a t h o g e n e s i s o f pneumonic

p a s t e u r e l l o s i s by a l t e r i n g c e l l u l a r lung d e f e n s e mechanisms and

c a u s i n g n e u t r o p h i l l y s i s t h a t r e l e a s e s i n f l ammat ory m e d i a t o r s .

The c y t o t o x i n o f P. h a e m o l y t i c a was i n i t i a l l y c h a r a c t e r i z e d as a

high m o l e c u l a r w e i g h t , h e a t s e n s i t i v e p r o t e i n t h a t was l i b e r a t e d

8 9d u r i n g l o g a r t h mi c phase g r owt h . * Cy to t o x i n was l a t e r shown t o cause

c y t o c i d a l e f f e c t s in r umi nan t l e u k o c y t e s , b u t d i d no t a d v e r s e l y a f f e c t

nonrumi nan t c e l l s . A l l s e r o t y p e s o f P. h a e m o l y t i ca produce

c y t o t o x i n which i s immunogenic and n e u t r a l i z a b l e by a n t i b o d y from a

12-15v a r i e t y o f s o u r c e s . High serum a n t i b o d y c y t o t o x i n n e u t r a l i z i n g

t i t e r s have been c o r r e l a t e d wi t h r e s i s t a n c e t o e x p e r i m e n t a l l y induced

15-17pneumonic p a s t e u r e l l o s i s . R e c e n t l y , t h e c y t o t o x i n has been

c l on e d and e x p r e s s e d in E s c h e r i c h i a c o l i a l l o w i n g i t s i d e n t i f i c a t i o n ,

g e n e t i c , and b i oc he mi c a l p r o p e r t i e s t o be more e x t e n s i v e l y

19-21c h a r a c t e r i z e d . However, l i t t l e i s known a bou t t h e e f f e c t o f

c y t o t o x i n a t t h e c e l l u l a r l e v e l . Seve r a l methods have been deve l oped

t o q u a n t i t a t e c y t o t o x i n a c t i v i t y , u s i n g rumi nan t c e l l s , which i n c l u d e s

51v i t a l d y e s , chromium r e l e a s e , l u mi n o l - d e p e n de n t

c h e m i l u m i n e s c e n c e - i n h i b i t i o n , and m i c r o s c o p y . ^ " * 7 These s t u d i e s have

i n d i c a t e d t h a t t h e d e g r e e o f s t r u c t u r a l , f u n c t i o n a l and m e t a b o l i c

e f f e c t s a r e r e l a t e d t o c y t o t o x i n dose and ex p o s u r e t i me .

The s e v e r e f i b r i n o u s bronchopneumonia produced by P. h a e m o l y t i ca

i s c h a r a c t e r i z e d by t h e a c c u m u l a t i o n o f p r e d o m i n a t e l y n e u t r o p h i l s in

22 23a l v e o l a r s p a c e s . * N e u t r o p h i l s a r e c o n s i d e r e d i m p o r t a n t in t h e

p a t h o g e n e s i s no t o n ly b e ca us e o f t h e i r i n t e n s e pulmonary a c c u m u l a t i o n ,

b u t a l s o be c a use o f t h e i r a b i l i t y t o c l e a r b a c t e r i a and r e l e a s e

i n f l ammat o r y m e d i a t o r s . C y t o t o x i n i s r e c o g n i z e d t o d e s t r o y t h e

Page 86: Characterization and Application of Monoclonal Antibody

7 ftp h a g o c y t i c c a p a b i l i t i e s o f n e u t r o p h i l s and l e ad t o c e l l l y s i s . *

Upon u n c o n t r o l l e d d e g r a n u l a t i o n o r l y s i s , n e u t r o p h i l s r e l e a s e p o t e n t

oxygen depende n t and i n d e p e n d e n t m i c r o b i o c i d a l f a c t o r s which can

24-27f u r t h e r damage pulmonary t i s s u e and e x a c e r b a t e d i s e a s e .

L i k e wi s e , s t i m u l a t e d n e u t r o p h i l s m o b i l i z e and m e t a b o l i z e a r a c h a d o n i c

2fta c i d t o form many i m p o r t a n t i n f l ammat ory m e d i a t o r s . The i n t e r a c t i o n

o f _P. h a e m o l y t i c a c y t o t o x i n wi t h bov ine n e u t r o p h i l s i s c l e a r l y an

i m p o r t a n t o c c u r r e n c e in t h e p a t h o g e n e s i s o f pneumonic p a s t e u r e l l o s i s

and t h e t o p i c o f many i n v e s t i g a t i o n s . However, t h e mechanism o f

c y t o t o x i n ' s c y t o c i d a l e f f e c t s on n e u t r o p h i l s has remained o bs cu r e .

To ga i n a b e t t e r u n d e r s t a n d i n g o f c y t o t o x i n ' s mechanism o f

n e u t r o p h i l c y t o t o x i c i t y and hence i t s r o l e in t h e p a t h o g e n e s i s o f

pneumonic p a s t e u r e l l o s i s a f u r t h e r c h a r a c t e r i z a t i o n o f t h e t o x i n s

i n t e r a c t i o n w i t h n e u t r o p h i l s i s needed. The pu r poses o f t h i s s t u d y

were t o m i c r o s c o p i c a l l y c h a r a c t e r i z e t h e s t r u c t u r a l changes in bov ine

n e u t r o p h i l s exposed t o P. ha e mol y t i ca c y t o t o x i n o ve r d i f f e r e n t t i me

i n t e r v a l s and c y t o t o x i n c o n c e n t r a t i o n s .

MATERIALS AND METHODS

P. h a e m o l y t i c a c y t o t o x i n :

C y to t o x i n from P a s t e u r e l l a h a e mo l y t i ca b i o t y p e A, s e r o t y p e 1 was

p roduced in a d e f i n e d medium, c o n c e n t r a t e d by u l t r a f i l t r a t i o n ( 1 5 : 1 ) ,

and q u a n t i t a t e d u s i n g bov i ne n e u t r o p h i l s as t a r g e t c e l l s in a

c o l o r i m e t r i c a s s a y as p r e v i o u s l y d e s c r i b e d ( Chap t e r 2 ) . Cy t o t o x in

d i l u t i o n s were per formed i n D u l b e c c o ' s PBS (pH 7 . 4 ) .

Page 87: Characterization and Application of Monoclonal Antibody

73

Bovine n e u t r o p h i l s and ex p o s u r e t o c y t o t o x i n :

Bovine n e u t r o p h i l s were i s o l a t e d from p e r i p h e r a l b lood by double

d i s c o n t i n u o u s d e n s i t y g r a d i e n t c e n t r i f u g a t i o n ( Chap t e r 2 ) . I s o l a t e d

n e u t r o p h i l s were suspended in D u l b ec c o ' s PBS t o a f i n a l c o n c e n t r a t i o n

o f 5X106 c e l l s / m l . Appr ox i ma t e l y 5-10% o f t h i s c e l l p o p u l a t i o n was

mononuc lear c e l l s wich c o - p u r i f i e d wi t h t h e n e u t r o p h i l s . A l i q u o t s o f

t h e n e u t r o p h i l s u sp e n s i o n ( 2 . 0 mi s ) were exposed t o 1 . 0 ml volumes o f

a 1 :8 d i l u t i o n o f c o n c e n t r a t e d c y t o t o x i n f o r 5 min i n t e r v a l s t o 20

min in t h e t empora l s t u d y . In t h e dose s t u d y , 2 . 0 ml a l i q u o t s o f t h e

n e u t r o p h i l s u sp e n s i o n were exposed t o 1 . 0 ml volumes o f a 2 - f o l d

c y t o t o x i n d i l u t i o n s e r i e s f o r 20 min. To h a l t c y t o t o x i c i t y , c e l l s

were f i x e d o v e r n i g h t w i t h 3 . 0 mis 0.2M sodium c a c o d y l a t e b u f f e r

(pH7.2) c o n t a i n i n g 3% g l u t a r a l y d e h y d e . Cont ro l n e u t r o p h i l s were

exposed t o D u l b e c c o ' s PBS o r RPMI-1640 c o n t a i n i n g 10 mM sodium

b i c a r b o n a t e and L - g l u t a m i n e under i d e n t i c a l c o n d i t i o n s . D u p l i c a t e

samples were p r e p a r e d f o r l i g h t and t r a n s m i s s i o n e l e c t r o n mi c roscopy .

The t empora l and dose s t u d i e s were per formed as s e p a r a t e e x p e r i m e n t s .

Microscopy o f N e u t r o p h i l s :

L i gh t mi c roscopy was pe r fo rmed on wet mounted s l i d e s s t a i n e d wi t h

e i t h e r new me t hy l ene b l u e o r t r y p a n b l u e . S l i d e s were examined a t

400x and lOOOx m a g n i f i c a t i o n . P r e p a r a t i o n o f t h e n e u t r o p h i l s f o r

t r a n s m i s s i o n e l e c t r o n mi c ros copy was a d ap t ed from t h e e n c a p s u l a t i o n

29method o f K e l l e n b e r g e r , e t a l . B r i e f y , t h e c e l l s were g e n t l y washed

w i t h f i x a t i v e , s t a i n e d wi t h 1% OsO^, and r ewashed. The osmium f i x e d

p e l l e t was e n c a p s u l a t e d w i t h 3% a g a r o s e c o n t a i n i n g u r any l a c e t a t e and

g l u t a r a l d e h y d e . Fo l lowing e n c a p s u l a t i o n , samples were a l co h o l

Page 88: Characterization and Application of Monoclonal Antibody

74

d e hy d r a t e d and i n f i l t r a t e d wi t h e p o n / a r a l d i t e and a l l owed t o

po l ymer i ze o v e r n i g h t a t 60C. Samples were s e c t i o n e d a t 60-80 nm and

p i c ke d up on 200-300 mesh coppe r g r i d s . The g r i d s were t he n s t a i n e d

30 31wi t h u r any l a c e t a t e and l e a d n i t r a t e s o l u t i o n s . ’ Gr ids were

examined u s i n g a Ze i s s EM 10-A t r a n s m i s s i o n e l e c t r o n mi c r os c ope .

RESULTS

Li gh t Microscopy:

L i g h t mi c roscopy o f wet mounted c o n t r o l n e u t r o p h i l s , no t exposed

t o c y t o t o x i n , d e m o n s t r a t e d b a s i c a l l y round and h i g h l y l i g h t r e t r a c t i l e

c e l l s . The m u l t i l o b e d n u c l e i o f t h e s e c e l l s were c e n t r a l l y l o c a t e d

and t h e c y t o p l a s mi c g r a n u l e s appea r ed e v e n l y d i s t r i b u t e d . C e l l u l a r

a g g r e g a t i o n was no t e v i d e n t g r o s s l y o r m i c r o s c o p i c a l l y . Cont ro l

n e u t r o p h i l s r e a d i l y e xc l ud e d t r y p a n b l u e dye.

Fo l lowing a f i v e min e xpos u r e t o c y t o t o x i n , t h e m a j o r i t y o f c e l l s

l o s t t h e i r r e t r a c t i l i t y and round morphology becoming oval t o

e l o n g a t e d . P rominan t c y t o p l a s m i c p r o j e c t i o n s deve l oped and

c y t o p l a s mi c g r a n u l e s were obs e r ve d t o be p o l a r i z e d t o t h e o p p o s i t e

s i d e f rom t h e s e p r o j e c t i o n s . Plasma membrane damage was conf i rmed by

t h e up t a ke o f t r y p a n b l u e dye . C e l l u l a r a g g r e g a t i o n was a p p a r e n t , bu t

no t pronounced .

A f t e r t e n min ex p o s u r e t o c y t o t o x i n , c e l l morphology became more

oval t o e l o n g a t e d . Large c y t o p l a s mi c p r o j e c t i o n s ex t ende d from c e l l

s u r f a c e s . Many c e l l s were r e c o gn i z e d t o have plasma membrane d e f e c t s

l a r g e enough f o r g r a n u l e s and n u c l e i t o e x i t t h e c y t op l a sm th r ough

t h e s e p r o j e c t i o n s . C e l l u l a r a g g r e g a t i o n was more prounounced and most

c e l l s r e a d i l y took up t r y p a n b l u e dye.

Page 89: Characterization and Application of Monoclonal Antibody

75

By 15 t o 20 min n e u t r o p h i l c y t o t o x i c i t y was j udge d as c o m p l e t e ,

on l y a g g r e g a t e d g h o s t c e l l s and c e l l u l a r d e b r i s r emained . Al l

n e u t r o p h i l s were s e v e r e l y a f f e c t e d , h i g h l y i r r e g u l a r c e l l shapes

c o n t a i n i n g few i n t r a c y t o p l a s m i c g r a n u l e s were o b s e r v a b l e . No

d i f f e r e n c e s were no t e d between t h e t empora l and dose s t u d i e s , s i m i l a r

mor pho l og i a l changes were o bs e r ved in s h o r t e xpos u r e s t o h igh

c y t o t o x i n c o n c e n t r a t i o n s . Exposure o f c e l l s t o h igh c y t o t o x i n

c o n c e n t r a t i o n s (<1 : 8 d i l u t i o n ) f o r p ro l onged t i mes (>20 min) caused

compl e t e n e u t r o p h i l l y s i s . L i g h t mi c r os co p i c ex a mi n a t i o n o f t h e

n e u t r o p h i l d e b r i s r e v e a l e d low numbers o f i n t a c t mononuc lear c e l l s

which were a p p a r e n t l y r e s i s t a n t t o c y t o t o x i n a t t h e d e s c r i b e d t i mes

and c o n c e n t r a t i o n s .

Tr an s mi s s i on e l e c t r o n mi c roscopy :

T r a n s mi s s i on e l e c t r o n mi c roscopy o f normal n e u t r o p h i l morphology

r e v e a l e d c e l l s w i t h a round shape c o n t a i n i n g a c e n t r a l l y l o c a t e d

m u l t i l o b e d n u c l e u s , c o n f i r m i n g l i g h t mi croscopy o b s e r v a t i o n s . The

c e l l s u r f a c e s were u n i f o r m l y i n v o l u t e d and c y t o p l a s mi c g r a n u l e s were

a b u nd an t , e v e n l y d i s t r i b u t e d , and d i s p l a y e d e l l i p s o i d a l t o round

p r o f i l e s , i n d i c a t i n g rod t o s p h e r i c a l s h a p e s . D i f f e r e n c e s in s i z e and

e l e c t r o n d e n s i t y o f t h e g r a n u l e s were a l s o e v i d e n t . Mi toc hondr i a were

e a s i l y d i f f e r e n t i a t e d from t h e g r a n u l e s based on t h e s e c h a r a c t e r i s t i c s

( F i g u r e I V . 1) .

Page 90: Characterization and Application of Monoclonal Antibody

76

Fi g u r e I V . 1. T r a n s mi s s i on e l e c t r o n mi c r ogr aph o f a normal bov ine

n e u t r o p h i l . Note round s h a p e , c e n t r a l l y l o c a t e d n u c l e u s , and wel l

d e f i n e d , e v e n l y d i s t r i b u t e d g r a n u l e s o f v a r i o u s s i z e s , s h a p e s , and

d e n s i t i e s . X10.000.

Fo l lowing a 5 min ex p o s u r e t o c y t o t o x i n ( 1 : 8 d i l u t i o n )

c o n s i d e r a b l e s t r u c t u r a l changes o c c u r e d . Prominant uropods deve l oped

from c e l l s u r f a c e s ( F i g u r e I V . 2 ) .

Page 91: Characterization and Application of Monoclonal Antibody

77

psSiip''

Fi g u r e I V . 2. E l e c t r o n mi c r og r aph o f a bov i ne n e u t r o p h i l exposed t o

c y t o t o x i n ( 1 : 8 d i l u t i o n ) f o r 5 min. Note e l o n g a t e d s h a p e , e c c e n t r i c

n u c l e u s , p o l a r i z e d g r a n u l e s , and p r omi nan t c y t o p l a s m i c p r o j e c t i o n

( u r op od ) . Granu l es a p p e a r l a r g e r , l e s s d i s t i n c t and more e l e c t r o n

d e n s e . X10,000.

Membranes l i m i t i n g t h e s e uropods had a moth e a t e n a p p e a r e n c e ,

i n d i c a t i n g damage which was conf i rmed by t h e i n a b i l i t y t o e x c l u d e

t r y p a n b lu e dye in l i g h t mi c r os c o p y . The c e l l s became p o l a r i z e d , in

t h a t n u c l e i were s h i f t e d t o an e c c e n t r i c s i t e and g r a n u l e s were

Page 92: Characterization and Application of Monoclonal Antibody

78

m o b i l i z e d t o t h e o p p o s i t e s i d e from t h e uropods l i m i t e d by damaged

membrane ( F i g u r e I V . 2 ) . Al l g r a n u l e s appe a r e d l a r g e r , more e l e c t r o n

d e n s e , and t h e i r s h a r p n e s s became l e s s d i s t i n c t . Higher m a g n i f i c a t i o n

o f t h e s e e n l a r g e d f uz z y g r a n u l e s r e v e a l e d a l t e r a t i o n o f t h e i r

i n t e g r i t y c h a r a c t e r i z e d by changes r e m i n i s c e n t o f smal l v a c u o l a r o r

t u b u l a r f o r ma t i o n s ( F i g u r e IV. 3 ) .

F i g u r e I V . 3. A l t e r a t i o n o f bov ine n e u t r o p h i l g r a n u l e i n t e g r i t y

o c c u r r i n g a t 5 min c y t o t o x i n ( 1 : 8 d i l u t i o n ) e xpos u r e s u g g e s t i v e o f

smal l v a c u o l a r o r t u b u l a r f o r m a t i o n s . X60,000.

Page 93: Characterization and Application of Monoclonal Antibody

79

A f t e r 10 min e xpos u r e t o c y t o t o x i n l a r g e r and b r o a d e r uropods

l i m i t e d by i n c o mp l e t e membranes were commonly obs e rved ( F i g u r e I V . 4 ) .

F i g u r e I V . 4. Bovine n e u t r o p h i l w i t h 2 l a r g e , broad c y t o p l a s m i c

p r o j e c t i o n s (u ropods ) t y p i c a l o f c e l l s f o l l o w i n g a 10 min c y t o t o x i n

( 1 : 8 d i l u t i o n ) e x p o s u r e . The plasma membrane l i m i t i n g t h e uropods has

a moth e a t e n a pp e a r a n c e and l a r g e dense p e r s i s t e n t g r a n u l e s c o n t a i n i n g

f o l d e d c o r d l i k e s t r u c t u r e s domina te in t h e cy t op l a s m. X10.000.

Page 94: Characterization and Application of Monoclonal Antibody

80

A d r a m a t i c d e c r e a s e in g r a n u l e numbers was obs e r ved and t h e r ema i n i ng

g r a n u l e s were much l a r g e r and more e l e c t r o n de ns e . The r emain ing

l a r g e g r a n u l e s c o n t a i n e d e l e c t r o n dense f o l d e d c o r d - l i k e s t r u c t u r e s

which e x h i b i t e d a s t r i k i n g p e r i o d i c i t y a t h i g h e r m a g n i f i c a t i o n s

( F i g u r e IV.5A and B).

‘ . -

'J .

Fi g u r e I V . 5. T r a n s mi s s i on e l e c t r o n mi c r og r aphs showing g r a n u l e s i n

n e u t r o p h i l s exposed t o c y t o t o x i n ( 1 : 8 d i l u t i o n ) f o r 10 min. (A)

f o l d e d c o r d - l i k e i n t r a g r a n u l a r s t r u c t u r e s o f i n c r e a s e d e l e c t r o n

d e n s i t y . X31.500. (B) Higher m a g n i f i c a t i o n o f F i g . IV.5A

d e m o n s t r a t i n g p e r i o d i c i t y . X63.000.

Page 95: Characterization and Application of Monoclonal Antibody

81

At 15 min, t h e l a r g e broad uropods commonly p r e s e n t in t h e 10 min

e x p o s u r e s , were r a r e l y o b s e r v e d . Round t o oval c e l l shapes wi t h a

h i g h l y i r r e g u l a r s u r f a c e and i nc ompl e t e membranes p r edomi na ted ( F i g u r e

I V . 6 ) .

F i g u re I V . 6. Ne u t r o p h i l f o l l o w i n g a 15 min c y t o t o x i n ( 1 : 8 d i l u t i o n )

e x p o s u r e . Note l a ck o f a p romi nan t uropod and plasma membrane

i n t e g r i t y . There i s a d e c r e a s e in t he number o f p e r s i s t e n t g r a n u l e s

which a r e forming c o n c e n t r i c a l l y l a mi n a t ed s t r u c t u r e s ( a r r o w ) .

X10.000.

Page 96: Characterization and Application of Monoclonal Antibody

82

The number o f l a r g e , d e n s e , p e r s i s t e n t g r a n u l e s d e c r e a s e d f u r t h e r and

many were in t h e p ro c e s s o f forming mye l in f i g u r e s . These

c o n c e n t r i c a l l y l a mi n a t ed s t r u c t u r e s w i t h a c e n t r a l e l e c t r o n d e n s i t y

were obs e r ve d t o r e p l a c e t h e l a r g e dense g r a n u l e s p e r s i s t i n g a t 10

min c y t o t o x i n e xpos u r e ( F i g u r e I V . 7 ) .

fL*

F i g u r e I V . 7. C o n c e n t r i c a l l y l a mi n a t ed mye l in f i g u r e formed from t h e

l a r g e p e r s i s t e n t g r a n u l e s . Note l a ck o f i n t e g r i t y and moth e a t e n

a pp e a r a n c e o f plasma membrane.

Page 97: Characterization and Application of Monoclonal Antibody

83

At 20 min, c e l l shape remained round t o oval wi th an i r r e g u l a r

s u r f a c e , r e s e mbl ing t h e 15 min e x p o s u r e . However, many c y t o p l a s mi c

v a c u o l e s were p r e s e n t t h a t c o n t a i n e d a f l o c c u l a n t m a t e r i a l and few t o

no g r a n u l e s remained ( F i g u r e I V . 8 ) .

F i g u r e IV. 8. Typi ca l n e u t r o p h i l a t 20 min p o s t c y t o t o x i n ( 1 : 8

d i l u t i o n ) e x p os u r e . There i s a l a ck o f membrane i n t e g r i t y and

c y t o p l a s m i c g r a n u l e s . Numerous vac u o l e s c o n t a i n i n g a f l o c c u l a n t

m a t e r i a l a r e p r e s e n t in t h e c y t o p l a s m. X10,000.

Page 98: Characterization and Application of Monoclonal Antibody

84

The n u c l e i o f t h e r e ma i n i ng c e l l s l o s t t h e i r t i g h t l y wound form and

became s wo l l e n .

At a low c y t o t o x i n c o n c e n t r a t i o n (1 :512 d i l u t i o n ) f o r 20 min,

mos t n e u t r o p h i l s formed uropods and became p o l a r i z e d . Nucle i s h i f t e d

t o an e c c e n t r i c l o c a t i o n and g r a n u l e s were a lways p r e s e n t a t a s i t e

o p p o s i t e f rom t h e c y t o p l a s mi c e x t e n s i o n s . Granule morphology appea r ed

normal i n t h a t s i z e s h a p e , and d e n s i t y remained unchanged ( F i g u r e

I V . 9 ) .

F i g u re I V . 9. T r a n s mi s s i on e l e c t r o n mi c rograph o f a bov ine n e u t r o p h i l

exposed t o a 1:512 c y t o t o x i n d i l u t i o n f o r 20 min. The c e l l s d i s p l a y s

a p o l a r i z e d morphology and 2 uropods a t t h e p o s t e r i o r a s p e c t . Plasma

membrane i n t e g r i t y and g r a n u l e morphology remain normal .

Page 99: Characterization and Application of Monoclonal Antibody

85

Plasma membranes were no t obse r ved t o be damaged us i ng e l e c t r o n

mi c roscopy and ve ry few n e u t r o p h i l s took up t r y pa n b l u e a t t h i s

c y t o t o x i n c o n c e n t r a t i o n i n l i g h t mi c r oscopy .

Doubl ing t h e dose o f c y t o t o x i n (1 :256 d i l u t i o n ) produced

n o t i c e a b l e changes in t h e plasma membrane and g r a n u l e s . Prominant

uropods d e v e l o p e d , i n d e n t i c a l t o t h o s e o c c u r r i n g in t h e t empora l

s t u d y , which were l i m i t e d by a membrane wi t h a moth e a t e n a p pe a r a n c e .

Granu l es appea r ed e n l a r g e d , l e s s c l e a r l y d e m a r ca t e d , and more e l e c t r o n

d en s e . These s t r u c t u r a l changes were i n d i s t i n g u i s h a b l e from t h o s e

o c c u r r i n g a t 5 min in t h e t empora l s t u d y ( F i g u r e I V . 10) .

F i g u r e I V . 10. N e u t r o p h i l exposed t o a 1 :2 5 6 c y t o t o x i n d i l u t i o n f o r 20

m in . Note i d e n t i t y w i t h F i g u r e 2 . X 1 0 . 0 0 0 .

Page 100: Characterization and Application of Monoclonal Antibody

86

Higher c o n c e n t r a t i o n s o f c y t o t o x i n ( 1 : 6 4 d i l u t i o n ) produced l a r g e

broad uropods i n c o m p l e t e l y l i m i t e d by a plasma membrane. Granule

number d e c r e a s e d and t h e p e r s i s t e n t ones became s w o l l e n , more e l e c t r o n

d e n s e , and c o n t a i n e d t h e f o l d e d c o r d - l i k e s t r u c t u r e s ( F i g u r e I V . 11) .

F ig u r e I V . 11. N e u t r o p h i l exposed t o a 1 :6 4 c y t o t o x i n d i l u t i o n f o r 20

m in . Note i d e n t i t y w i t h F i g u r e 4 . X 1 0 , 0 0 0 .

Page 101: Characterization and Application of Monoclonal Antibody

87

These s t r u c t u r a l changes were i d e n t i c a l t o t h o s e o c c u r i n g a t 10

min e xpos u r e t o a 1:8 c y t o t o x i n d i l u t i o n .

The l a r g e broad uropods o c c u r r i n g d u r in g exposu r e t o a 1:64

c y t o t o x i n d i l u t i o n were no t e v i d e n t i n n e u t r o p h i l s exposed t o 1:32

d i l u t i o n . I n c r e a s i n g c y t o t o x i n c o n c e n t r a t i o n produced round t o oval

shaped c e l l s w i t h an i r r e g u l a r ma rg i n , p a r a l l e l i n g t h o s e changes

t y p i f y i n g a 15 min e xpos u r e t o a 1:8 c y t o t o x i n d i l u t i o n ( F i g u r e

I V . 12) .

F i g u r e I V . 12. N e u t r o p h i l exposed t o a 1 :3 2 c y t o t o x i n d i l u t i o n f o r 20

m in . Note s i m i l a r i t i e s w i t h F ig u r e 6 . X 1 0 , 0 0 0 .

Page 102: Characterization and Application of Monoclonal Antibody

88

No d i f f e r e n c e s were obs e r ve d between a 1:16 and 1:8 c y t o t o x i n d i l u t i o n

in t h e dose s t u d y which were t y p i c a l o f c e l l s in F i gu r e 8. S t r u c t u r a l

changes were r ema r kab l y s i m i l a r t h r o u g h o u t t h e t ime and dose s t u d i e s .

DISCUSSION

Fol lowing s t i m u l a t i o n wi t h c h e m o t a t i c f a c t o r s n e u t r o p h i l s

commonly undergo s t r u c t u r a l changes c h a r a c t e r i z e d by an e l o n g a t e d

32-36p o l a r i z e d form. " P o l a r i z e d n e u t r o p h i l s deve l op l amel l apod ium o r

pseudopods towards t h e l e a d i n g edge o f s t i m u l a t i o n . P o s t e r i o r

c y t o p l a s mi c p r o j e c t i o n s o r uropods form t h e t a i l o f p o l a r i z e d c e l l s

j u s t behi nd t h e n u c l e u s . Dur ing p o l a r i z a t i o n c y t o p l a s mi c g r a n u l e s a r e

m o b i l i z e d a n t e r i o r l y , t owards t h e ps eudopods , f o r d e g r a n u l a t i o n w i t h i n

phagosomes. C e l l u l a r p o l a r i z a t i o n o f membrane r e c e p t o r s and

c o n t r a c t i l e f i l a m e n t s has a l s o been obse r ved t o o c c u r f o l l o w i n g

34 35 37-39c h e m o t a c t i c f a c t o r s t i m u l a t i o n . 5 * Membrane r e c e p t o r s a r e

d i f f u s e l y d i s t r i b u t e d o ve r t h e s u r f a c e o f u n s t i m u l a t e d c e l l s , bu t a r ep C p p p Q

found p r e d om i n a t e l y in t h e uropod o f p o l a r i z e d c e l l s . ’ * A f t e r

c y t o t o x i n e x p o s u r e , n e u t r o p h i l s in t h i s s t u d y were obse r ved t o

e l o n g a t e and assume a p o l a r i z e d o r i e n t a t i o n , s u g g e s t i n g s t i m u l a t o r y

c h e m o t a t i c f a c t o r s a r e p r e s e n t in t h e c y t o t o x i n p r e p a r a t i o n . The

p r e s e n c e o f c h e m o t a c t i c f a c t o r s in c y t o t o x i n p r e p a r a t i o n s cou l d be

r e l a t e d t o t h e e a r l y and i n t e n s e pulmonary n e u t r o p h i l a cc u mu l a t i o n

f o l l o w i n g e x p e r i me n t a l c h a l l e n g e . The c y t o p l a s mi c p r o j e c t i o n s

obs e r ved h e r e i n deve l oped p o s t e r i o r l y wi t h r e s p e c t t o t h e p o l a r i z e d

o r i e n t a t i o n , t e n t a t i v e l y i d e n t i f y i n g t h e s e s t r u c t u r e s as u ropods .

These s t r u c t u r e s b e a r r e ma r ka b l e s i m i l a r i t y t o uropods i nduced by

32-34c h e m o t a c t i c f a c t o r s in o t h e r s t u d i e s . These uropods i n c r e a s e d in

Page 103: Characterization and Application of Monoclonal Antibody

89

s i z e and l o s t membrane i n t e g r i t y as c y t o t o x i n dose and exposu r e t ime

i n c r e a s e d . The d i s r u p t i o n o f t h e uropod plasma membrane i n t e g r i t y

s u g g e s t s a r e c e p t o r me d i a t e d mechanism of c y t o t o x i c i t y s i n c e r e c e p t o r s

a r e known t o be c o n c e n t r a t e d in t h i s a r e a f o l l o w i n g s t i m u l a t i o n . The

c o n t e n t i o n o f a r e c e p t o r me d i a t e d mechanism o f c y t o t o x i c i t y may

e x p l a i n t h e rumi nan t c e l l s p e c i f i c a c t i o n o f c y t o t o x i n .

I n v e s t i g a t i o n s i n t o t h e d e g r a n u l a t i v e p ro c e s s o f human bovine

n e u t r o p h i l s has r e v e a l e d a complex e v e n t in which more t h a n one s i g n a l

i s i n v o l v e d . Calcium i onophor es (A23187) , phorbol m y r i s t a t e a c e t a t e ,

and immune complexes caus e a t i me and dose dependen t r e l e a s e o f

e nzyma t i c a c t i v i t y a s s o c i a t e d wi t h t h e s p e c i f i c g r a n u l e s wh i l e

40-42a z u r o p h i l g r a n u l e s remain c e l l a s s o c i a t e d . Fo l lowing

p h a g o c y t o s i s o r e xpos u r e t o s o l u b l e s t i m u l i , bov ine n e u t r o p h i l s

d i s c h a r g e by t r u e s e c r e t i o n bo th t h e i r l a r g e and s p e c i f i c g r a n u l e s .

43Azurophi l g r a n u l e s a r e f u l l y r e t a i n e d . These f i n d i n g s have

s u p p o r t e d a s e l e c t i v e i n d e p e n d e n t m o b i l i z a t i o n o f c y t o p l a s mi c g r a n u l e s

upon ex p o s u r e t o p a r t i c u l a t e as wel l as s o l u b l e s t i m u l i . This

d i f f e r e n t i a l d e g r a n u l a t i o n was a l s o not ed in n e u t r o p h i l s exposed t o

c y t o t o x i n by t h e p e r s i s t e n c e o f t h e l a r g e dense g r a n u l e s c o n t a i n i n g

t h e c o r d - l i k e s t r u c t u r e s e x h i b i t i n g p e r i o d i c i t y . The d i f f e r e n t i a l

i n t r a c e l l u l a r d e g r a n u l a t i o n o f bov ine n e u t r o p h i l s exposed t o c y t o t o x i n

c ou l d be r e l a t e d t o t h e mechanism o f c y t o t o x i c i t y .

Human n e u t r o p h i l g r a n u l e s have been r e p o r t e d t o c o n t a i n a c e n t r a l

44-46c r y s t a l o f wel l d e f i n e d p e r i o d i c i t y . A d d i t i o n a l l y , bovine

n e u t r o p h i l l a r g e ( t h i r d ) g r a n u l e s a r e a c c e p t e d t o c o n t a i n a c e n t r a l

47c o r e o f m a t r i x m a t e r i a l . The p e r s i s t e n t l a r g e g r a n u l e s d e s c r i b e d in

Page 104: Characterization and Application of Monoclonal Antibody

90

t h i s s t u d y a l s o c o n t a i n e d s u b g r a n u l a r s t r u c t u r e s e x h i b i t i n g

p e r i o d i c i t y . These g r a n u l e s were l a t e r obs e r ved t o form mye l in

f i g u r e s . However, t h e s i g n i f i c a n c e and f u n c t i o n of t h e s e s t r u c t u r e s

remain un d e t e r mi n e d . The number and morphology o f t h e p e r s i s t e n t

g r a n u l e s a r e c o n s i s t a n t w i t h d e s c r i p t i o n s o f t h e l a r g e ( t h i r d )

g r a n u l e s i n bov i ne n e u t r o p h i l s . 4 3 ’47 Thi s l a r g e g r a n u l e i s r e p o r t e d

t o c o n t a i n p r i m a r i l y l a c t o f e r r i n and o t h e r l e s s p romi nan t c a t i o n i c

43p r o t e i n s . I t i s i n t e r e s t i n g t o n o t e t h a t l a c t o f e r r i n and o t h e r i r o n

b i n d i n g compounds may s up p l y a u s a b l e s ou r c e o f i r o n f o r t o x i n o g e n e s i s

48by P. h a e m o l y t i c a . L a c t o f e r r i n r e l e a s e by n e u t r o p h i l s exposed t o

c y t o t o x i n may i n c r e a s e c y t o t o x i n p r o d u c t i o n in v i vo and e x a c e r b a t e

d i s e a s e .

Al l r umi nan t l e u k o c y t e s a r e r e p o r t e d t o be s e n s i t i v e t o

49-52P a s t e u r e l l a c y t o t o x i n . The d i f f e r e n t i a l s u s c e p t i b i l i t y o f bov ine

l e u k o c y t e s t o c y t o t o x i n has been p r e v i o u s l y r e p o r t e d and n e u t r o p h i l s

53were found t o be t h e most s e n s i t i v e . In t h i s s t u d y , a n e u t r o p h i l

p o p u l a t i o n c o n t a i n i n g 5-10% mononuc lear c e l l s was exposed t o an exce s s

o f c y t o t o x i n a c t i v i t y (15 : 1 c o n c e n t r a t e ) f o r p r o l onge d t i mes (>20

min) and r e s i s t a n t c e l l s were i d e n t i f i e d as mononuc lear u s i n g l i g h t

mi c r oscopy ( no t shown) . Our r e s u l t s s u g g e s t t h a t n e u t r o p h i l s a r e more

s e n s i t i v e t o c y t o t o x i n t h a n mononuc lear c e l l s and s u p p o r t s t h e

c o n t e n t i o n o f d i f f e r e n t i a l l e u k o c y t e s u s c e p t i b i l i t y .

Page 105: Characterization and Application of Monoclonal Antibody

BIBLIOGRAPHY

1. C a r t e r GR. O b s e r v a t i o n s on t h e p a t h o lo g y and b a c t e r i o l o g y of s h i p p i n g f e v e r i n Canada. Con J Comp Med 1954;18 : 359-364 .

2. J ensen R, P i e r s o n RE, Braddy PM, e t a l . Shipp ing f e v e r pneumonia in y e a r l i n g f e e d l o t c a t t l e . J Am Vet Med Assoc 1976 ;169: 500-506 .

3. L i l l i e LE. The bovine r e s p i r a t o r y d i s e a s e complex. Can Vet J 1974 ;15 : 233-242 .

4. Thompson RG, Chand l e r S, Savan M, e t a l . I n v e s t i g a t i o n o f f a c t o r s o f p r o ba b l e s i g n i f i c a n c e in t h e p a t h o g e n e s i s o f pneumonic p a s t e u r e l l o s i s in c a t t l e . Can J Comp Med 1975;39 : 194-207 .

5. Benson ML, Thompson RG, V a l l i e VEO. The bov ine a l v e o l a r macrophage I I . In v i t r o s t u d i e s wi t h P a s t e u r e l l a h a e m o l y t i ca .Can J . Comp Med 1978;42 : 368-369 .

6. Shewen PE, Wi l k i e BN. Cy t o t ox i n o f P a s t e u r e l l a haemol y t i ca a c t i n g on bovine l e u k o c y t e s . I n f e c t Immun 1982; 35 : 91-94 .

7. Berggren KA, Ba l uyut CS, Simonson RR, e t a l . Cy t o t o x i c e f f e c t s o f P a s t e u r e l l a h a e m o l y t i ca on bovine n e u t r o p h i l s . Am J Vet Res 1981;42 : 1383-1388 .

8. Ba l uyu t CS, Simonson RR, Bemrick WJ, Maheswaran SK. I n t e r a c t i o n o f P a s t e u r e l l a ha e mol y t i ca w i t h bovine n e u t r o p h i l s :I d e n t i f i c a t i o n and p a r t i a l c h a r a c t e r i z a t i o n o f a c y t o t o x i n . Am J Vet Res 1981 ; 42 : 1920-1926 .

9. Himmel ME, Yates MD, Lauerman LH, Sq u i r e PG. P u r i f i c a t i o n and p a r t i a l c h a r a c t e r i z a t i o n o f a macrophage c y t o t o x i n from P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1982; 4 3 ( 5 ) :764-767.

10. Kaeh le r KL, Markham RJF, Muscopla t CC, Johnson DW. Evidence o f t he s p e c i f i c i t y i n t h e c y t o c i d a l e f f e c t s o f P a s t e u r e l l a h a e m o l y t i c a . I n f e c t Immun 1980 ; 30 : 615-616 .

11. Chang YF, Renshaw HW, Mar tens RJ, L i v i n g s t o n CW. P a s t e u r e l l a ha e mol y t i ca l e u k o t o x i n : che mi l umi ne s c e n t r e s p o n s e s o f p e r i p h e r a l blood l e u k o c y t e s f rom s e v e r a l d i f f e r e n t mammial ian s p e c i e s t o l e u k o t o x i n - a n d o p s o n i n - t r e a t e d l i v i n g and k i l l e d P a s t e u r e l l a ha e mol y t i ca and S t a p h y l oc o c c u s a u r e u s . Am J Vet Res 1986 ; 47 : 67 - 74 .

12. Shewen PE, Wi l k i e BN. P a s t e u r e l l a haemol y t i ca c y t o t o x i n : P r od uc t i o n by r e c o gn i z e d s e r o t y p e s and n e u t r a l i z a t i o n by t ype s p e c i f i c r a b b i t a n t i s e r a . Am J Vet Res 1983;44 : 715-719 .

13. Moore RN, Walker RD, Shaw GA, Hopkins FM, Shul l EP.A n t i l e u k o t o x i n a n t i b o d y produce in t he bovine lung a f t e r a e r o s o l e xpos u r e t o v i a b l e P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res. 1985 ; 46 : 1949-1952 .

91

Page 106: Characterization and Application of Monoclonal Antibody

92

14. Chang YF, Renshaw HW, Young R. Pneumonic p a s t e u r e l l o s i s : Examinat ion o f t y p a b l e and u n t y p a b l e P a s t e u r e l l a haemol y t i ca s t r a i n s f o r l e u k o t o x i n p r o d u c t i o n , p l a smid c o n t e n t , and a n t i m i c r o b i a l s u s c e p t i b i l i t y .

15. Cho HJ, Bohoc JG, Yates WDG, Ohmann HB. A n t i c y t o t o x i n a c t i v i t y o f bovine s e r a and body f l u i d s a g a i n s t P a s t e u r e l l a haemol y t i ca Al c y t o t o x i n . Can J Comp Med 1984 ;48 : 151-155 .

16. Shewen PE, Wi lk ie BN. P a s t e u r e l l a ha e mol y t i ca c y t o t o x i nn e u t r a l i z i n g a c t i v i t y in s e r a from O n t a r i o b e e f c a t t l e . Can JComp Med 1983;47 : 497-498 .

17. Gent ry MJ, Confer AW, Po n c e r i a RJ. Serum n e u t r a l i z a t i o n o f c y t o t o x i n from P a s t e u r e l l a ha e mol y t i ca s e r o t y p e - 1 and r e s i s t a n c e t o e x p e r i me n t a l bov ine pneumonic p a s t e u r e l l o s i s . Vet Immuno Immunopathol . 1985 ;9 : 239-250 .

18. Mosier DA, Confer AW, Hal l SM, Gent ry MJ, P a nc i e r a RJ. Enzyme- l inked immunosorbent a s s a y f o r d e t e c t i o n o f serum a n t i b o d i e s t o P a s t e u r e l l a h a e mol y t i ca c y t o t o x i n ( l e u k o t o x i n ) in c a t t l e . J C l i n Microbi o l 1986;24 : 218-222 .

19. Lo RYC, Shewen PE, S t r a t h d e e CA, Gr ee r CN. Cloning and e x p r e s s i o n o f t h e l e u k o t o x i n gene o f P a s t e u r e l l a h a emol y t i ca A- l in Eschenchia c o l i K-12. I n f e c t Immun 1985;50 : 667-671 .

20. Chang YF, Young RY, Pos t D, S t r uc k DK. I d e n t i f i c a t i o n and c h a r a c t e r i z a t i o n o f t h e P a s t e u r e l l a ha e mol y t i ca l e u k o t o x i n .I n f e c t Immun 1987;55:2348-2354.

21. S t r a t h d e e CA, Lo RYC. E x t en s iv e homology between t he l e u k o t o x i n o f P a s t e u r e l l a h a emol y t i ca A- l and t h e a l p h a - h e m o l y s i n o f E s c h e r i c h i a colT^ I n f e c t Immun 1987;55 : 3233-3236 .

22. F r i end S, Thompson R, Wi lk i e B. Pulmonary l e s i o n s produced by P a s t e u r e l l a haemol y t i ca i n c a t t l e . Can J Comp Med 1977 ;41 : 219-223 .

23. Rehmutul l a AJH, Thompson RG. A r ev i ew o f t h e l e s i o n s in s h i p p i n g f e v e r o f c a t t l e . Can Vet J 19 8 1 ; 2 2 : 1 - 8 .

24. El sbach P, Weiss J . Oxygen-dependent and o x y g en - i nde penden t mechanisms o f m i c r o b i c i d a l a c t i v i t y o f n e u t r o p h i l s . Immunol. L e t t e r s 1985;11 : 159-163 .

25. Ayars GH, Altman LC, Rosen H, Doyle T. The i n j u r i o u s e f f e c t o f n e u t r o p h i l s on pneumoncytes in v i t r o . Am Rev Resp Dis 1984;130 : 964-973 .

26. Mar t i n WJ. N e u t r o p h i l s k i l l pulmonary e n d o t h e l i a l c e l l s by a h y d r o g en - p e r o x i d e - d e p e n de n t pathway. Am Rev Resp Dis 1984;130: 209-213 .

Page 107: Characterization and Application of Monoclonal Antibody

93

27. Worthen GS, H a s l e t t C, Rees AJ, Gumbay RS, Henson JE , Henson PM. N e u t r o p h i 1- me d i a t e d pulmonary v a s c u l a r i n j u r y : S y n e r g i s t i c e f f e c t o f t r a c e amounts o f 1 i p o p o l y s a c c h a r i d e and n e u t r o p h i l s e q u e s t r a t i o n in t h e l ung . Am Rev Resp Dis 1987;136 : 19-28 .

28. T a y l o r SM, L a e g r e i d WW, Heidel JR, e t a l . Ar a c h i d o n i c and e i c o s a p e n t a e n o i c a c i d me tabo l i s m in bovine n e u t r o p h i l s and p l a t e l e t s : E f f e c t o f c a l i cum ionophone . J Leuko Biol 1987 ; 42 : 253-262 .

29. K e l l e n b e r g e r E, R y t e r A. Ce l l wal l and c y t o p l a s mi c membrane o f E s c h e r i c h i a c o l i . J Biophys Biochem Cytol 1958 ; 4 : 323- 326 .

30. G l a u e r t AM. S e c t i o n s t a i n i n g , c y t o t o l g y , a u t o r o d i o g r a p h y and immunochemist ry f o r b i o l o g i c a l spec imans . In : Kay, Desmond H,Ed. Techniques f o r e l e c t r o n mi c roscopy 2d, ed Oxford , B a l c k w e l l , 1965:254-273.

31. Reynolds ES. The use o f l e ad c i t r a t e a t h igh pH as an e l e c t r o n - o p a q u e s t a i n in e l e c t r o n mi c r oscopy . J Cel l Biol 1963 ; 17 : 208- 212 .

32. F o r s e l l JH, K a t e l ey JR, Smith CW. Bovine n e u t r o p h i l s t r e a t e d w i t h c h e m o t a t i c a g e n t s : Morpholog ica l c hange s . Am J Vet Res 1985 ; 46 : 1971-1974 .

33. Smith CW, H o l l e r s JC, P a t r i c k RA, e t a l . M o t i l i t y and a d h e s i v e n e s s in human n e u t r o p h i l s : e f f e c t s o f c h e m o t a t i c f a c t o s .J Cl i n I n v e s t 1979; 63 : 221-229 .

34. Anderson DC, Hughes BJ, Smith CW. Abnormal m o b i l i t y o f ne ona t a l po l ymor phonuc l ea r l e u k o c y t e s : R e l a t i o n s h i p t o impa i r ed r e d i s t r i b u t i o n o f s u r f a c e a dhe s i on s i t e s by c h e m o t a t i c f a c t o r o r c o l c h i c i n e . J Cl i n I n v e s t 1981 ;68 : 863-874 .

35. Smith CW, H o l l e r s JC. M o t i l i t y and a d h e s i v e n e s s in humann e u t r o p h i l s : R e d i s t r i b u t i o n o f c h e m o t a t i c f a c t o r - i n d u c e da dh e s io n s i t e s . J C l i n I n v e s t 1980 ; 65 : 804-812 .

36. Donabedian H, Sawyer T, S e n i t z e r . I n h i b i t i o n o f n e u t r o p h i l shape change by an i n h i b i t o r o f c hemot ox i s . J Leuko Biol 1 987 ; 42 : 510-518 .

37. Boyles J , Ba i n t on DF. Changing p a t t e r n s o f plasmame mb r an e - a s s o c i a t e d f i l a m e n t s d u r in g t h e i n i t i a l phases o f po l ymor phonuc l ea r l e u k o c y t e a d h e r e n c e . J Cel l Biol 1979 ; 82 : 347 - 368 .

38. Ryan GB, Borysenko J Z , Karnovski MJ. F a c t o r s a f f e c t i n g t h er e d i s t r i b u t i o n o f s u r f a c e bound c o n c a n a v a l i n A on human po l ymor phonuc l ea r l e u k o c y t e s . J Cel l Biol 1974 ; 62 : 351-365 .

Page 108: Characterization and Application of Monoclonal Antibody

94

39. B e r l i n RD, O l i v e r JM. Analogous u l t r a s t r u c t u r e and s u r f a c e p r o p e r t i e s d u r i n g c app i ng and p h o go cy t o s i s in l e u k o c y t e s . J Cel l Biol 1978 ; 77 : 789-804 .

40. Es t e nsen RD, Whi te JG, Holmes B. S p e c i f i c d e g r a n u l a t i o n o f human p o l ymorphonuc l ea r l e u k o c y t e s . Nature 1974;248: 347-348 .

41. Wright DG, Bra l ove DA, G a l l i n J I . The d i f f e r e n t i a l m o b i l i z a t i o n o f human n e u t r o p h i l g r a n u l e s . Am J Pa tho l 1977 ;87 : 273-281 .

42. L e f f e l l MS, S p i t z n a g e l JK. I n t r a c e l l u l a r and e x t r a c e l l u l a r d e g r a n u l a t i o n of human po l ymorphonuc l ea r a z u r o p h i l and s p e c i f i c g r a n u l e s by immune campl exe s . I n f e c t Immun 1974; 10: 1241-1249.

43. Gennaro R, Donald B, H o r i s b e r g e r U, e t a l . A novel t yp e o f c y t o p l a s mi c g r a n u l e in bov ine n e u t r o p h i l s . J Cel l Biol 1983;96 : 1651-1661 .

44. Ba i n ton DF, U l l y o t JL , Fa rquhar MG. The development o f n e u t r o p h i l i c p o l ymor phonuc l e a r l e u k o c y t e s in human bone marrow: o r i g i n and c o n t e n t o f a q u r o ph i l and s p e c i f i c g r a n u l e s . J Exp Med 1971 ;134: 904-914 .

45. B r e t o n -G o r i u s J , Reyes F. U l t r a s t r u c t u r e o f human bone marrow c e l l m a t u r a t i o n I n t Rev Cytol 1976; 46 : 251 - 259 .

46. Daems WT. On t h e f i n e s t r u c t u r e o f human n e u t r o p h i l i c l e u ko cy te g r a n u l e s . J U l t r a s t r u c t Res 1968;24 : 343-352 .

47. B a g g i o ! i n i M, H o r i s b e r g e r U, e t a l . I d e n t i f i c a t i o n o f t h r e e t y p e s o f g r a n u l e s in n e u t r o p h i l s o f r umi na n t s : U 1 t r a s t r u c t u r e o f c i r c u l a t i n g and m a t u r in g c e l l s . Lab I n v e s t 1985 ;52 : 151-158 .

48. Gent ry MJ, Confer AW, Weinberg ED, Homer JT. Cy t o t ox i n ( l e u k o t o x i n ) p r o d u c t i o n by P a s t e u r e l l a h a e m o l y t i c a : Requi rement f o r an i r o n c o n t a i n i n g compound. Am J Vet Res 1986;47 : 1919-1923 .

49. Shewen PE, Wi l k i e BN. Cy t o t ox i n o f P a s t e u r e l l a h a emol y t i ca a c t i n g on bovine l e u k o c y t e s . I n f e c t Immun 1 9 82 ; 35 : 91 - 94 .

50. Kaeh le r KL, Markham RJF, Musconpla t CC, Johnson DW. Evidence o f s p e c i e s s p e c i f i c i t y i n t h e c y t o c i d a l e f f e c t s o f P a s t e u r e l l a h a e m o l y t i c a . I n f e c t Immun 1980;30 : 615-616 .

51. S u t h e r l a n d AD. E f f e c t s o f P a s t e u r e l l a ha e mol y t i ca c y t o t o x i n on o v i ne p e r i p h e r a l b lood l e u k o c y t e s and lymphocytes o b t a i n e d from g a s t r i c lymph. Vet Mi c r ob i o l 1985 ; 10 : 431-438 .

Page 109: Characterization and Application of Monoclonal Antibody

95

52. Chang YF, Renshaw HW, Mar tens RJ, L i v i n g s t o n CW. P a s t e u r e l l a ha e mol y t i ca l e u k o t o x i n : Chemi luminescen t r e s p o n s e s o f p e r i p h e r a l b lood l e ukocy t e s f rom s e v e r a l d i f f e r e n t mammalian s p e c i e s t o l e u k o t o x i n and o p s o n i n - t r e a t e d l i v i n g and k i l l e d P a s t e u r e l l a ha e mol y t i ca and S t r a p h y l o c o c c u s a u r e u s . Am J Vet Res 1 986 ; 47 : 67 - 74 .

53. O ' B r i en JK, Duffus WPH. P a s t e u r e l l a h a e m o l y t i c a c y t o t o x i n : R e l a t i v e s u s c e p t i b i l i t y o f bov ine l e u k o c y t e s . Vet Mic rob i o l 1987;13 : 321-334 .

Page 110: Characterization and Application of Monoclonal Antibody

CHAPTER 5

PURIFICATION OF THE SEROTYPE 1 SPECIFIC EPITOPE FROM

PASTEURELLA HAEMOLYTICA USING MONOCLONAL ANTIBODY IMMUNOAFFINITY

SUMMARY

A mur ine monoclonal IgM a g g l u t i n a t i n g a n t i b o d y was used in

i mm u n o a f f i n i t y t o p u r i f y t h e s e r o t y p e 1 s p e c i f i c e p i t o p e from

P a s t e u r e l l a h a e m o l y t i ca ( P h - 1 ) . The Ph-1 s p e c i f i c a n t i b o d y was

p r e c i p i t a t e d from p e r i t o n e a l a s c i t i c f l u i d , d i a l y z e d , e v a l u a t e d f o r

a c t i v i t y , and c o v a l e n t l y a t t a c h e d t o CNBr a c t i v a t e d Sepharos e 4B a t

a l k a l i n e pH. R e t e n t i o n o f p u r i f i e d a n t i b o d y a c t i v i t y and c o up l i n g

e f f i c i e n c y t o t h e s u p p o r t m a t e r i a l were g r e a t e r t han 99% when e v a l u a t e d

by ELISA, a g g l u t i n a t i o n , and p r o t e i n d e t e r m i n a t i o n s . KSCN was s e c l e c t e d

as an e l u a n t based upon r e v e r s i b l e d i s s o c i a t i o n o f b a c t e r i a l

a g g l u t i n a t i o n and t i t r a t e d f o r t h e l owes t e f f e c t i v e c o n c e n t r a t i o n .

Immunobead a c t i v i t y was o b s e r ve d m i c r o s c o p i c a l l y by i m m o b i l i z a t i o n o f

e n c a p s u l a t e d Ph-1 and r e v e r s i b l e d i s s o c i a t i o n a f t e r e l u t i o n wi t h 0.4M

KSCN. S p e c i f i c i t y o f i m m o b i l i z a t i o n was conf i rmed u s i n g P. h a e mo l y t i ca

s e r o t y p e s 2 and 5 which were no t bound and by b l o c k i n g Ph-1 b i n d i n g w i t h

homologous c a p s u l a r m a t e r i a l . S a l i n e e x t r a c t a b l e c a p s u l a r m a t e r i a l

from Ph-1 was used as an a n t i g e n s o u r ce and r e a c t e d w i t h an equal

volume o f immunobeads. The immobi l i zed a n t i g e n was s e p a r a t e d and

washed by c e n t r i f u g a t i o n . Fo l lowing e l u t i o n o f t h e Ph-1 s p e c i f i c

e p i t o p e , t h e p r o d u c t was d i a l y z e d and a n a l yz e d u s i n g chemica l and

immunologic methods . The p u r i f i e d Ph-1 s p e c i f i c e p i t o p e c o n t a i n e d no

d e t e c t a b l e p r o t e i n and a t l e a s t o n e - h a l f t h e o r i g i n a l hexosamine

96

Page 111: Characterization and Application of Monoclonal Antibody

97

c o n t e n t . Using d e f i n e d monoclonal a n t i b o d i e s i n ELISA, t i t r a t i o n of

t h e i mmunoa f f i n i t y p r od u c t and o r i g i n a l c a p s u l a r m a t e r i a l r ev e a l e d

s p e c i f i c r e t e n t i o n o f 1i p o p o l y s a c c h a r i d e , p a n - p a s t e u r e l l a c a r b o h y d r a t e ,

and s e r o t y p e 1 c a p s u l a r p o l y s a c c h a r i d e , s u g g e s t i n g e p i t o p e s h a r i n g

among hexosamine a n t i g e n s o f Ph-1.

INTRODUCTION

P a s t e u r e l l a h a e m o l y t i ca s e r o t y p e 1 (Ph-1) i s r e c o g n i ze d as t he

major cause o f s e v e r e f i b r i n o u s pneumonia in c a t t l e t ermed pneumonic

1 2p a s t e u r e l l o s i s o r s h i p p i n g f e v e r . * Al though g r e a t e r t ha n 12 s e r o t y p e s

o f P. h a emol y t i ca have been d e f i n e d , i t i s p r e d o mi n a t e l y s e r o t y p e 1

and l e s s f r e q u e n t l y s e r o t y p e 2 o r P. mu l to c i da which a r e a s s o c i a t e d wi th

t h i s d i s e a s e .

The s e r o t y p e s o f P. h a e m o l y t i ca have been d e f i n e d by e i t h e r

i n d i r e c t h e a m a g g l u t i n a t i o n o r r a p i d p l a t e a g g l u t i n a t i o n u s i n g d i f f u s a b l e

4 5 6s u r f a c e a n t i g e n s or e n c a p s u l a t e d b a c t e r i a r e s p e c t i v e l y . * ’ An

a g e - de p e n d e n t c a p s u l a r m a t e r i a l has been d em o n s t r a t e d on e a r l y

l o g a r i t h m i c g rowt h-phase b a c t e r i a . ® Thi s c a p s u l a r m a t e r i a l i s

r e a d i l y d i f f u s a b l e and e a s i l y removed w i t h o u t a d v e r s e l y a f f e c t i n g

b a c t e r i a l v i a b i l i t y . 7 P o l y s a c c h a r i d e s p r e s e n t in c a p s u l a r m a t e r i a l a r e

8-10t h o u g h t t o c o n f e r s e r o t y p e s p e c i f i c i t y among t h e P a s t e u r e l l a e .

Because b a c t e r i a l c a p s u l a r p o l y s a c c h a r i d e s a r e r ec o g n i ze d as

p a t h o l o g i c a l d e t e r m i n a n t s i n numerous d i s e a s e s , t h e r o l e of

c a p s u l a r m a t e r i a l in pneumonic p a s t e u r e l l o s i s has been t h e s u b j e c t of

many i n v e s t i g a t i o n s . Immuniza t ion wi t h l i v e e n c a p s u l a t e d Ph-1 o r

c a p s u l a r e x t r a c t s has r e s u l t e d in enhanced r e s i s t a n c e t o expe r i me n t a l

Page 112: Characterization and Application of Monoclonal Antibody

1 5 -1 9c h a l l e n g e s . Large amounts o f c a p s u l a r m a t e r i a l have been

a s s o c i a t e d wi t h Ph-1 i s o l a t e d from c a t t l e wi t h pneumonic

p a s t e u r e l l o s i s ; l i t t l e t o no c a p s u l e e x i s t s on t h e o rgan i sm i s o l a t e d

from n o n d i s ea s ed a n i m a l s . 3 F u r t he r more , h igh a n t i b o d y t i t e r s t o

p o l y s a c c h a r i d e a n t i g e n s , d e r i v e d from s a l i n e e x t r a c t a b l e c a p s u l a r

m a t e r i a l o f Ph-1 , has been c o r r e l a t e d wi t h d i s e a s e r e s i s t a n c e . ^ These

f i n d i n g s s i g n i f y t h e impor t ance o f c a p s u l a r m a t e r i a l and e s p e c i a l l y t h e

Ph-1 s p e c i f i c a n t i g e n in t h e p a t h o g e n e s i s o f pneumonic p a s t e u r e l l o s i s .

However, c a p s u l a r m a t e r i a l e x t r a c t e d from Ph-1 i s known t o c o n t a i n

1i p o p o l y s a c c h a r i d e s and o u t e r membrane p r o t e i n s in a d d i t i o n t o c a p s u l a r

7 20-22p o l y s a c c h a r i d e s . ’ The r e l a t i v e c o n t r i b u t i o n o f t h e s e component

a n t i g e n s t o t h e impor t ance a t t r i b u t e d t o c a p s u l a r m a t e r i a l r emains

un d e t e r mi n e d . V e r s a t i l e p r o ce d u r e s a r e needed t o p u r i f y c a p s u l a r

a n t i g e n s in o r d e r t o d e t e r mi n e t h e i r i mpor t a nc e . Se ve r a l p r o c e d u r e s

9 21 23 24have been a dop t ed o r deve l oped t o s e p a r a t e c a p s u l a r a n t i g e n s . * 5 ’

The purposes o f t h i s s t u d y were t o e s t a b l i s h an o p t i mi z e d monoclonal

a n t i b o d y i mmu n o a f f i n i t y p r oc e d u r e t o p u r i f y t h e s e r o t y p e 1 s p e c i f i c

e p i t o p e from P. h a e m o l y t i ca and i d e n t i f y t h e p r od uc t a n t i g e n ( s ) . We

b e l i e v e t h i s i s t he f i r s t immunological p u r i f i c a t i o n o f b a c t e r i a l

p o l y s a c c h a r i d e a n t i g e n s .

a C o r s t v e t , RE, u n p ub l i sh e d o b s e r v a t i o n .

Page 113: Characterization and Application of Monoclonal Antibody

99

MATERIALS AND METHODS

Monoclonal a n t i b o d i e s :

The development and c h a r a c t e r i z a t i o n o f mur ine monoclonal

a n t i b o d i e s has been d e s c r i b e d (Chap t e r 1) . A Ph-1 s p e c i f i c IgM

a g g l u t i n a t i n g a n t i b o d y was used as t h e l i g a n d in i m mu n o a f f i n i t y . Other

d e f i n e d monoclonal a n t i b o d i e s t o a n t i g e n s o f P. ha e mol y t i ca were

used t o e v a l u a t e t h e i m mu n o a f f i n i t y p r o d u c t . Hybridomas were i n j e c t e d

i n t o t h e p e r i t o n e a l c a v i t y o f p r i s t a n e pr imed BALB/c mice f o r a s c i t i c

f l u i d p r o d u c t i o n . Monoclonal a n t i b o d i e s were f r a c t i o n a t e d from a s c i t i c

f l u i d by p r e c i p i t a t i o n in 50% s a t u r a t e d ammonium s u l f a t e a t 4C. The

p r e c i p i t a t e d a n t i b o d i e s were c o l l e c t e d by c e n t r i f u g a t i o n and

r e s us pended in PBS (pH7.2) t o one h a l f t h e o r i g i n a l a s c i t i c f l u i d

volume. Res idua l ammonium s u l f a t e was removed by d i a l y s i s a g a i n s t PBS

(0.1M, pH 7 . 2 ) a t 4C f o r 48 h r . P u r i f i e d monoclonal a n t i b o d i e s were

f i l t e r s t e r i l i z e d ( 0 . 22 ym) and s t o r e d a t -70C p r i o r t o u s e . The

r e t e n t i o n o f p u r i f i e d a n t i b o d y a c t i v i t y r e l a t i v e to p e r i t o n e a l a s c i t i c

f l u i d was e v a l u a t e d u s i n g a n t i b o d y ELISA and a g g l u t i n a t i o n t i t e r sor

( Chap t e r I ) and Brad f o r d p r o t e i n d e t e r m i n a t i o n s . All ELISA t i t e r s

were e x p r e s s e d as t h e i n v e r s e o f t h e h i g h e s t d i l u t i o n p roduc i ng an

a bs o r ba nc e va l ue 1.5 t i mes g r e a t e r t han normal mouse serum (1 :100

d i l u t i o n ) used as a c o n t r o l .

An t igen s o u r ce :

Ca p s u l a r m a t e r i a l f rom Ph-1 s e r o t y p e 1 was e x t r a c t e d from 6 hourQ

c u l t u r e s a t 41C f o r 1 hour in PBS us i ng t h e method o f Gent ry .

E x t r a c t e d c a p s u l a r a n t i g e n s were e x t e n s i v e l y d i a l y z e d a g a i n s t 4 changes

Page 114: Characterization and Application of Monoclonal Antibody

100

of PBS o ve r 48 h r a t 4C and f i l t e r s t e r i l i z e d ( 0 . 2 2 urn). Capsu l a r

m a t e r i a l was c h a r a c t e r i z e d p r i o r t o i m mu n o a f f i n i t y u s i n g p r o t e i n and

26hexosamine d e t e r m i n a t i o n s . Ant i gens p r e s e n t in c a p s u l a r m a t e r i a l

were q u a n t i t a t e d u s i n g d e f i n e d monoclonal a n t i b o d i e s in ELISA (Chap t e r

1).

E l u a n t s e l e c t i o n :

E l u a n t s e l e c t i o n was based on d i s s o c i a t i o n o f b a c t e r i a l

a g g l u t i n a t i o n and r e v e r s i b i 1i t y upon d i l u t i o n wi t h d i s t i l l e d w a t e r .

The s e l e c t e d e l u a n t was t he n t i t r a t e d f o r t h e l owes t c o n c e n t r a t i o n

c a u s i n g d i s s o c i a t i o n p r i o r t o use .

Suppor t m a t e r i a l and c o u p l i n g c o n d i t i o n s :

CNBr a c t i v a t e d Sepharose 4B was used as t h e s u pp o r t m a t e r i a l and

t h e monoclonal a n t i bo dy was c o v a l e n t l y a t t a c h e d a t 10 mg/ml p r e s wo l l e n

beads a t pH8.3 in NaHCO^ (0.1M) b u f f e r c o n t a i n i n g 0.5M NaCl f o r 2 hr a t

room t e m p e r a t u r e . The p o s t - c o u p l i n g s u p e r n a t e was r e t a i n e d f o r

s ubs e que n t a n a l y s i s . Remaining b i n d i ng groups on t h e s u p p o r t m a t e r i a l

were b locked wi t h 0.1M T r i s b u f f e r pH 8 . 5 f o r 2 a d d i t i o n a l h r . Unbound

p r o t e i n was deso r bed from t h e immunobeads by r e p e a t e d a l t e r n a t e washes

o f a c e t a t e b u f f e r (0.1M, pH 4 . 0 ) and t h e c o u p l i n g b u f f e r , each

c o n t a i n i n g 0 . 5 M NaCl . The immunobeads were s t o r e d a t 4C and

r e p e a t e d l y washed wi t h PBS p r i o r t o u s e . Ant ibody c o u p l i ng e f f i c i e n c y

was de t e r mi n e d by compar ing t h e p u r i f i e d a n t i b o d y t o t h e p o s t - c o u p l i n g

25s u p e r n a t e u s i n g ELISA and a g g l u t i n a t i o n t i t e r s and p r o t e i n

d e t e r m i n a t i o n s . Immunobead a c t i v i t y was d e t e r mi n e d m i c r o s c o p i c a l l y by

o bs e r v i n g f o r immunobi1i z a t i o n o f e n c a p s u l a t e d Ph-1. The e f f i c a c y o f

Page 115: Characterization and Application of Monoclonal Antibody

101

t h e s e l e c t e d e l u a n t was conf i r med by o b s e r v i n g b a c t e r i a l e l u t i o n from

t h e immunobead s u r f a c e . S p e c i f i c i t y o f b a c t e r i a l i m m o b i l i z a t i o n was

e v a l u a t e d u s i n g e i t h e r e n c a p s u l a t e d P. ha e mol y t i ca s e r o t y p e 2 o r 5 and

b l o c k i n g Ph-1 b i n d i n g wi t h homologus c a p s u l a r m a t e r i a l .

An t i gen s e p a r a t i o n and a n a l y s i s :

C a p s u l a r m a t e r i a l was r e a c t e d wi t h an equal volume o f immunobeads,

in a p o l y p r o p y l e n e t e s t t u b e , f o r 30 min a t 37C w h i l e g e n t l y r o c k i n g .

The s e r o t y p e 1 s p e c i f i c e p i t o p e was s e p a r a t e d and washed 3 t i me s wi t h

PBS-Tween (pH 7 . 2 , 0.05% Tween 20) by c e n t r i f u g a t i o n a t 50 Xg f o r 2

min a t 22C. Al l s u p e r n a t e s from t h e s e washes were saved f o r f u r t h e r

a n a l y s i s . The s e r o t y p e 1 s p e c i f i c e p i t o p e was e l u t e d from t h e

immunobeads wi t h an equal volume o f 0 . 4 M KSCN f o r 15 min a t 22C w h i l e

g e n t l y r o c k i n g . The e l u a n t was removed from t h e s e r o t y p e 1 s p e c i f i c

e p i t o p e by d i a l y s i s a g a i n s t PBS a t 4C S e p a r a t i o n e f f i c i e n c y d u r i n gpc pp.

i m m u n o a f f i n i t y was d e t e r mi n e d by compar ing p r o t e i n and hexosamine

d e t e r m i n a t i o n s o f c a p s u l a r m a t e r i a l t o t h e PBS-Tween washes . The

d i a l y z e d i mm u n o a f f i n i t y p r o d u c t was a n a l y z e d u s i n g p r o t e i n and

hexosamine d e t e r m i n a t i o n s and d e f i n e d monoclonal a n t i b o d i e s in ELISA

( Ch a p t e r 1) .

RESULTS

Fol lowing p r e c i p i t a t i o n , d i a l y s i s , and f i l t e r s t e r i l i z a t i o n o f t h e

Ph-1 s p e c i f i c monoclonal a n t i b o d y , ELISA and a g g l u t i n a t i o n t i t e r s were

o bs e r ved t o i n c r e a s e r e l a t i v e t o p e r i t o n e a l a s c i t i c f l u i d (Tab l e V . l ) .

Page 116: Characterization and Application of Monoclonal Antibody

102

Table V. l - R e t e n t i o n o f Ant ibody A c t i v i t y and P r o t e i n C o n c e n t r a t i o n

o f P u r i f i e d Monoclonal Ant ibody .

A s c i t i c P u r i f i e d

Assay F lu i d Ant ibody

ELISA t i t e r 107 > i o n★

A g g l u t i n a t i o n t i t e r 32 64

P r o t e i n c o n c e n t r a t i o n NT 11.43 mg/ml

T i t e r s e x p r e s s e d as i n v e r s e o f h i g h e s t d i l u t i o n i m p a r t i n g a p o s i t i v e

r e s u l t .

NT = no t t e s t e d

ELISA a n t i b o d y t i t e r i n c r e a s e d more t ha n t h e a g g l u t i n a t i o n t i t e r .

P r o t e i n c o n c e n t r a t i o n o f t h e p u r i f i e d a n t i b o d y was d e t e r mi ne d f o r

op t i ma l c o u p l i n g t o CNBr a c t i v a t e d Sepharose 4B and subse quen t

e v a l u a t i o n s .

S a l i n e e x t r a c t a b l e c a p s u l a r m a t e r i a l f rom Ph-1 used as an a n t i g e n

s o u r c e in i m m u n o a f f i n i t y , was d e t e r mi n e d t o c o n t a i n 60 wg/ml p r o t e i n

and 0 . 20 pM/ml hexosamine . T i t r a t i o n o f c a p s u l a r m a t e r i a l in ELISA

us i n g d e f i n e d monoclonal a n t i b o d i e s , a t c o n s t a n t c o n c e n t r a t i o n ,

a l l owed q u a n t i f i c a t i o n o f s p e c i f i c a n t i g e n s f o r s ub se q u e n t compar i son

wi t h t h e i mm u n o a f f i n i t y p r o d u c t (Tab l e V.2 ) .

Page 117: Characterization and Application of Monoclonal Antibody

103

Table V.2 - C h a r a c t e r i z a t i o n o f S a l i n e E x t r a c t a b l e C a p s u l a r Ma t e r i a l

o f F\ h a e m o l y t i ca s e r o t y p e 1.

Assay R e s u l t

P r o t e i n (ug/ml ) 60

Hexosamine (uM/ml) 0 .2 0★

McAbs in ELISA

L i p o p o l y s a c c h a r i d e 32

P a n - P a s t e u r e l l a CH^O >512

Ph-1 s p e c i f i c Ag 16

29 KD P r o t e i n 8

★Ca p s u l a r a n t i g e n s were t i t r a t e d in ELISA and d e f i n e d monoclonal

a n t i b o d i e s (McAbs) were used t o i d e n t i f y t h e t i t e r e x p r e s s e d as t h e

i n v e r s e o f h i g h e s t c a p s u l a r a n t i g e n d i l u t i o n g i v i n g a p o s i t i v e r e s u l t .

CH^O = c a r b o h y d r a t e , Ag = a n t i g e n .

KSCN was s e l e c t e d as an i mmu n o a f f i n i t y e l u a n t based on r e v e r s i b l e

d i s s o c i a t i o n o f e n c a p s u l a t e d Ph-1 a g g l u t i n a t i o n by t h e Ph-1 s p e c i f i c

monoclonal a n t i b o d y . D i l u t i o n o f t h e KSCN d i s s o c i a t e d a g g l u t i n a t i o n

r e a c t i o n wi t h d i s t i l l e d w a t e r conf i rmed r e v e r s i b i l i t y o f t h e e f f e c t by

c a u s i n g a g g l u t i n a t i o n t o r e o c c u r . However, t h e de g r e e o f b a c t e r i a l

a g g l u t i n a t i o n was v i s u a l l y reduced upon d i l u t i o n . T i t r a t i o n o f KSCN

f o r t h e l o w e s t e f f e c t i v e c o n c e n t r a t i o n c a u s i n g d i s s o c i a t i o n o f

a g g l u t i n a t i o n r e v e a l e d 0.4M t o be t h e op t i mal c o n c e n t r a t i o n f o r

a n t i g e n e l u t i o n . R e v e r s i b i 1i t y o f a g g l u t i n a t i o n was e a s i l y a c h i eve d

Page 118: Characterization and Application of Monoclonal Antibody

104

wi t h minimum d i l u t i o n o f t h e 0.4M KSCN d i s s o c i a t e d a g g l u t i n a t i o n .

Na2^2^3 was found t 0 cause d i s s o c i a t i o n o f a g g l u t i n a t i o n , bu t t h i s

e f f e c t was n o t as comple t e as w i t h KSCN and cou l d no t be r e v e r s e d upon

d i l u t i o n . Glycine-HCL (0.2M,pH 2 . 5 ) d i d no t cause d i s s o c i a t i o n o f

a g g l u t i n a t i o n (Table V.3) .

Table V.3 - S e l e c t i o n o f an Optimal E l u a n t f o r Immunoaf f i n i t y Based on

D i s s o c i a t i o n o f B a c t e r i a l A g g l u t i n a t i o n .

E l uan t D i s s o c i a t i o n Re v e r s i b i 1 i t y C o n c e n t r a t i o n

KSCN +4 +2 0.4M

Na2S2°3 +4 Neg NT

Glycine-HCL Neg NT NT

(pH 2 . 5 0.2M)

NT = not t e s t e d

Ant ibody c o u p l i ng e f f i c i e n c y t o CNBr a c t i v a t e d Sepharose 4B was

de t e r mi ne d by compar ing t h e p u r i f i e d a n t i b o d y t o t h e p o s t - c o u p l i n g

s u p e r n a t e (Tab l e V. 4 ) . The l ack o f d e m o n s t r a b l e ELISA and

a g g l u t i n a t i o n t i t e r s and n e g l i g i b l e amount o f p r o t e i n in t h e

p o s t - c o u p l i n g s u p e r n a t e i n d i c a t e d g r e a t e r t han 99% o f t he Ph-1

s p e c i f i c a n t i b o d y was c o v a l e n t l y a t t a c h e d t o t h e s u pp o r t m a t e r i a l .

Page 119: Characterization and Application of Monoclonal Antibody

105

Table V.4 - Monoclonal Ant ibody Coupl ing E f f i c i e n c y t o CNBr A c t i v a t e d

Sepharose 4B.

P u r i f i e d P o s t - c o u p l i n g

Assay Ant ibody s u p e r n a t e

ELISA t i t e r >10U 0

A g g l u t i n a t i o n t i t e r 64 0

P r o t e i n 11.43 mg/ml <5.0ug/ml

Page 120: Characterization and Application of Monoclonal Antibody

Fi gu r e V. l - Phase c o n t r a s t mi c rograph o f e n c a p s u l a t e d P. h ae m o l y t i c a

s e r o t y p e 1 immobl ized on immunobead s u r f a c e . X400.

Page 121: Characterization and Application of Monoclonal Antibody

107

Phase c o n t r a s t mi c r oscopy d e m o n s t r a t e d immunobead a c t i v i t y by

i m m o b i l i z a t i o n o f e n c a p s u l a t e d Ph-1 on t h e s u r f a c e ( F i g u r e V . l ) . The

number o f b a c t e r i a bound was found t o be r e l a t e d t o t h e amount o f

c a p s u l a r m a t e r i a l in s o l u t i o n s i n c e t h i s i m m o b i l i z a t i o n cou l d be

c o m p l e t e l y b locked by p r e i n c u b a t i o n o f t h e immunobeads w i t h c a p s u l a r

m a t e r i a l . S p e c i f i c i t y o f b a c t e r i a l i m m o b i l i z a t i o n was conf i r med us i ng

e i t h e r P. h ae m o l y t i c a s e r o t y p e s 2 o r 5 which were no t bound ( F i g u r e

V . 2 ) .

Page 122: Characterization and Application of Monoclonal Antibody

108

F i g u r e V.2 - Phase c o n t r a s t mi c rograph o f e n c a p s u l a t e d P. ha e mol y t i ca

s e r o t y p e 2 and immunobeads d e m o n s t r a t i n g s p e c i f i c i t y by a l a ck o f

i m m o b i l i z a t i o n . P. h a e m o l y t i c a s e r o t y p e 5 was no t immobi l i zed and

mi c r ogr aph i s t y p i c a l f o l l o w i n g e l u t i o n wi t h 0.4M KSCN. X400.

Page 123: Characterization and Application of Monoclonal Antibody

109

E l u t i o n o f e n c a p s u l a t e d Ph-1 from t h e immunobead s u r f a c e wi t h 0.4M

KSCN was co mp l e t e , t y p i c a l o f F i g u r e V.2, and r e v e r s i b l e upon d i l u t i o n

w i t h d i s t i l l e d w a t e r , however , on l y a smal l number o f b a c t e r i a would

r e a s s o c i a t e ( n o t shown) . Immunobeads r e g e n e r a t e d by a n t i g e n e l u t i o n

wi t h 0.4M KSCN and e x t e n s i v e washing wi t h PBS c o n s i s t e n t l y bound

numerous e n c a p s u l a t e d s e r o t y p e 1 b a c t e r i a r e p r e s e n t a t i v e o f F i gu r e 1.

S e p a r a t i o n o f Ph-1 c a p s u l a r a n t i g e n s d u r i n g i mmunoa f f i n i t y was

e v a l u a t e d us i ng chemica l d e t e r m i n a t i o n s o f t h e washes r e l a t i v e t o t he

o r i g i n a l c a p s u l a r e x t r a c t (Tab l e V.5) .

Table V.5 - Chemical D e t e r m i n a t i on o f I mmunoa f f i n i t y Ant igen

S e p a r a t i o n .

Washes

Assay o r i g i n a l s t a r t 1 2 3

P r o t e i n (ug/ml ) 60 36 <18 <10 <4

Hexosamine (yM/ml) 0 .2 0 0 .1 0 ND ND ND

ND = not de t e rmined beca use below t e s t l i m i t s •

P r o t e i n and hexosamine c o n c e n t r a t i o n s d e c r e a s e d c o n s i s t e n t l y

t h r ou g ho u t washing i n d i c a t i n g h igh f i d e l i t y in s e p a r a t i o n . P r o t e i n

c o n c e n t r a t i o n approached z e r o wi t h r e p e a t e d washing whi l e one h a l f of

t h e o r i g i n a l c a p s u l a r hexosamines were r e t a i n e d by t h e immunobeads.

Page 124: Characterization and Application of Monoclonal Antibody

110

Chemical a n a l y s i s o f t h e i mmunoa f f i n i t y p r od uc t r e v e a l e d a l a ck

o f d e t e c t a b l e p r o t e i n and a p p r o x i m a t e l y one h a l f t h e hexosamine

c o n t e n t as t h e o r i g i n a l c a p s u l a r e x t r a c t (Tab l e V.6) .

Table V.6 - A na l y s i s o f t h e I mmunoa f f i n i t y P r oduc t .

Assay R e s u l t

P r o t e i n (yg/ml ) z e r o

Hexosamine (uM/ml) 0 .1 2

McAbs in ELISA

L i p o p o l y s a c c h a r i d e 16

P a n - p a s t e u r e l l a CH^O >512

Ph-1 s p e c i f i c Ag 16

29 KD p r o t e i n ze r o

★I mmunoa f f i n i t y p r o d u c t was t i t r a t e d in ELISA and d e f i n e d monoclonal

a n t i b o d i e s (McAbs) were used t o d e t e r mi n e t he t i t e r e x p r e s s e d as t h e

i n v e r s e o f o f t h e h i g h e s t d i l u t i o n p roduc i ng an abs o r ba nc e va l ue 1.5

t i mes g r e a t e r t han normal mouse serum used as a c o n t r o l . CH^O =

c a r b o h y d r a t e , Ag = a n t i g e n .

T i t r a t i o n o f t h e i mm u n o a f f i n i t y p r o d u c t in ELISA, us i ng d e f i n e d

monoclonal a n t i b o d i e s a t c o n s t a n t c o n c e n t r a t i o n s , r e v e a l e d 3 mo l ecu l e s

were s e l e c t i v e l y p u r i f i e d by t h e p r oc e du r e (Tab l e V.6) .

L i p o p o l y s a c c h a r i d e and p a n - p a s t e u r e l l a c a r b o h y d r a t e c o - p u r i f i e d wi t h

s e r o t y p e 1 s p e c i f i c a n t i g e n . One h a l f o f t h e o r i g i n a l c a p s u l a r

Page 125: Characterization and Application of Monoclonal Antibody

I l l

e x t r a c t 1i p o p o l y s a c c a r i d e was r e c o v e r e d u s i ng t h e s e methods . Al though

t h e t i t e r o f t he p a n - p a s t e u r e l l a c a r b o h y d r a t e was g r e a t e r than

a s s a y e d , in both t h e o r i g i n a l c a p s u l a r e x t r a c t and i mmunoa f f i n i t y

p r o d u c t , t h e o v e r a l l a b s o r b a n c e v a l ue s were g r e a t e r in t he

immunoa f f i n i t y p r od uc t i n d i c a t i n g s e l e c t i v e r e t e n t i o n o f t h i s mol ecu l e

( n o t shown) . The t i t e r o f t h e Ph-1 s p e c i f i c a n t i g e n was t h e same in

t h e o r i g i n a l c a p s u l a r e x t r a c t and t h e i mmunoa f f i n i t y p r o d u c t . The 29

KD p r o t e i n was a b s e n t , as e x p e c t e d s i n c e a l l p r o t e i n was removed by

wash ing , from t he p r o d u c t .

DISCUSSION

R e v e r s i b l e d i s s o c i a t i o n o f b a c t e r i a l a g g l u t i n a t i o n was used in

t h i s s t udy t o s e l e c t an op t i ma l e l u a n t f o r i mmu n o a f f i n i t y . Glyc i ne -

HCL (0.1M, pH 2 . 5 ) and Na2S203 were found t o be u n s u i t a b l e as e l u a n t s

u s i n g t h i s c r i t e r i a . Gl yc i ne - HCL, o f low pH has been used97 n

s u c c e s s f u l l y as an IgG e l u a n t in a v a r i e t y o f p r ev io us s t u d i e s .

A p p a r e n t l y , a s h i f t in pH had no e f f e c t on t he IgM - Ph-1 complex as i t

does wi t h IgG a n t i g e n complexes and a g g l u t i n a t i o n was not d i s s o c i a t e d .

N02S2O3 caused d i s s o c i a t i o n o f a g g l u t i n a t i o n , however , r e v e r s i b i 1i t y

cou l d no t be a c h i eve d upon d i l u t i o n wi t h d i s t i l l e d w a t e r . The r eason

f o r i r r e v e r s i b i l i t y e n c o u n t e r e d wi t h Na2S20g remains unknown, bu t

permanent a n t i g e n o r a n t i b o d y d e n a t u r a t i o n a r e p o s s i b i l i t i e s .

Cha o t rop i c t h i o c y a n a t e s have been p r e v i o u s l y used as s u c c e s s f u l

30-34i mmu n o a f f i n i t y e l u a n t s in a v a r i e t y o f a p p l i c a t i o n s . KSCN was

found t o s a t i s f y ou r c r i t e r i a in t h e s e l e c t i o n o f an e l u a n t and was

t i t r a t e d f o r t he l owes t c o n c e n t r a t i o n c a u s i n g d i s s o c i a t i o n . The l owes t

d i s s o c i a t i v e c o n c e n t r a t i o n was c o n s i d e r e d opt imal because i t produced

Page 126: Characterization and Application of Monoclonal Antibody

112

mi l d e l u t i o n c o n d i t i o n s which were e a s i l y r e v e r s i b l e . These r e s u l t s

i n d i c a t e p r o p e r t i e s o f i mmunoglobul ins , p a r t i c u l a r l y a g g l u t i n a t i o n and

p o s s i b l y p r e c i p i t a t i o n , can be used in t h e s e l e c t i o n and o p t i m i z a t i o n

o f i mm u n o a f f i n i t y e l u a n t s .

Immunobead a c t i v i t y was a s s e s s e d by m i c r o s c o p i c o b s e r v a t i o n o f

e n c a p s u l a t e d b a c t e r i a l i m m o b i l i z a t i o n . The a g g l u t i n a t i n g a c t i v i t y of

t h e Ph-1 s p e c i f i c IgM monoclonal a n t i b o d y was u n d oub t e d l y r e s p o n s i b l e

f o r t h i s phenomena. Fo l lowing e s t a b l i s h m e n t o f immunobead a c t i v i t y ,

t h e s p e c i f i c i t y o f b a c t e r i a l i m m o b i l i z a t i o n was e v a l u a t e d u s i n g P.

h ae m o l y t i c a s e r o t y p e s 2 and 5 and by b l o c k i n g Ph-1 b i n d i ng wi th

homologous c a p s u l a r m a t e r i a l . E n c a p s u l a t e d Ph-1 c ou l d be r e v e r s i b l y

d i s s o c i a t e d from t h e bead s u r f a c e u s i n g t h e o p t i mi z e d e l u a n t . These

f i n d i n g s s u pp o r t e d p r ev i o u s r a t i o n a l and c o n c l u s i o n s and p r ov i de d a

f a s t , e a s y , and p r a c t i c a l means o f a s s e s s i n g immunobead a c t i v i t y p r i o r

t o u s e . Ot he r i m mu n oa f f i n i t y p r oc e d u r e s have on l y t o r e l y on p r od uc t

e v a l u a t i o n , somet imes days t o weeks l a t e r , as an a s s e s s m e n t o f

a c t i v i t y . Thus , a g g l u t i n a t i o n by immunoglobul ins can be a p p l i e d t o

t e s t t h e f e a s i b i l i t y and s p e c i f i c i t y o f u s i n g d i f f e r e n t a n t i b o d y

c o u p l i n g p r o c e d u r e s , s u p p o r t m a t e r i a l s , and e l u a n t s in i m mu n oa f f i n i t y .

S e p a r a t i o n and washing o f t h e immunobead a n t i g e n complex was

per formed by low speed c e n t r i f u g a t i o n . Thi s proved t o be a f a s t , e a sy

means o f s e p a r a t i n g and washing t h e bound complex. Another adva n t age

of t h i s method was t h a t volumes o f wash and e l u a n t s o l u t i o n s were

e a s i l y c o n t r o l a b l e and he l d c o n s t a n t f o r s u b s e qu e n t e v a l u a t i o n s .

Common problems e n c o u n t e r e d wi t h a f f i n i t y columns a r e d i l u t i o n o f t h e

p r o d u c t upon e l u t i o n , pH n e u t r a l i z a t i o n , and i d e n t i f i c a t i o n o f t h e

p r o d u c t in numerous f r a c t i o n s . In t h i s s t u d y , volumes o f wash and

Page 127: Characterization and Application of Monoclonal Antibody

113

e l u a n t s o l u t i o n s e q u i v a l e n t w i t h t h e a n t i g e n volume were used a l l o w i n g

e a s y t r a c k i n g and e v a l u a t i o n o f t h e component s . Thi s method a l s o

d e l e t e d t h e need f o r s p e c i a l , e x p e n s i v e , and somet imes cumbersome

mechanica l equ i qmen t .

The p r oc e d u r e s used in t h i s s t u d y were e v a l u a t e d by chemica l and

immunological me thods . An t ibody a c t i v i t y was a s s e s s e d u s i n g ELISA and

a g g l u t i n a t i o n t i t e r s which were ob s e r ve d t o i n c r e a s e f o l l o w i n g

p u r i f i c a t i o n and c o n c e n t r a t i o n o f monoclonal a n t i b o d y from p e r i t o n e a l

a s c i t i c f l u i d . Thi s may have been due t o removal o f i n h i b i t o r y

s u b s t a n c e s , such as p r i s t a n e , l i p i d s , o r p r o t e o l y t i c enzymes d u r i n g

p u r i f i c a t i o n . The a g g l u t i n a t i o n t i t e r d i d no t i n c r e a s e as much as t h e

ELISA t i t e r and was a t t r i b u t e d t o s o l u b i l i z a t i o n o f c a p s u l a r a n t i g e n s ,

s i n c e Ph-1 b i n d i n g c ou l d be b locked wi t h c a p s u l a r m a t e r i a l . These

t i t e r s w i t h p r o t e i n d e t e r m i n a t i o n s were a l s o used t o e v a l u a t e c o v a l e n t

a n t i b o d y a t t a c h m e n t t o t h e s u p p o r t m a t e r i a l and i n d i c a t e d t h e d e s c r i b e d

c o n d i t i o n s removed a l l a n t i b o d y a c t i v i t y from s o l u t i o n .

C a p s u l a r m a t e r i a l from Ph-1 has been shown t o c o n t a i n bo th p r o t e i n

and hexosamine a n t i g e n s q u a n t i f i a b l e by chemica l and immunological7 q i n i c

methods . » » » » Chemical d e t e r m i n a t i o n s o f t h e c a p s u l a r

m a t e r i a l , wash s o l u t i o n s , and i mm u n o a f f i n i t y p r o du c t a l l owed e v a l u a t i o n

o f t h e s e p a r a t i o n p r o c e d u r e s . P r o t e i n c o n c e n t r a t i o n s d e c r e a s e d

c o n s i s t e n t l y and o n e - h a l f t h e hexosamines were removed d u r i n g wash i ng ,

i n d i c a t i n g t h e Ph-1 s p e c i f i c a n t i g e n was hexosamine in n a t u r e . Thi s

c o n c l u s i o n s u p p o r t s t h e work o f o t h e r i n v e s t i g a t o r s who have i d e n t i f i e d

9 10t h e Ph-1 s p e c i f i c a n t i g e n as hexosamine . ’

Fo l l owi ng a n t i g e n e l u t i o n and d i a l y s i s , chemica l a n a l y s i s o f t h e

i mm u n oa f f i n i t y p r o d u c t r e v e a l e d a l a c k o f d e t e c t a b l e p r o t e i n and

Page 128: Characterization and Application of Monoclonal Antibody

o n e - h a l f t h e o r i g i n a l hexosamine c o n t e n t . ELISA i d e n t i f i c a t i o n and

t i t r a t i o n o f t h e p r od u c t a n t i g e n s d e m o ns t r a t e d s e l e c t i v e r e t e n t i o n o f

1i p o p o l y s a c c h a r i d e , p a n - p a s t e u r e l l a c a r b o h y d r a t e and t h e Ph-1 s p e c i f i c

c a p s u l a r p o l y s a c c h a r i d e ; a l l hexosamine c o n t a i n i n g a n t i g e n s . The LPS

ELISA t i t e r , i n t he p r o d u c t , was d e c r e a s e d by one h a l f and t h e

p a n - p a s t e u r e l l a c a r b o h y d r a t e t i t e r r emained g r e a t e r t han a s s ay e d .

However, t h e a bs o r ba nc e v a l u e s ( no t shown) o f t h e p a n - p a s t e u r e l l a

c a r b o h y d r a t e were h i g h e r in t h e p r od u c t t han t h e o r i g i n a l c a p s u l a r

m a t e r i a l . The Ph-1 s p e c i f i c c a p s u l a r p o l y s a c c h a r i d e t i t e r remained t he

same f o l l o w i n g i m mu no a f f i n i t y . The r e a s o n f o r t h e s e l e c t i v e r e t e n t i o n

o f t h e 2 unexpec t ed a n t i g e n s remains u n de t e r mi n e d , however s e v e r a l

p o s s i b i l i t i e s e x i s t .

N o n - s p e c i f i c r e t e n t i o n o f a n t i g e n s t h r ough i m mu n o a f f i n i t y

35p r oc e d u r e s i s a common problem. Suppor t m a t e r i a l s may

n o n - s p e c i f i c a l l y a bs o r b a n t i g e n s by h y d ro ph ob i c , h y d r o p h i l i c , o r i o n i c

i n t e r a c t i o n s . These i n t e r a c t i o n s have been e x p l o i t e d in many a f f i n i t y

35p r oc e d u r e s t o p u r i f y v a r i o u s m o l e c u l e s . L i k e wi s e , i t i s no t

i n c o n c i e v a b l e t h a t , b l o c k i n g r e a g e n t s can modi fy s up p o r t s u r f a c e s

l e a d i n g t o n o n - s p e c i f i c a b s o r b t i o n . The r e l a t i v e l y mi ld washing

c o n d i t i o n s used h e r e i n may no t have been s t r i n g e n t enough t o remove

1i p o p o l y s a c c h a r i d e and p a n - p a s t e u r e l l a c a r b o h y d r a t e n o n - s p e c i f i c a l l y

a bs o r be d t o t h e s u pp o r t m a t e r i a l . Ano t he r p o s s i b i l i t y i n c l u d e s t h e

p r e s e n c e o f o t h e r immunog lobu l ins , in p e r i t o n e a l a s c i t i c f l u i d , which

bind 1i p o p o l y s a c c h a r i d e and p a n - p a s t e u r e l l a c a r b o h y d r a t e . However, one

would e x p e c t n o n - s p e c i f i c a b s o r b t i o n t o o c c u r on l y i n t r a c e amounts ,

l e a d i n g t o low, but d e t e c t a b l e l e v e l s o f c o n t a m i n a n t s . The p r o b a b i l i t y

o f n o n - s p e c i f i c r e t e n t i o n seems low beca use o f t h e l a r g e and n e a r l y

Page 129: Characterization and Application of Monoclonal Antibody

115

e q u i v a l e n t amount o f a n t i g e n s in t h e p r od u c t r e l a t i v e t o t h e o r i g i n a l

c a p s u l a r m a t e r i a l .

In s u p p o r t o f t h e s p e c i f i c r e t e n t i o n o f t h e two unexpec t ed

a n t i g e n s , t h e Ph-1 s p e c i f i c e p i t o p e cou l d be p r e s e n t on s e v e r a l

m o l e c u l e s . Using monoclonal a n t i b o d i e s , E s c h e r i c h i a c o l i K5 c a p s u l a r

p o l y s a c c h a r i d e has been shown t o s h a r e an a n t i g e n i c d e t e r m i n a n t w i t h

t h e e n t e r o b a c t e r i a l common a n t i g e n . S i m i l a r l y , l i p i d has been

i d e n t i f i e d on t h e c a p s u l a r p o l y s a c c h a r i d e s o f many Gram-nega t ive

37b a c t e r i a and common l i p i d c a r r i e r s have been i m p l i c a t e d in t he

s y n t h e s i s o f 1i p o p o l y s a c c h a r i d e s , p e p t i d o g l y c a n , and c a p s u l a r

38p o l y s a c c h a r i d e s . L i k e w i s e , k e t o - d e o x y - o c t o n o i c m o i e t i e s , known t o

compr i se t h e c o r e o f 1 i p o p o l y s a c c h a r i d e s , have been l o c a t e d on c a p s u l a r

39-42p o l y s a c c h a r i d e s . These s t u d i e s i n d i c a t e t h a t p o l y s a c c h a r i d e

e p i t o p e s can be s h a r e d by a v a r i e t y o f d i f f e r e n t c a r b o h y d r a t e

c o n t a i n i n g m o l e c u l e s . R e c e n t l y , i t was s u g ge s t e d t h a t s e r o t y p e

s p e c i f i c a n t i g e n s o f P. h a e m o l y t i ca a r e a p a r t o f t he

431i p o p o l y s a c c h a r i d e complex, s p e c i f i c a l l y t h e 0 - a n t i g e n s i d e c h a i n .

Othe r i n v e s t i g a t o r s have r e p o r t e d s e r o t y p e s p e c i f i c i t y r e s i d e s in

c a p s u l a r p o l y s a c c h a r i d e s . Our r e s u l t s s u g g e s t t h a t t h e Ph-1 s p e c i f i c

e p i t o p e i s p r e s e n t on c a p s u l a r p o l y s a c c h a r i d e , 1i p o p o l y s a c c h a r i d e , and

t h e p a n - p a s t e u r e l l a c a r b o h y d r a t e . Ep i t ope s h a r i n g among hexosamine

a n t i g e n s c ou l d have i m p o r t a n t i m p l i c a t i o n s i n p o l y s a c c h a r i d e

i mmunogeni c i t y .

Page 130: Characterization and Application of Monoclonal Antibody

BIBLIOGRAPHY

1. C o l l i e r JR. P a s t e u r e l l a e in bov ine r e s p i r a t o r y . J Am Vet Med Assoc 1968; 152:824-828.

2. Rehmutul l a AJ, Thompson RG. A r ev i ew of t h e l e s i o n s in s h i p p i n g f e v e r o f c a t t l e . Can Vet J 198 1 ; 2 2 : 1 - 8 .

3. B i b e r s t e i n EL. B i o t y p in g and s e r o t y p i n g o f P a s t e u r e l l a h a e m o l y t i c a . Methods in Mi c rob i o l 1978; 10 :255-269 .

4. Frank GH, Wessman GE. Rapid p l a t e a g g l u t i n a t i o n p r oc e du r e f o r s e r o t y p i n g P a s t e u r e l l a h a e m o l y t i c a . J C l i n M i c r o b i o l . 1978; 7 : 142-145 .

5. B i b e r s t e i n EL, G i l l s M, Knight H. S e r o l o g i c a l t y p e s o f P a s t e u r e l l a h a e m o l y t i c a . Cor ne l l Vet 1960; 50 :283-300 .

6 . C o r s t v e t RE, Gent ry MJ, Newman PR, e t a l . Demons t r a t i on o f a g e - de p e n d e n t c a p s u l a r m a t e r i a l on P a s t e u r e l l a haemol y t i ca s e r o t y p e 1. J Cl i n Mi c r ob i o l 1982; 1 6 : 1 1 2 3 - 1 1 2 ^

7. Gent ry MJ, C o r s t v e t RE, P onc i e r a RJ. E x t r a c t i o n o f c a p s u l a r m a t e r i a l from P a s t e u r e l l a h a e m o l y t i c a . Am J Vet Res 1982:43 : 2070-2073 .

8 . C a r t e r GR. A s e r o l o g i c a l s t u d y o f P a s t e u r e l l a h a e m o l y t i c a . Can J Mi c rob i o l 1956; 2 : 483 - 488 .

9. Adlam C, Knight s JM, Muqridge A, e t a l . P u r i f i c a t i o n , c h a r a c t e r i z a t i o n and immunological p r o p e r t i e s o f t h e s e r o t y p e s p e c i f i c c a p s u l a r p o l y s o c c h a r i d e o f P a s t e u r e l l a haemol y t i ca ( s e r o t y p e Al) o r ga n i s ms . J Gen Mic rob i o l 1984; 130:2415-2426.

10. Townsend EL, Maheswaran SK, L e i n i n g e r JR, Ames TR. D e t e c t i o n ofimmunoglobul in G t o P a s t e u r e l l a ha e mol y t i ca c a p s u l a r p o l y s a c c h a r i d e by e nz yme - l i nke d immunosorbent a s s a y . J Cl inMi c rob i o l 1987 ; 25 : 242- 247 .

11. Lee CJ, Review: B a c t e r i a l c a p s u l a r p o l y s a c c h a r i d e s - b i o c h e m i s t r y , immuni ty, and v a c c i n e . Mol Immuno 1987: 24: 1005-1019.

12. McLeod G r i f f i s J , A p i c e l l a MA, Greenwood B, Makela PH. Vaccines a g a i n s t e n c a p s a l a t e d b a c t e r i a : A g l obo l agenda . Rev I n f e c t Dis 1987; 9 :176 - 188 .

13. Jann K, Jann B. P o l y s a c c h a r i d e a n t i g e n s o f E s c h e r i c h i a c o l i .Rev I n f e c t Dis 1987; 9 ( s u p p l . 5 ) : S517-S526.

14. Lu CH, Hugh R, Lee CJ. C h a r a c t e r i z a t i o n of t h e b i n d i n g o f andt h e immune r e s po ns e t o pneumococcal group 9 c a p s u l a r p o l y s a c c h a r i d e s . Mol Immuno 1987 ;24 : 427-433 .

116

Page 131: Characterization and Application of Monoclonal Antibody

117

15. Confer AW, L e s s l e y BA, P a n c i e r a RJ, Fu l t o n RW, Kreps JA. Serum a n t i b o d i e s t o a n t i g e n s a s s o c i a t e d wi t h a s a l i n e e x t r a c t o f P a s t e u r e l l a h a e m o l y t i c a : C o r r e l a t i o n wi t h r e s i s t a n c e t o e x p e r i me n t a l bov ine pneumonic p a s t e u r e l l o s i s . Vet . Immunol Immunopathol 1985 ;10 : 265-278 .

16. Gi lmour NJL, Mar t i n WB, Sharp JM, e t a l . Exper i ment a l immuniza t ion of lambs a g a i n s t pneumonic p a s t e u r e l l o s i s . Res Vet Sci 1983; 3 5 : 80 - 86 .

17. Yates WGD, STockdale PGH, Babink LA. P r e v e n t i o n o f e x p e r i m e n t a l bov ine penumonic p a s t e u r e l l o s i s w i t h an e x t r a c t o f P a s t e u r e l l a h a e m o l y t i c a . Can J Comp Med 1983 ; 47 : 250-256 .

18. Tadayon RA, Laurtman LH. The c a p a c i t y o f v a r i o u s f r a c t i o n s o f P a s t e u r e l l a h a emol y t i ca t o s t i m u l a t e p r o t e c t i v e immunity in mice and h a m s t e r s . Vet Mi c rob i o l 1 9 8 1 ; 6 : 85 - 93 .

19. Evans HB, Wel ls PW. A mouse model o f P a s t e u r e l l a ha e mol y t i ca and i t s use in a s s e s sm e n t o f P. h a e mo l y t i ca v a c c i n e s . Res Vet Sci 1979; 27 :213-217 .

20. S q u i r e PG, Smi ley DW, Cr o s k e l l RB. I d e n t i f i c a t i o n and e x t r a c t i o n o f P a s t e u r e l l a ha e mol y t i ca membrane p r o t e i n s . I n f e c t Immun 1984;45 : 667-673 .

21. McKinney KL, Confer AW, Rummage JA, Gent ry MJ. Durham JA. P a s t e u r e l l a h a e m o l y t i c a : P u r i f i c a t i o n o f s a l i n e - e x t r a c t a b l e p r o t e i n s by i s o e l e c t r a f o c u s i n g . Vet Mi c rob i o l 1985;10 : 465-480 .

22. Durham JA, Confer AW, Mosier DA, L e s s l e y BA. Comparison o f t h e a n t i g e n s a s s o c i a t e d wi t h s a l i n e s o l u t i o n , p o t a s s iu m t h i o c y a n a t e , and sodium s a l i c y l a t e e x t r a c t s o f P a s t e u r e l l a haemol y t i ca s e r o t y p e l . Am J Vet Res 1986;47 : 1946-1951 .

23. Donachie W, Gi lmour NJL, Mould DL, Paxton IR. Comparison o f c e l l s u r f a c e a n t i g e n e x t r a c t s from two s e r o t y p e s o f P a s t e u r e l l a ha e mol y t i ca J Gen Mi c rob i o l 1984 ; 130: 1209-1216 .

24. Gonzalez-Rayos C, Lo RYC, Shewen PE, Bever i dge TJ. Cloning o f a s e r o t y p e - s p e c i f i c a n t i g e n from P a s t e u r e l l a ha e mol y t i ca I n f e c t Immun 1986 ; 53 : 505-510 .

25. Brad f o r d MM. A r a p i d and s e n s i t i v e method f o r t h e q u a n t i t a t i o n o f microgram q u a n t i t i e s o f p r o t e i n u t i l i z i n g t h e p r i n c i p l e o f p r o t e i n - d y e b i n d i n g . Anal Biochem 1976 ; 72 : 248-254 .

26. Smith RL, G i l k e r s o n E. Q u a n t i t a t i o n o f g lycosaminog l ycon hexosamine u s i n g 3 - m e t h y l - 2 - b e n z o t h i a z o l o n e hydrazone h y d r o c h l o r i d e . Anal Biochem 1979 ; 98 : 478-480 .

Page 132: Characterization and Application of Monoclonal Antibody

118

27. Dekozak Y, Mi r shah i M, e t a l . P r e v e n t i o n o f autoimmune u v e o r e t i n i t i s by a c t i v e immuniza t ion wi t h a u t o a n t i g e n - s p e c i f i c monoclonal a n t i b o d i e s . Eur J Immunol 1987 ; 17 : 541-547 .

28. C a r t e r CE, Co l l ey DG. Schstosoma j aponicum s o l u b l e egg a n t i g e n s : s e p a r a t i o n by Con A chromatography and i mmunoaf f i n i t y p u r i f i c a t i o n . Mol Immunol. 1981 ;18 : 219-255 .

29. T a u s s i g MJ, Brown N, e t a l . A n t i - i d i o t y p i c s e r a a g a i n s t monoclonal a n t i - p r o g e s t e r o n e a n t i b o d i e s : p r o d u c t i o n in r a b b i t s and r a t s and c h a r a c t e r i z a t i o n o f s p e c i f i c i t y . Immunol. 1986 ; 58 : 445- 452 .

30. Johnson G, Garvey JS. Improved methods f o r s e p a r a t i o n and p u r i f i c a t i o n by a f f i n i t y chroma tography . J Immunol Meth 1 977 ; 15 : 29 - 37 .

31. Mudget t M, Co l i gan JE , Kindt TJ. I s o l a t i o n and c h a r a c t e r i z a t i o n o f d i s t i n c t a n t i b o d y p o p u l a t i o n s from a n t i s e r a d i r e c t e d a g a i n s t i d i o t y p e s o f r a b b i t homogenous a n t i b o d i e s . J Immunol1 9 7 8 ; 1 2 0 (1 ) : 2 93 -3 0 1 .

32. Baker JR, Lukes YG, Burman KD. P r o d u c t i o n , i s o l a t i o n , and c h a r a c t e r i z a t i o n o f r a b b i t a n t i - i d i o t y p i c a n t i b o d i e s d i r e c t e d a g a i n s t human a n t i t h y r o t r o p h i n r e c e p t o r a n t i b o d i e s . J Cl i n I n v e s t 1984 ; 74 : 488 - 495 .

33. Dunn PL, Johnson CA, S t y l e s JM, e t a l . V a c c i n a t i on wi t h s yngene i c monoclonal a n t i - i d i o t y p e p r o t e c t s a g a i n s t a tumour c h a l l e n g e . Immunol 1987 ; 60 : 181- 186 .

34. Edgi n ton TS. D i s s o c i a t i o n o f a n t i b o d y from e r y t h r o c y t e s u r f a c e s by c h a o t r o p h i c i o n s . J Immunol 1971;106: 673-680 .

35. Cooke, N. High pe r fo rmance a f f i n i t y chromotography LC.GC 1987 ; 5 : 866 - 872 .

36. P e t e r s H, J u r s M, Jann B, e t a l . Monoclonal a n t i b o d i e s to e n t e r o b a c t e r i a l common a n t i g e n and t o E s c h e r i c h i a c o l i1i p o p o l y s a c c h a r i d e o u t e r c o r e : Demons t r a t i on o f an a n t i g e n i c d e t e r m i n a n t s h a r ed by e n t e r o b a c t e r i a l common a n t i g e n and E. c o l i K5 c a p s u l a r p o l y s a c c h a r i d e . I n f e c t Immun 1985;50 : 459-466 .

37. G o t s c h l i c h EC, F r a z e r BA, Nishimura 0 , e t a l . L i p i d on c a p s u l a r p o l y s a c c h a r i d e s o f g r a m - n e g a t i v e b a c t e r i a . J Biol Chem 1982 ; 257: 7720-7729 .

38. Masson L, Holbe in BE. Role o f l i p i d i n t e r m e d i a t e s in t h e s y n t h e s i s o f s e ro g r ou p B N e i s s e r i a m e n i n g i t i d i s c a p s u l a r p o l y s a c c h a r i d e . J B a c t e r i o l 1985;161: 861-867 .

Page 133: Characterization and Application of Monoclonal Antibody

119

39. Jann K, Hofmann P, J ann B. S t r u c t u r e o f t h e2 - k e t o - 3 - de o x y -D - ma n n o -o c t o n i c a c i d (KDO) c o n t a i n i n g c a p s u l a r p o l y s a c c h a r i d e (K14 a n t i g e n ) f rom E s c h e r i c h i a c o l i 9 6 : K14: H. Car bohydr a t e Res 1983 ; 120 : 131-141 .

40. J en n i n g s HJ, Ros e l l KG, Johnson KG. S t r u c t u r e o f t h e3- deoxy- D- Ma nno- oc t u l o s on i c a c i d c o n t a i n i n g p o l y s a c c h r o i d e (KG a n t i q e n ) from E s c h e r i c h i a c o l i LP1092. Ca rbohydra t e Res 1982 ; 105 : 45- 56 .

I

41. Neszmelyi A, Jann K, Messner P , . l i n ge r F. C o n s t i t u t i o n a l and c o n f i g u r a t i o n a l a s s i g n me n t s by CNMR s p e c t r o s c o p y o f E s c h e r i c h i a c o l i c a p s u l a r p o l y s a c c h a r i d e s c o n t a i n i n g r i b o s e and 3-deoxy- D- Ma nno- oc t u l o s on i c a c i d (KDO). J Chem Soc, Chem Commun 1982;1017-1019.

42. B h a t t a c h a j e e AK, J en n i n g s HJ, Kenny CP. S t r u c t u r a l e l u c i d a t i o n o f t h e 3 - doxy- D-Manno- oc t u l oson i c a c i d c o n t a i n i n g meningococcal 29-e c a p s u l a r p o l y s a c c h a r i d e a n t i g e n u s i n g c a r bon - 13 n u c l e a r magne t i c r e s o n a n ce . Biochem 1980 ; 17 : 654-651 .

43. Tas i LH, C o l l i n s MT, Hdibg N. A n t i g e n i c a n a l y s i s o f P a s t e u r e l l a ha e mol y t i ca s e r o u a r s 1 t r hough 15 by c r o s s e d i m mu n o e l e c t r o p h o r e s i s . Am J Vet Res 1988;49 : 213-222 .

Page 134: Characterization and Application of Monoclonal Antibody

CHAPTER 6

CONCLUSIONS AND FUTURE PERSPECTIVES

Bas ic r e s e a r c h c o n s i d e r e d n e c e s s a r y f o r a b e t t e r u n d e r s t a n d i n g o f

t h e p a t h o g e n e s i s in pneumonic p a s t e u r e l l o s i s was c o n d uc t e d . The

r a t i o n a l c o n s t r u c t i o n o f a component v a c c i n e i s dependen t on an

a d eq ua t e comprehens ion o f t h e p a t h o g e n e s i s . T h e r e f o r e , a

c h a r a c t e r i z a t i o n o f monoclonal a n t i b o d y and bovine n e u t r o p h i l

r e a c t i v i t y t o P a s t e u r e l l a h a e m o l y t i ca s e r o t y p e 1 (Ph-1) a n t i g e n s was

per formed t o a i d in a c h i e v i n g t h e s e g o a l s .

The monoclonal a n t i b o d i e s (McAbs) p r e p a r e d and c h a r a c t e r i z e d

a g a i n s t Ph-1 c a p s u l a r m a t e r i a l p r ov i d e s some b a s i c m a t e r i a l s t o

i d e n t i f y , q u a n t i t a t e , and p u r i f y a n t i g e n s . I n f o r m a t i on c o n c e r n i n g t he

p a t h o g e n e s i s may be o b t a i n e d by i d e n t i f y i n g t h e amount o f Ph-1 a n t i g e n s

p r e s e n t in inoculums and b r o n c h o a l v e o l a r l a vage f l u i d s . The

i d e n t i f i c a t i o n and d i s t r i b u t i o n o f Ph-1 a n t i g e n s in pneumonic lung

t i s s u e u s i n g t h e McAbs and immunohis tochemical t e c h n i q u e s may a l s o a i d

in u n d e r s t a n d i n g t h e p a t h o g e n e s i s . I d e n t i f i c a t i o n and l a r g e s c a l e

p r u i f i c a t i o n o f s p e c i f i c Ph-1 a n t i g e n s i m p o r t a n t i n t h e p a t h o g e n e s i s

w i l l be r e q u i r e d t o c o n s t r u c t an e f f e c t i v e component v a c c i n e . The

McAbs d eve l oped and c h a r a c t e r i z e d in t h i s r e s e a r c h can a i d in

u n d e r s t a n d i n g t h e p a t h o g e n e s i s and in d e v e l o p i n g a v a c c i n e .

An u n d e r s t a n d i n g o f n e u t r o p h i l i n t e r a c t i o n wi t h Ph-1 a n t i g e n s i s

i m p o r t a n t i n t h e comprehens ion of t h e p a t h o g e n e s i s in pneumonic

p a s t e u r e l l o s i s . The l o g i c a l deve lopment o f a component v a c c i n e s hou l d

a d d r e s s t h e i n t e r a c t i o n o f n e u t r o p h i l s w i t h Ph-1 a n t i g e n s . The MTT

c o l o r i m e t r i c a s s a y a d a p t ed h e r e i n p r ov i d es a means o f measur i ng

120

Page 135: Characterization and Application of Monoclonal Antibody

121

n e u t r o p h i l c y t o t o x i c i t y and s t i m u l a t i o n . The a c t i v a t i o n o f n e u t r o p h i l s

by Ph-1 a n t i g e n s may e x p l a i n t h e i r r a p i d and i n t e n s e acc umul a t i on in

pulmonary t i s s u e f o l l o w i n g e x p e r i m e n t a l c h a l l e n g e . An e f f e c t i v e

component v a c c i n e shou ld r e s u l t in n e u t r a l i z a t i o n o f c y t o t o x i c a c t i v i t y

and b lock a c t i v a t i o n o f n e u t r o p h i l s . The Ph-1 a n t i g e n ( s ) r e s p o n s i b l e

f o r n e t u r o p h i l a c t i v a t i o n needs t o be i d e n t i f i e d and e f f e c t i v e l y

b l oc ke d .

The c y t o t o x i n - n e u t r a l i z i n g monclonal a n t i bo dy (nMcAb) p r e p a r e d and

p a r t i a l l y c h a r a c t e r i z e d h e r e i n m e r i t s f u r t h e r s t u d y . A l t e r n a t i v e s t o

de m o n s t r a t e nMcAb b i nd i ng t o c y t o t o x i n shou ld be sought t o i d e n t i f y and

q u a n t i t a t e c y t o t o x i n in inoculums and c l i n i c a l s ampl es . Because nMcAb

b i nd i ng t o c y t o t o x i n was d e m o ns t r a b l e by immunoblo t t ing i t i s p r o b ab l e

t h a t t h e a n t i b o d y can be used t o p u r i f y c y t o t o x i n u s i n g i m mu n o a f f i n i t y .

The a b s o l u t e c o n t r i b u t i o n o f c y t o t o x i n t o t h e p a t h o g e n e s i s c ou l d then

be de t e r mi n e d and pure c y t o t o x i n coul d be used i n a component v a c c i n e .

S t r u c t u r a l changes in n e u t r o p h i l s exposed t o c y t o t o x i n a r e

i m p o r t a n t t o comprehend t h e p a t h o g e n e s i s in pneumonic p a s t e u r e l l o s i s .

Neu t r op h i l p o l a r i z a t i o n wi t h uropod f o r ma t io n i s s u g g e s t i v e o f

a c t i v a t i o n by a c h e m o t a c t i c f a c t o r . V i s u a l i z a t i o n o f s t r u c t u r a l

changes in n e u t r o p h i l s o f f e r s an a l t e r n a t i v e t o t he MTT c o l o r i m e t r i c

a s s a y as a means o f i d e n t i f y i n g t h e Ph-1 component ( s ) c a u s in g

a c t i v a t i o n . A c t i v a t i o n o f n e u t r o p h i l s shou l d be i n h i b i t e d by an

e f f e c t i v e v a c c i n e .

The l a r g e s c a l e p u r i f i c a t i o n o f Ph-1 a n t i g e n s i s n e c e s s a r y f o r

d e t e r m i n i n g t h e i r c o n t r i b u t i o n t o t h e p a t h o g e n e s i s and f o r t h e

c o n s t r u c t i o n o f a v a c c i n e . I mmunoaf f i n i t y p r o c e d u r e s deve l oped in t h i s

Page 136: Characterization and Application of Monoclonal Antibody

122

r e s e a r c h p r o v i d e s a means o f e p i t o p e p u r i f i c a t i o n . P u r i f i e d e p i t o p e s

can t h e n be s t u d i e d t o d e t e r mi n e t h e i r c o n t r i b u t i o n t o n e u t r o p h i l

a c t i v a t i o n and t h e p a t h o g e n e s i s i n v i v o . P u r i f i e d e p i t o p e s i d e n t i f i e d

as i m p o r t a n t i n t h e p a t h o g e n e s i s can t h e n be i n c l u d e d i n a component

v a c c i n e .

Thi s r e s e a r c h s u p p l i e s some m a t e r i a l s , methods and r e s u l t s f o r a

g r e a t e r u n d e r s t a n d i n g o f t h e p a t h o g e n e s i s i n pneumonic p a s t e u r e l l o s i s

and c o n s t r u c t i o n o f a component v a c c i n e . F u r t h e r r e s e a r c h i s n e c e s s a r y

u s i n g monoclonal a n t i b o d i e s and n e u t r o p h i l s t o more f u l l y u n d e r s t a n d

t h e p a t h o g e n e s i s in pneumonic p a s t e u r e l l o s i s and c o n s t r u c t an e f f e c t i v e

component v a c c i n e .

Page 137: Characterization and Application of Monoclonal Antibody

VITAE

Name; Frank Wi l l i am A u s t i n

P r e s e n t A d d r e s s : 3350 Tula S t . #3Baton Rouge, LA 70802

Permanent A d d r e s s : 5708 Ra i nc r eek ParkwayA u s t i n , Texas 78750 (512) 345-5577

S . S . # : 553-84-6079

Date and P l a c e o f B i r t h : 11-24-57 A u s t i n Texas

Ma r i t a l S t a t u s : S i n g l e

Secondary E d u c a t i o n : Memorial High Schoo l , T u l s a , OK

U n i v e r s i t y E d u c a t i o n :Oklahoma S t a t e U n i v e r s i t y 1975-79, M i c r o b i o l o g y , B.S.Oklahoma S t a t e U n i v e r s i t y 1979-83, V e t e r i n a r y Medi c i ne , D.V.M. Lo u i s i a n a S t a t e U n i v e r s i t y 1984-1988, V e t e r i n a r y M i c r o b i o l o g y ,

Ph.D. (Minor : V e t e r i n a r y P a t ho l ogy ) (August 1988)

P r o f e s s i o n a l Employment :Resea rch A s s i s t a n t , Dept , o f M i c r o b i o l o g y , Oklahoma S t a t e

U n i v e r s i t y , 1978-1979.P r a c t i c i n g V e t e r i n a r i a n , S t a t e Line Animal C l i n i c , Poco l a ,

Oklahoma, 1983-1984.Gradua te Research A s s i s t a n t , Dept , o f V e t e r i n a r y Mi c r ob i o l ogy

and P a r a s i t o l o g y , L o u i s i an a S t a t e U n i v e r s i t y , 1984-1988.

P r o f e s s i o n a l A f f i l i a t i o n s :Oklahoma V e t e r i n a r y Medical A s s o c i a t i o n American V e t e r i n a r y Medical A s s o c i a t i o n American A s s o c i a t i o n f o r Advancement o f Sc i ence American A s s o c i a t i o n o f V e t e r i n a r y Immunologi s t s

P r o f e s s i o n a l L i c e n s e s :Oklahoma Board o f V e t e r i n a r y Medical Examiners (L i ce ns e #2458)USDA A c c r e d i t a t i o n f o r S t a t e o f Oklahoma

P r o f e s s i o n a l P r e s e n t a t i o n s :A u s t i n , F.W. , C o r s t v e t , R . E . , S c h n o r r , K.L. In v i t r o s t u d i e s on t h e

n e u t r a l i z a t i o n o f c y t o t o x i n from P a s t e u r e l l a ha e mol y t i ca t y p e 1. Animal D i sease Resea r ch Workers in t h e Sou t he rn S t a t e s , Mar. 1985, At he ns , GA, p. 34.

Nob l es , D. , C o r s t v e t , R . E . , S c h n o r r , K . L . , Aus t i n F.W. P r od uc t i o n and s p e c i f i c i t y o f monoclonal a n t i b o d i e s t o P a s t e u r e l l a h a e m o l y t i c a . Animal Di s e a s e Resea r ch Workers in t h e Sou t he rn S t a t e s , Mar. 1985, At he ns , GA, p. 71.

123

Page 138: Characterization and Application of Monoclonal Antibody

124

A u s t i n , F.W., C o r s t v e t , R . E . , S c h n o r r , K . L . , Nobles , D. R e a c t i v i t y o f monoclonal a n t i b o d i e s p r e p a r e d a g a i n s t P a s t e u r e l l a h a emol y t i ca s e r o t y p e 1. Confe r ence o f Research Workers i n Animal D i s e a s e ,Nov. 1985, Chicago , 1 1 1 . , ( # 2 3 3 ) :43.

S ch n or r , K . L . , Todd, W . J . , C o r s t v e t , R . E . , A u s t i n , F.W. , Nob l es , D. I d e n t i f i c a t i o n and l o c a l i z a t i o n o f P a s t e u r e l l a h a e m o l y t i ca a n t i g e n s by monoclonal a n t i b o d i e s . The F i r s t I n t e r n a t i o n a l V e t e r i n a r y Immunology Symposium pg. 133.

A u s t i n , F.W. , C o r s t v e t , R . E . , S c h n o r r , K.L. C h a r a c t e r i z a t i o n o f a n e u t r a l i z i n g monoclonal a n t i b o d y p r e p a r e d a g a i n s t P a s t e u r e l l a ha e mol y t i ca s e r o t y p e 1 c y t o t o x i n . Animal Di s e a s e Research Workers in t h e Sou t he r n S t a t e s , Mar. 1986, G a i n e s v i l l e , FL. , ( # 1 4 ) : 6 .

A u s t i n , F.W., Lozano, F . , C o r s t v e t , R.E. A t empora l and dose a n a l y s i s o f s t r u c t u r a l changes in bov ine n e u t r o p h i l s exposed t o P a s t e u r e l l a h a e mo l y t i ca s e r o t y p e 1 c y t o t o x i n . Animal D i s ea s e Research Workers in t h e Sou t he r n S t a t e s , Mar . , 1987, Co l l ege S t a t i o n , TX, ( # 3 ) : 2 2 .

B u r g e r m e i s t e r , D . , C o r s t v e t , R . E . , A u s t i n , F . , Gaunt , S. E h r l i c h i a r i s t i c i i - P r o p a g a t i o n ; s e r o l o g i c s t u d i e s ; p roduc t i on" ! ) ? monoclonal a n t i b o d i e s . Animal D i s ea s e Research Workers i n t h e Sou t he r n S t a t e s , Mar. 1987, C o l l eg e S t a t i o n , TX, ( # 3 ) : 2 3 .

A u s t i n , F.W. , C o r s t v e t , R.E. I mmunoa f f i n i t y p u r i f i c a t i o n o f t heP a s t e u r e l l a h a e m o l y t i c a s e r o t y p e 1 s p e c i f i c a n t i g e n . Conference o f Research Workers i n Animal D i s e a s e , No. 1987, Ch i cago , 11 1 . , ( # 3 0 ) : 5 .

G o s s e t t , K.A. , A u s t i n , F.W. , C o r s t v e t , R . E . , e t . a l . B r o n c h o a l v e o l a r l a vage c y t o l o g y and hematology in c a l v e s f o l l o w i n g i n t r a b r o n c h i a l i n o c u l a t i o n wi t h P a s t e u r e l l a h a e m o l y t i ca s e r o t y p e 1 ( P h - 1 ) , dead Ph-1 wi t h c a p s u l e removed, s e m i - p u r i f i e d Ph-1 c y t o t o x i n , o r Ph-1 c a p s u l a r m a t e r i a l . Confe r ence o f Resea r ch Workers in Animal D i s e a s e , No. 1987, Ch i cago , 1 1 1 . , ( # 3 9 ) : 7 .

A u s t i n , F.W. , C o r s t v e t , R.E. E v a l u a t i o n o f bov ine n e u t r o p h i l r e s p o n s e t o P a s t e u r e l l a h a e m o l y t i ca s e r o t y p e 1 c y t o t o x i n . Confe r ence o f Research Workers in Animal D i s e a s e , Nov. 1987, Ch i cago , 111 . ,( # 4 0 ) : 7 .

Schmi dt , S . P . , C o r s t v e t , R . E . , A u s t i n , F.W. , e t a l . A s t u d y o f l e s i o n s and l e s i o n volumes ca us e d by i n t r a b r o n c h i a l i n o c u l a t i o n o f P a s t e u r e l l a h a e m o l y t i ca s e r o t y p e 1 component s . Animal Di s e a s e Research Workers in t h e Sou t he rn S t a t e s , Mar. 1988, Baton Rouge, LA, ( # 3 5 ) :9 .

P r o f e s s i o n a l M e e t i n g s :NC-107 Te c h n i c a l Commit tee on Bovine R e s p i r a t o r y D i s e a s e , Baton

Rouge, LA. , 1987.

Research G r a n t s :G o s s e t t , K.A. , A u s t i n , F.W. , B e a d l e , R . E . , F l o r y , W. Mechanisms o f

lung i n j u r y in t h e h o r s e : N e u t r op h i l p r o t e o l y t i c enzymes.Lo u i s i a n a S t a t e U n i v e r s i t y , School o f V e t e r i n a r y Med i c i ne , C o mp e t i t i v e I n d i v i d u a l G r a n t s , $ 3 , 9 6 0 . 0 0 funded .

Page 139: Characterization and Application of Monoclonal Antibody

125

Honors and Awards :Omega Tau Sigma Phi Zeta Sigma XiEx c e l l e n c e in r e s e a r c h in m i c r o b i o l o g y o f animal d i s e a s e s awarded a t Animal Di s e a s e Resea r ch Workers in Sou t he r n S t a t e s , Mar. 1986.

Research E x p e r i e n c e :I s o l a t i o n and i d e n t i f i c a t i o n o f b a c t e r i a f o r m i c r o b i a l enhanced

o i l r e c o v e r y .P ro d u c t i o n and c h a r a c t e r i z a t i o n o f P a s t e u r e l l a a n t i g e n s and

c y t o t o x i n . Development and a p p l i c a t i o n o f ELISA and b i o l o g i c a l a s s a y s f o r P a s t e u r e l l a a n t i g e n s . I n t e r a c t i o n o f P a s t e u r e l l a a n t i g e n s and c y t o t o x i n w i t h bov ine l e u k o c y t e s . Enzymat ic a n a l y s i s o f bov i ne n e u t r o p h i l s .

P r o d u c t i on and c h a r a c t e r i z a t i o n o f monoclonal a n t i b o d i e s .Monoclonal a n t i b o d y i mm u n o a f f in i t y p u r i f i c a t i o n s .

Animal models o f pulmonary d i s e a s e . B r o nc h o a l v e o l a r l avage t e c h n i q u e s and a n a l y s i s . Gross and h i s t o p a t h o l o g i c d i a g n o s i s .

Teaching E x p e r i e n c e :P r i v a t e t u t o r ; u n d e r g r a d u a t e m i c r o b i o l o g y and c h e m i s t r y . Mi n i -Cour s e V e t e r i n a r y I n t e r n s h i p Program a t LSU, summer 1984. Mi n i - Cour se V e t e r i n a r y I n t e r n s h i p Program a t LSU, summer 1985. Speaker f o r t h e Gr adua t e S t u d e n t s o f V e t e r i n a r y Mi c r ob i o l ogy and

P a r a s i t o l o g y , LSU, 1985-86.S t u d e n t Summer Resea r ch A p p r e n t i c e Program a t LSU, summer 1986. Gr adua t e A s s i s t a n t in S e n i o r V e t e r i n a r y S t u d e n t Necropsy

L a b o r a t o r y .S t u d e n t Summer Research A p p r e n t i c e Program a t LSU, summer 1987. Le c t u r e d t o s e n i o r v e t e r i n a r y s t u d e n t s i n C l i n i c a l V i r o l o g y , 1987. L e c t u r e s t o g r a d u a t e s t u d e n t s i n C e l l u l a r Immunology, 1987.

Community S e r v i c e :LeF l o re County 4-H Club Group Leader .Roland, Oklahoma High School C a r e e r Day.N o n - p r o f i t v a c c i n a t i o n c l i n i c t o b e n e f i t Pocola High School

marching band.N o n - p r o f i t v a c c i n a t i o n c l i n i c t o b e n e f i t L e f l o r e County 4-H Club.

P r o f e s s i o n a l I n t e r e s t :Hos t - Pa t hogen i n t e r a c t i o n s Monoclonal a n t i b o d y t e c h n o l o g y Novel d i a g n o s t i c t e c h n i q u e s Animal models o f pulmonary d i s e a s e Mechanisms o f b a c t e r i a l p a t h o g e n e s i s

Page 140: Characterization and Application of Monoclonal Antibody

DOCTORAL EXAMINATION AND DISSERTATION REPORT

Candidate: Frank W. Aus t i n

Major Field: V e t e r i n a r y Mi c r ob i o l ogy

Title of Dissertation: C h a r a c t e r i z a t i o n and A p p l i c a t i o n o f Monoclonal Ant ibody andBovine N e u t r op h i l R e a c t i v i t y t o P a s t e u r e l l a h a e m o l y t i ca A n t i g e n s .

Approved:

M a j o r P r o f e s s o r a n d C h a i r m a n

D e a n o f t h e G r a d u a t e S c | j 6 d l '

EXAM INING COMMITTEE:

/ Kc

Date of Examination: